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ABSTRACT 
 
There are many contradictory reports in the literature involving the culture of Spiroplasma 
mirum, its resistance to disinfectants and antibiotics, and its potential role in Transmissible 
Spongiform Encephalopathies (TSEs).  These contradictions led to an interest in a possible link 
between spiroplasma and TSEs and the development of a research plan to elucidate this 
connection.   It was hypothesized that Spiroplasma was associated with a neurodegenerative 
disease such as TSE.  In this work we further characterized S. mirum laboratory strains and 
continued to evaluate the possible correlations they have with TSE infections and the prion.  
 
To optimize recovery of S. mirum from experimental infections, we established reproducible 
culture conditions in M1D media, embryonated eggs, and SP4 plates.  Overall, results indicated 
that SP4 plates are the most accurate quantitative method for S. mirum.  However, plate counts 
should be accompanied by qualitative assessments of cultures in liquid M1D as well.   
 
A susceptibility profile for physical and environmental disinfectants and antibiotics for 
spiroplasma was also determined.  The three species of Spiroplasma tested were susceptible to 
minimal dilutions of common laboratory disinfectants.  They were also susceptible to many of 
the antibiotics in use for other mollicutes. Although Spiroplasma and prions, the presumed 
infectious agent of TSEs, may both persist in neurologic tissues for extended periods of time, the 
two do not share the same properties of resistance.   
 
Experimental neonatal goat infections with a S. mirum laboratory strain SMCA using three 
different inoculation routes did not result in pathology, clinical signs, or an immune response 
over a two year time period.  In addition, the organism was not detected via PCR or culture.  The 
same strain did cause minimal clinical signs in one animal when inoculated into five month old 
white-tailed deer and was recovered from the cortex of the clinically-affected deer after multiple 
passages in culture. Although the goat experiments did not result in TSE-like disease, an 
improved methodology for a spiroplasmosis animal model was developed, and further research 
should be conducted using similar methods in neonatal white-tailed deer. 
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CHAPTER 1:  INTRODUCTION/ REVIEW OF LITERATURE 
 
Introduction 
 
Mollicutes are the smallest known self-replicating organisms.  Classified by their genome size, 
sterol requirement, morphology, urea utilization, and other biochemical properties, they are 
divided into five genera: Acholeplasma, Anaeroplasma, Mycoplasma, Spiroplasma and 
Ureaplasma (Murray and Schleifer, 1994).  This group of organisms is believed to have resulted 
from degenerative evolution of Gram-positive bacteria (Davis et al., 1972; Woese et al., 1980).  
The members of the genus Spiroplasma were first recognized as helical, wall less bacteria in 
1972 (Davis et al., 1972).  Taxonomically, spiroplasmas are in the Domain Bacteria, Phylum 
Firmicutes, Class Mollicutes, Order Entomoplasmatales, Family Sprioplasmataceae, and Genus 
Spiroplasma.  They received their name from a description of their motility in 1973 (Davis et al., 
1972).  The first named spiroplasma was Spiroplasma citri, the causative agent of citrus stubborn 
disease, which was originally considered a virus (Saglio et al., 1973).  The Suckling Mouse 
Cataract Agent (SMCA), isolated from rabbit ticks, was originally considered a virus because it 
was filtered through such a small pore size (Clark, 1964).     Spiroplasmas have also been 
misidentified as spirochetes because of their similar appearance in dark field microscopy. The 
sex ratio organism, SRO, which causes a disease fatal to only males of certain Drosophila 
species, was originally considered a spirochete in 1961 but was later identified as a spiroplasma 
(Williamson et al., 1983).   
 
Spiroplasma were classified as Mollicutes (renamed from mycoplasma) because they form “fried 
egg colonies” on solid media, pass through 0.22µm pore filters, fail to revert to walled bacteria, 
are completely resistant to penicillin, and lack cell wall or murien cell wall precursors (Bove, 
1984a; Saglio et al., 1973).  When first defined, spiroplasmas were classified by G+C content, 
their ability to utilize glucose and arginine, their host/habitat, serological tests, metabolism 
inhibition, and spiroplasma deformation tests (Whitcomb, 1981).  As more isolates were 
characterized, serological cross reactions were helpful in establishing groupings; however, the 
results needed to be duplicated in the deformation and metabolism inhibition tests in order to 
fully establish a connection within a group (Whitcomb et al., 1983).  Williams, et al. suggested 
that as a last criterion, DNA-DNA homology should be used to determine an isolate’s grouping 
into a single species (Davis et al., 1979; Williamson and Tully, 1982; Williamson et al., 1998).  
In 2007 the requirements were made more stringent to prevent inaccurate classifications.  
Currently the major requirements for placement to order and family include: tests for sterol 
requirements, lack of cell wall as shown by transmission electron microscopy, ability to form 
colonies on solid media, quantification of the ability to pass a graded series of ultra filters, 
demonstration of the ability of the organism to grow at various temperatures with determination 
of an approximate optimal temperature, determination of the base composition of organismal 
DNA, and demonstration of antigenic relationships by using the spiroplasma deformation and 
metabolism inhibition tests (Whitcomb, 2007).  To date, Spiroplasmas have been classified into 
34 groups and 14 subgroups (Padovan et al., 2000 ; Pettersson et al., 1996; Williamson et al., 
1998). Thirty-six representative members of these groups or subgroups have been described as 
species.  
 
 2 
Spiroplasmas have a variety of hosts including plants and arthropods.  There are three pathogenic 
plant spiroplasmas: S. citri, S. kunkelii and S. phoeniceum, which are all found within group I.  
These plant pathogens are most commonly found within plant phloem and flower nectar.  
Spiroplasma melliferum, a honeybee pathogen not pathogenic to plants, is also a member of 
group I (subgroup 1-2) and is closely related to the three pathogenic plant spiroplasmas. The 
other four spiroplasmas in this group are either plant surface- or arthropod-associated organisms. 
Plant surface spiroplasmas are thought to be deposited by insects, which are the major hosts of 
members of groups II to XXXIV (Williamson et al., 1998).  Spiroplasmas residing in arthropods 
are transmitted to plant surfaces by defecation and/or regurgitation of fluids on plant surfaces or 
may be introduced into the phloem by plant-sucking insects (Gasparich, 2002).   
 
All members of the genus Spiroplasma are obligately associated with insects, either as 
commensals, pathogens or mutualists (Gasparich, 2002). Most insect spiroplasmas are found 
within the following orders: Hymenoptera (bees and wasps), Diptera (flies, horseflies, fruit flies, 
mosquitoes), Coleoptera (beetles), Lepidoptera (butterflies), Homoptera (leafhoppers), 
Hemiptera (green leaf bugs), or Odonta (dragonflies) (Tully and Whitcomb, 1991; Williamson et 
al., 1997). Spiroplasmas are most commonly found in the gut, less frequently in the hemolymph, 
and occasionally in salivary glands and other organs (Bove, 1997). In some insects, spiroplasmas 
that are ingested may be highly invasive and pathogenic or lethal to the host. In addition to S. 
melliferum, lethal infections in honeybees were also observed following exposure to S. apis 
(Tully and Whitcomb, 1991). S. poulsonii is associated with sex ratio abnormalities in the 
progeny of Drosophila spp. (Williamson et al., 1999), and S. floricola is associated with a 
lethargy disease of the scarabaeid beetle Melolontha melolontha (Seemuller et al., 2002).  
Spiroplasmas were also isolated from blood sucking insects such as mosquitoes and tabanid flies 
(Tully and Whitcomb, 1991; Williamson et al., 1998). 
 
Spiroplasmas have also been isolated from ticks and rabbit ticks have yielded two spiroplasmas: 
S. mirum (SMCA, GT48, and TP-2) and Spiroplasma sp. strain 277F (Tully et al., 1982b).  
SMCA causes cataracts and persistent neurological infections in a variety of small mammals 
when inoculated intracerebrally (Clark, 1964).  GT48 causes encephalitis when inoculated 
intracerebrally and cataracts in experimental intraperitoneal inoculated rat infections (Bastian et 
al., 1984; Tully et al., 1984).  Spiroplasma sp. strain 277F caused mortality within three days 
after intracerebral inoculation in suckling rats.  Similar experiments with diluted cultures did not 
produce any clinical or pathological changes.  Strain 277F was not recovered from any 
experimental animals (Stalheim et al., 1978).   Eight serologically related isolates were also 
isolated from an ixodes tick.  A representative strain Y32 was characterized and designated S. 
ixodetis (Tully et al., 1995).   
 
Recently a spiroplasma has been implicated as the causative agent of tremor disease (TD) that 
affects the central and surrounding nerve systems of the Chinese mitten crabs, Eriocheir sinensis 
(Wang et al., 2004). This disease has had disastrous effects on aquaculture in China (Wei, 1999).  
Based on morphological and pathological studies (Wang and Gu, 2002; Wang et al., 2002; 
Zhang et al., 2000), the TD agent (TDA) was previously thought to be a rickettsia-like organism. 
Analysis using universal primers for bacterial 16S rRNA gene sequences, however, showed that 
the agent was not a rickettsia but a spiroplasma, showing 98% 16S rRNA gene sequence 
similarity to S. mirum (Wang et al., 2003; Wang et al., 2004). Spiroplasma has also been isolated 
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from the American crayfish (Procambarus clarkii) and freshwater-cultured Pacific white shrimp 
(Litopenaeus vannamei) in provinces of China (Wang et al., 2005).  It was also associated with 
mortalities in Pacific white shrimp of South America (Nunan et al., 2005; Nunan et al., 2004).  
The report of a spiroplasma in a fresh water species has changed the understanding of this 
organisms host range (Regassa and Gasparich, 2006).   
 
Spiroplasma is a difficult organism to cultivate and isolate, adding to the classification 
difficulties. Initially media was made for cultivation of spiroplasma with ingredients similar to 
plant phloem (Saglio et al., 1973).  As more spiroplasmas were identified from different hosts, 
media began to reflect insect hemolymph (Tully et al., 1977).  Most medias now contain 10-20% 
fetal bovine serum, PPLO broth base and/or peptone and tryptone supplements, tissue culture 
medium such as CMRL-1066 or Schneider’s Drosophila media, carbohydrates, fresh yeast 
extract, and yeastolate (Whitcomb, 1981).   
 
The first formulation for Spiroplasma growth was similar to mycoplasma media with the 
addition of soribitol, fructose, sucrose and DNA (Whitcomb, 1981).  Researchers were able to 
characterize S. citri using mycoplasma media but ran into difficulties characterizing a similar 
spiroplasma, the corn stunt spiroplasma (Saglio et al., 1971; Saglio et al., 1973).   This led to the 
formation of more complex media.  M1 medium was designed to be a very rich media and with 
slight variations has supported all spiroplasmas to date.  The SP-4 medium used CMRL-1066 
tissue culture supplement and was hypothesized to be best for those Spiroplasma with possible 
vertebrate affinities (Whitcomb, 1981).  This formulation was used to cultivate SMCA (Tully et 
al., 1976).  Table 1.1 lists the ingredients found in the most common spiroplasma media.  
Mycoplasma medium was originally used for characterizing spiroplasma isolates.  As research 
developed, M1A use resulted in better growth for insect/flower isolates.  The addition of yeast 
extract was made for M1D media, which allowed for better growth for some spiroplasma isolates 
and SP4 was developed for the tick isolates.    
 
The literature has ample evidence that spiroplasma may be isolated from a variety of different 
hosts.  However, the isolation methods are tedious depending on the inoculum (Whitcomb, 
1981).  Isolating the corn stunt spiroplasma (CSS) required blind passage of sap-inoculated 
cultures in contrast to easy primary isolation from infected maize (Jones et al., 1977).  The 
formulation of media also proved to be a critical factor in primary isolation.  Jones demonstrated 
that components of M1A medium are factors that allow for primary isolation of CSS from insect 
hemolymph in contrast to attempts with SP-4 (Jones et al., 1977).  Similarly, the isolation of 
SMCA was more readily observed in SP-4 rather than M1A medium (Tully et al., 1981).  
Research showed that different formulations are best for isolation and maintenance (Chen and 
Davis, 1979; Chen and Granados, 1970).  SRO is easily maintained in M1A, but attempts at 
primary isolation in the same media were futile (Williamson and Poulson, 1979). 
 
The research presented throughout this work will focus on S. citri, S. mirum, and S. melliferum.  
Spiroplasma citri, a flower pathogen, was the first spiroplasma identified and fully characterized. 
Spiroplasma mirum, isolated from ticks, was shown to be pathogenic to vertebrates.  
Spiroplasma melliferum, an insect pathogen, is associated with pathology leading to death in 
honey bees and has also been shown to multiply in vertebrates (LeGoff and Humphery-Smith, 
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1991).  Table 1.2 summarizes the host and pathology seen with these three species (Williamson 
et al., 1998). 
 
 
Table 1.1 Spiroplasma media (yields 300 mLs)  
Ingredients Standard Mycoplasma Medium M1A M1D SP4 
Autoclave at 15psi for 30min 
Mycoplasma broth 
base 
4.5 g 2.1 g 1 g 
Bacto-Tryptone  1 g 3 g 
Bacto-Peptone  0.8 g 1.6 g 
Glucose  0.1 g  
Fructose  0.1 g  
Sucrose  1 g  
Sorbitol  7 g  
Distilled water 200 mL 70 mL 197 mL 
For solid media Add 1.6 g Difco Noble Agar to 
autoclavable portion 
Add 2.4 g to 6.8 g Difco Noble 
agar to autoclavable portion 
Sterile filter 
Schneiders Drosophilia 
medium 
 160 mL  
CMRL-1066 (10x 
w/glutamine, w/out 
NaHCO3) 
  15 mL 
Fetal Bovine Serum  50 mL 50 mL 
Horse Serum 60 mL   
Fresh yeast extract 
(25%) 
30 mL  10 mL 30 mL 
Phenol Red 0.5% (0.1 %) 6mL 1.2 mL 1.2 mL 
Potassium Penicillin 
(100,000 U/ml) 
1.5 mL 2.5 mL 3 mL 
Yeastolate 2%   30 mL 
Glucose (50% solution) 3 mL  3 mL 
L-arginine-HCl 42% 1.5 mL   
 
 
Table 1.2 Summary of differences seen in separate species of Spiroplasmas. 
Identification 
Date 
Organism Group Isolation method Media Pathology 
1973 S. citri I-1 Mycoplasma broth M1D Citrus stubborn disease 
1982 S. mirum V Embryonated eggs SP4 Cataracts in suckling mice, 
spongiform encephalopathy 
1985 S. melliferum I-2 M1D broth M1D Death in honey bees 
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Spiroplasma citri 
 
Host(s):  Spiroplasma citri, known for its economic impact on citrus plants as the causative agent 
of citrus stubborn disease, can infect a wide variety of woody and herbaceous hosts (Whitcomb, 
1980).  It is restricted to the phloem sieve tubes and is transmitted by phloem sap-feeding insects 
(Bove et al., 2003).  Spiroplasma citri is naturally transmitted by leafhoppers: Circulifer tenellus, 
Scaphytopius nitrides and S. acutus delongi in California (Oldfield, 1988); Neoaliturus 
haemactoceps (Bove et al., 1987) and C. tenellus (Klein et al., 1988) in the Mediterranean area.  
Other insects may acquire the spiroplasma but do not transmit it (Bove and Saillard, 1979; Rana 
et al., 1975).   Spiroplasma citri is dependent on insect vectors for transmission and therefore the 
distribution follows the patterns of the leafhoppers’ movements (Golino and Oldfield, 1990).    
 
Isolation:  Spiroplasma citri was isolated in 1971 from a Washington naval sweet orange tree 
afflicted with stubborn disease (Bove and Saillard, 1979).  Stubborn disease was described in 
1944, and the causative agent was assumed to be a virus until this observation (Bove, 1984b).   
 
Media:  Spiroplasma citri was originally isolated in a moderately simple mycoplasma medium 
(see Table 1.1) (Whitcomb, 1983). It is now most commonly cultivated in M1D medium.  It has 
a temperature range of 20
o
C - 37
o
C with 32
o
C being optimal and a  4.1 hour doubling time 
(Konai et al., 1996).   
 
Disease/Pathology:  In the leafhopper, S. citri adheres to receptors within the gut and are taken 
into the cytoplasm by endocytosis.   After migrating through the cell, it is released by exocytosis 
into the hemolymph, where it circulates and replicates.  Spiroplasma citri is then transported 
from the hemolymph to the saliva by passing through the basal lamina and adhering to receptors 
on the plasmalemma outer surface, after which the spiroplasma are endocytosed, passed through 
the cell, and exocytosed into the salivary ducts.  From the ducts, they are introduced into the 
phloem of plants with the saliva of feeding leafhoppers. The latency period in the insect is at 
least two weeks (Liu et al., 1983).    
 
Once in the plants, S. citri remains restricted to the phloem tissue where it spreads in the plant.  It 
causes severe symptoms, such as stunting, yellowing of leaves, and yield losses, in a variety of 
economically important crops: grapefruits, lemons, mandarins, and oranges (Calavan, 1980).  
The spiroplasma develops best in citrus under hot conditions (28
o
C - 32
o
C) and may not give rise 
to symptoms at lower temperatures (Bove, 1988).   These organisms are not transmitted via plant 
seeds and are not transovarially transmitted to next-generation leafhoppers.  Therefore, they 
cannot survive outside their hosts and are dependent upon transmission for survival and dispersal 
(Gasparich, 2002).   
 
Other information:  Spiroplasma citri utilizes three sugars: glucose and fructose, presumably 
from the sieve tubes of the plant, and trehalose from the insect hemolymph (Bove et al., 2003). 
At least two mechanisms are utilized for sugar uptake by S. citri: the 
phosphoenolpyruvate:phosphotransferase system (PTS) and the SBP-ABC transporter system 
(Bai and Hogenhout, 2002; Gaurivaud et al., 2000a).  This could be characteristic of multiple-
host bacteria that need to rapidly adapt from a host or host-compartment that uses one sugar to a 
host or host-compartment that uses a different sugar (Bove et al., 2003).  The identification of 
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these systems within the spiroplasma genome may serve to determine the different hosts that 
other isolates might inhabit.   
 
Spiroplasma melliferum 
 
Host(s):  Spiroplasma melliferum,  the first spiroplasma to be isolated from an insect, was 
originally isolated from honey bees in Maryland in 1976 (Whitcomb, 1980).  The organism has 
also been isolated from bumble bees, andrenids, anthophors, robber flies, and one butterfly 
species (Clark et al., 1985).   
 
Isolation:  In 1976, Clark isolated S. melliferum from diseased honey bees, Apis mellifera, in 
Maryland (Clark, 1978) in M1D.  
 
Media:  Spiroplasma melliferum growth is supported well in M1D medium.  It has a temperature 
range of 20 - 41
o
C with 37
o
C being its optimal temperature with a 1.5 hour doubling time (Konai 
et al., 1996).   
 
Disease/Pathology:  Spiroplasma melliferum is able to cross the gut barrier of the honey bee, 
replicates at high numbers within the hemolymph and eventually kills its host (Bove, 1997).  
Spiroplasma melliferum-infected bees frequently exhibit neurological signs (Clark, 1978).  It can 
be found on flower surfaces that are frequented by infected honey bees (Whitcomb, 1981) but 
only causes fatality in the bee.   
 
Spiroplasma melliferum also persists in suckling mice post-intracerebral inoculation.  
Spiroplasma was found within the brain at high titers at 70 days post-inoculation and had limited 
recovery 285 days post inoculation (LeGoff and Humphery-Smith, 1991).   
 
Spiroplasma mirum 
 
Host(s): Spiroplasma mirum was isolated from Haemaphysalis leporis-palustris, a rabbit tick 
(Clark, 1964).  Experimental inoculation of honey bees, mice, rats, and chicks all showed 
evidence of a persistent infection (Bastian et al., 1984; Clark, 1964; Clark, 1969; Clark, 1974; 
Kirchhoff et al., 1981; Tully et al., 1984) 
 
Isolation:  The Suckling Mouse Cataract Agent (SMCA) was originally isolated from a small 
pool of rabbit ticks removed from a rabbit found dead on the road in Georgia in 1962.  
Researchers were searching for rickettsiae in wild animals when they came across this organism.  
SMCA was lethal to embryonated eggs but was nonculturable on a variety of bacterial or 
mycoplasmal media.  Due to its resistance to penicillin and streptomycin and its filterability 
through a 220nm pore, it was assumed to be a virus (Clark, 1964).  In 1973 it was described to 
have mycoplasma-like characteristics when seen via electron microscopy (Zeigel and Clark, 
1974). 
 
Strain GT48 was also isolated from a pool of rabbit ticks collected in Georgia in 1962, hence its 
name Georgia Tick 48 (Kotani et al., 1986).  It was determined that GT48 was antigenically 
indistinguishable from SMCA.  This organism was also lethal to embryonated eggs, exhibited a 
 7 
similar host range in experimentally infected animals, and had similar morphology and 
physicochemical characteristics as SMCA (Tully et al., 1984; Zeigel and Clark, 1974).   
 
Media: SMCA and GT48 are usually cultured in SP4 medium; however, most laboratory strains 
adapt well to M1D also (Regassa and Gasparich, 2006).  Growth occurs from 25
o
C - 41
o
C with 
the optimal temperature being 37
o
C.  S. mirum does represent the more fastidious spiroplasmas 
and, even at its optimal temperature, has a doubling time of 8 hours (Konai et al., 1996). 
 
Due to its fastidious nature, attempts were made to cultivate S. mirum in a variety of mammalian, 
avian and tick cell cultures but were unsuccessful due to cytopathic effects and slow growth from 
the organism (Bastardo et al., 1974; Clark, 1964; Clark, 1974; Fabiyi et al., 1971; Yunker et al., 
1987).  Chick embryo chorioallantoic membrane and yolk sac fragment cultures failed to support 
growth (Clark, 1964).  Successful cultures were made in a number of mosquito cell lines, and the 
growth was equivalent to that seen in SP4 media with minimal cytopathic effects (Yunker et al., 
1987).  Spiroplasma mirum was also able to grow in Drosophila Dm-1 cells, creating a chronic 
infection when maintained at 25ºC but showed cytopathic effects at 30ºC (Steiner et al., 1982).  
SMCA was also found to permanently transform NIH 3T3 mouse embryo fibroblast cells.  
Transformed 3T3 cells exhibited loss of contact inhibition, aggregating into one foci on the 
monolayer (Bove, 1997; Kotani et al., 1986).  SMCA also transformed monkey kidney CV-1 
cells (Kotani et al., 1986).  Due to the formation of cataracts in suckling mice, Megraud et al. 
experimented with ocular tissues and were able to establish spiroplasma growth on rabbit lens 
cultures that were comparable to the growth seen in SP4 media (Megraud et al., 1983).     
 
Disease/Pathology: Spiroplasma mirum is the only species found to be pathogenic to vertebrates 
(Bove, 1997).  As the name describes, SMCA, when inoculated intracerebrally, caused suckling 
mice to develop cataracts (Clark, 1964).  The organism was able to persist in suckling mice, 
specifically the brain tissues, for up to two years (Clark and Karson, 1968).  Due to this 
observation, it was tentatively included in the slow viruses or chronic infectious neuropathic 
agents (Hotchin, 1967).  When inoculated into suckling rats, 70% developed cataracts and 36% 
developed mild to severe hydrocephalus (Elizan et al., 1972).  The organism causes death 
between four and seven days post inoculation in seven day old embryonated eggs (Clark, 1964).  
In one day old chicks inoculated intracerebrally or subcutaneously, the organism caused death 
within five days (Clark, 1974).  When inoculated intracerebrally into day old hamsters, CNS 
signs and severe weight loss were observed (Kirchhoff et al., 1981).  Death and severe 
microphthalmia were seen in rabbits inoculated intracerebrally less than twenty-four hours after 
birth.  No clinical signs were seen when S. mirum was inoculated in adult mice, roosters, 
hamsters, rabbits, guinea pigs, or rhesus monkeys (Clark, 1974).   
 
Strain GT48 induces fatal encephalitis when inoculated intracerebrally into newborn mice and 
rats (Clark, 1964).  Suckling mice did not develop cataracts after inoculation with GT48 at even 
low doses (Clark and Karson, 1968).  Suckling rats developed cataracts as well as severe weight 
loss after intraperitoneal or subcutaneous inoculation with GT48 (Bastian et al., 1987b).  Strain 
GT48 also causes death in seven day old embryonated eggs, although the deaths are more 
sporadic and over a greater range of days (Clark, 1964).  Table 1.3 summarizes clinical findings 
found post S. mirum inoculation. 
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Transmission:  Spiroplasma mirum has only been isolated naturally from the rabbit tick.  The 
true pathogenicity has been questioned since the organism has only experimentally induced 
disease either by inoculation into the yolk sac of seven day old chick embryos; intracerebral 
injection into newborn rats, mice or hamsters; or by inoculation into the scarified cornea of adult 
rabbits (Bove, 1997).  The fastidious nature of the organism makes primary isolation challenging 
and leaves researchers questioning other possible hosts.   
 
Other information: Its persistence for long periods of time within the brains of experimentally 
inoculated animals led researchers to presume that SMCA should be categorized as “slow virus.”  
This family included the infectious agent for scrapie in sheep and the agent of Kuru in man 
(Schwartz and Elizan, 1972).   Tully suggested that this organism may be related to the causative 
agent of scrapie which had not yet been identified (Tully et al., 1976).  In 1979 Bastian reported 
spiral membranous inclusions seen by electron microscopy in brain biopsy tissues from a patient 
with Creutzfeldt-Jakob disease (CJD)(Bastian, 1979).  Following this initial finding of 
spiroplasma in CJD tissues, Reyes and Hoenig (Reyes and Hoenig, 1981) published two case 
reports of patients that were suspected of CJD to have similar inclusions. Electron microscopy 
revealed numerous membrane-bound vacuoles within the cell bodies of neurons and astrocytes.  
Elongated, spiral, membranous inclusions were occasionally present within cortical cell 
processes, as well as in synaptic terminals.  Reyes also reported successful transmission of CJD 
to spider monkeys from portions of brain tissues from one of these reported patients.  In 1980 
Gray reported a case of CJD to have spiral membranous inclusions, indicative of spiroplasma, 
with five to eight twists seen via electron microscopy (Gray et al., 1980).  In 1981 Bastian 
reported two more cases of CJD with similar spiral-like inclusions seen through electron 
microscopy (Bastian et al., 1981).    
 
After these case findings, more research was committed to spiroplasma in association with CJD 
cases.  Since morphological evidence was all that suggested an association between spiroplasma 
and CJD, other techniques, namely cultivation of the spiroplasma and serological tests, were 
used to identify spiroplasmas from confirmed cases of CJD.  These techniques failed to detect 
the organism.  No spiroplasma or other mollicutes were cultivated in SP4 medium from brain 
tissue in eighteen cases, and no antibodies to several recognized Spiroplasma spp., including S. 
mirum, were detected in sera from fifteen patients by immunofluorescence and metabolism 
inhibition tests.(Leach et al., 1983) 
 
In 1988 Humphery-Smith and Chastel proposed that the spiral-like inclusions seen in Gray and 
Reyes’ cases were actually crystalline artifacts (Humphery-Smith and Chastel, 1988).  Connolly 
reported a number of unidentifiable structures in a CJD case via electron microscopy including  
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Table 1.3 Summary of Spiroplasma mirum experimentally infected animals  
Species Age Route Death Disease Persistence of 
organism 
Ref 
Chicks <24 h IC 4 days pi Yellow livers and 
swollen spleens 
NT (Clark, 1974) 
<24 h SQ 5-6 days pi NT (Clark, 1974) 
Mice <96 h IC Rarely Cataracts 
1
 
Stunting 
Death 
827 days (Clark and Karson, 1968) 
>5 days IC No None 133 days (Clark and Karson, 1968) 
<96 h IP No None 9 days
2
 (Clark and Karson, 1968) 
<96 h IV No None NT (Clark and Karson, 1968) 
Adult IC 
 
IV, IN, IP, cornea 
No None 497 days 
 
NT 
(Clark and Karson, 1968) 
Rats <96 h IC Yes Cataracts 
3
 60 days (Clark, 1974) 
 <24 h SQ/IP
4
 No Cataracts 
Weight loss 
Alopecia 
50 days (Bastian et al., 1984) 
(Bastian et al., 1987b) 
Deer Mouse Adult SQ No None NT (Clark and Karson, 1968) 
Roosters Adult IM No None NT (Clark, 1974) 
Hamsters <24 h IC Variable CNS signs 
Dramatic loss of weight 
Runting 
NT (Kirchhoff et al., 1981) 
Adult IV No None NT (Clark, 1974) 
Rabbits <24 h IC 12 days Death 
Severe microphthalmia 
12 days (Kirchhoff et al., 1981) 
Adult IV, SQ No None NT (Kirchhoff et al., 1981) 
Scarified cornea No Ocular lesion AB negative (Clark, 1974) 
Guinea Pigs Adult IP, IM, SQ, cornea No None NT (Clark, 1974) 
Box Turtle Adult IP No None NT (Clark and Karson, 1968) 
Opossum Adult IP No None  NT (Clark and Karson, 1968) 
Rhesus Monkey Adult IV, SQ, cornea No None NT (Clark, 1974) 
IC: Intracereberal, SQ: Subcutaneous, IP: Intraperitoneal, IV: Intravenous, IN: Intranasal, IM: Intramuscular, NT: Not tested 
1 Cataracts were the most common clinical manifestation of SMCA inoculation 
2 Organism was not recovered from brain or eye tissues but was found in liver-spleen suspension  
3 Cataracts in suckling rats were more severe with a higher inoculation levels  
4 Rats were inoculated with GT48
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one which was tightly coiled, intranuclear, and which measured 570nm in length by 45 
nm in width, but specified that no spiroplasma-like shapes were seen (Connolly et al., 
1988). 
 
Further research was conducted to show similarities between the transmissible agent of 
CJD and spiroplasma.  Bastian reported that the tissue response to experimental 
spiroplasma infection in the suckling rat brain resembles the spongiform degenerative 
brain diseases of both man and other mammals.  The degenerative changes are localized 
to the gray matter, as seen in CJD cases (Bastian and Jennings, 1984).  The optimal 
growth temperature for S. mirum and other spiroplasma isolates was 37
o
C, suggesting 
that spiroplasmas could be found in a mammalian host (Bastian and Jennings, 1984; 
Konai et al., 1996).  The organism’s proven ability to produce an acute or persistent brain 
infection in small mammals was also used as evidence.  Subsequent studies have shown 
some resistance of spiroplasma organisms to chemical factors with some resemblance to 
the resistance exhibited by the transmissible agent of CJD (Bastian and Fermin, 2005).  
Bastian concluded that the size and membranous nature of spiroplasma organisms would 
best fit with the data regarding the elusive CJD agent (Bastian et al., 1984).   
 
In 1987 a scrapie-associated fibril was identified as a consistent finding and possible 
infectious unit of the transmissible spongiform encephalopathies.  Cross reactions with 
this fibril to S. mirum fibril proteins supported evidence of an association between 
spiroplasma and TSEs (Bastian et al., 1987a). In 2001 Bastian and Foster (Bastian and 
Foster, 2001) reported the presence of spiroplasma ribosomal DNA in CJD and scrapie-
infected brains.  In 2004 eight of ten scrapie infected brains, five of seven CWD infected 
brains, and two of two CJD brains were found to be positive for S. mirum via southern 
blotting of PCR products (Bastian et al., 2004).    PCR products obtained from the 
scrapie, CWD, and CJD cases had 99% homology with published S. mirum 16S rDNA 
sequences (Bastian et al., 2004).  In this study, it was reported that the mode of DNA 
extraction was critical.  The most reliable method involved initial solubilization with 
guanidine thiocyanate followed by phenol/chloroform extraction (Bastian et al., 2004).  
Southern blotting was also acknowledged as the more sensitive method of detection, 
allowing detection of spiroplasma DNA where PCR product was not readily apparent 
(Bastian et al., 2004).  This study is in contrast to the 2006 study of experimentally-
infected scrapie hamsters that found no evidence of bacterial 16S rRNA (Alexeeva et al., 
2006).  It should be noted that Bastian’s tissues were all from naturally infected animals, 
and those in Alexeeva’s study were experimentally infected. 
 
In 2005 Bastian et al. (Bastian et al., 2005) isolated a spiroplasma from homogenates of 
CWD and scrapie infected brains. The brains were homogenized in SP4 media and then 
inoculated into eight day old embryonated eggs.  Allantoic fluids from the inoculated 
eggs were then passaged into SP4 media and incubated for sixteen days at 37ºC.  
Evidence of spiroplasma growth was found via phase microscopy, electron microscopy, 
and PCR.  DNA sequence analysis showed 98% homology with S. mirum but revealed 
nucleotide substitutions unlike any known spiroplasma strain.   The isolates from this 
experiment were later inoculated into neonatal goats and sheep (Bastian et al., 2007).  No 
clinical signs were seen, but all brains had evidence of spongiform changes.  At eleven 
months post inoculation, one goat and one sheep had severe cerebella and hippocampal 
spongiform degeneration with neuronal vacuolization in the brain stem.  All other 
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animals were reported to have spongiform changes to a lesser degree.  It was noted that 
the intraneuronal vacuoles in the cerebellar cortex and brain stem seen in the Spiroplasma 
spp. inoculated ruminants were identical to lesions typical of naturally occurring TSE 
(Bastian et al., 2007).   
 
In 2007 Bastian et al. induced spongiform encephalopathy in neonatal deer inoculated 
intracerebrally with SMCA.  Three of four deer developed clinical signs of neurological 
deterioration between 1.5 months and 5.5 months post inoculation.  One deer brain 
showed signs of hydrocephalus, while all others were grossly normal.  Histological 
sections of all deer showed spongiform encephalopathy in the cerebral cortex, cerebellar 
cortex, and the brain stem.  Severity of neuropathology was noted as incubation time 
increased.  In the same publication, sheep were inoculated intracerebrally with varying 
dilutions of SMCA.  No clinical signs were noted, but spongiform encephalopathy was 
seen histologically.  Severity of lesions was decreased as the dosage of the inoculum 
decreased.    Neonatal goats were also inoculated intracerebrally with SMCA.  After five 
months no clinical signs were seen and only minimal vacuolization was noted 
histologically (Bastian et al., 2007).   
 
In another study, S. mirum failed to induce spongiform encephalopathy when 
experimentally inoculated into 5.5 month old raccoons.  Raccoons are used as an 
experimental model for transmissible mink encephalopathy (TME).  In this study, one 
group of raccoons was inoculated intracerebrally with low doses of SMCA and another 
group was inoculated intracerebrally with high doses of GT48.  The strains of S. mirum 
used in this study were adapted to growth at 31ºC with minimal passages in artificial 
media.  None of the raccoons had any clinical signs and no significant histological 
changes could be found >900 days later (Hamir et al., 2011).   
 
Most recently, a spiroplasma isolate has been recovered from ocular fluid taken 
aseptically from scrapie-infected sheep.  Minced corneal tissues were inoculated into 
M1D, and spiroplasma organisms were evident via dark field microscopy.  These 
organisms did not propagate and the culture was lost after several passages (Bastian et al., 
2011). This has recently been repeated and efforts are ongoing to passage the spiroplasma 
to a substantial culture (data not published).    
 
Transmissible Spongiform Encephalopathies 
 
Transmissible Spongiform Encephalopathies (TSEs) encompass a condition that affects 
humans and a variety of animals with a fatal neurodegenerative disease and associated 
neurological clinical signs.  The disease presents with morphological and 
pathophysiological features that parallel other progressive encephalopathies such as 
Alzheimer’s and Parkinson’s diseases (Aguzzi and Haase, 2003).  Research currently 
supports evidence that the agent responsible for TSE is a prion, a small proteinaceous 
infectious particle (Prusiner, 1982).  The prion is a cell surface glycoprotein (Stahl et al., 
1987) with an unknown function.  The pathogenesis for the prion is still widely unknown; 
however it is accepted that the normal prion PrP
C
  undergoes some sort of 
posttranslational modification that converts it to a pathogenic prion PrP
SC
.  PrP
SC
 is an 
insoluble and partially protease-resistant isoform that propagates itself by imposing its 
abnormal conformation onto other PrP
C
 molecules (Aguzzi and Calella, 2009).  The 
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human prion diseases include Kuru, CJD, variant CJD, Gerstmann-Straussler-Scheinker 
(GSS) disease, and fatal familial insomnia (FFI).  The most common animal TSEs are 
scrapie, which affects sheep and goats; bovine spongiform encephalopathy (BSE); and 
chronic wasting disease (CWD), which affects deer and elk.  
  
Scrapie, the TSE disease of sheep and goats, was characterized as early as 1738 (Parry, 
1983).  The etiology of the disease can be traced back to a vaccination of sheep for 
louping-ill virus with formalin-treated extracts of ovine lymphoid tissues that were 
unknowingly contaminated with scrapie prions (Gordon, 1946).  In 1998 atypical scrapie 
was described in a herd of Norway sheep.  Following this disease characterization, a 
more active surveillance program was instituted in European countries and far more cases 
of atypical scrapie were reported (A Buschmann, 2004; SJ Everest, 2006).  Scrapie and 
atypical scrapie can be easily transmitted through flocks, but the mechanism for disease 
spread is still not understood (Aguzzi and Calella, 2009). 
 
In 1986 an epidemic of BSE or “mad cow” disease occurred in Great Britain (Westaway 
et al., 1987).  The source of this disease spread was traced back to the meat and bone 
meal nutritional supplements used in cattle feed (Wilesmith et al., 1992).  The BSE 
epidemic reached its peak in 1992 with over 35,000 cattle affected.  Cases of BSE are 
now rarely reported.  Brain extracts of BSE cattle have transmitted disease to mice, cattle, 
sheep, pigs, and non human primate marmoset after intracerebral inoculation (Baker et 
al., 1993; Bruce, 1993; Dawson et al., 1990a; Dawson et al., 1990b; Fraser et al., 1988). 
 
Chronic wasting disease (CWD), the TSE affecting deer and elk, was initially reported in 
a captive research herd of deer in Colorado (Williams and Young, 1980).  Cases of CWD 
have since been detected in free-ranging mule deer (Odoncoileus hemionus), white-tailed 
deer (O. virginanus), and Rocky Mountain elk (Cervus elaphus nelsoni) in areas close to 
Colorado (Nebraska, New Mexico, and Utah) but also in distant states (Wisconsin, 
Illinois, Canada) (Aguzzi and Calella, 2009).  Research indicates that CWD is easily 
transmitted among cervids through grazing in areas contaminated with prion-infected 
secretions, excretions, tissues or decomposed carcasses (Miller and Williams, 2003; 
Miller et al., 2004).  
 
The human prion diseases have been classified as infectious, inherited, or sporadic, 
depending on the clinical, genetic, and neuropathological findings.  The clinical signs 
include progressive dementia, myoclonus, visual or cerebellar impairment, 
pyramidal/extrapyramidal signs, and akinetic mutism.  With the exception of one case, all 
reported CJD cases have been in people over 40 (Packer et al., 1980).  The first 
documented case of iatrogenic prion transmission occurred in 1974 from a corneal 
transplantation from a CJD patient (Duffy et al., 1974).  Iatrogenic transmission has also 
been reported after neurosurgery with contaminated instruments (Bernoulli et al., 1977; 
Davanipour et al., 1984; Masters and Richardson, 1978), human growth hormone (Brown 
et al., 1985; Buchanan et al., 1991; Fradkin et al., 1991), and human pituitary 
gonadotropin (Healy and Evans, 1993). Familial TSEs were characterized after discovery 
of an autosomal dominant PRNP gene alteration, the gene encoding cellular PrP.  The 
three familial TSEs can be described clinically as fCJD: rapid progressive dementia with 
myoclonus and pseudoperiodic discharges of electroencephalogram; GSS: slow 
progression of ataxia followed by later onset dementia; FFI: refractory insomnia, 
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hallucinations, dysautonomia, and motor signs.  Sporadic CJD (sCJD) accounts for 85% 
of all human prion diseases (Aguzzi and Calella, 2009).  With sCJD there is no 
association with mutant PRNP allele or any epidemiological evidence for TSE agent 
exposure.  New variant CJD (vCJD) was first described in 1996 and has been linked to 
BSE (Will and Zeidler, 1996).  New variant CJD is clinically characterized by psychiatric 
abnormalities, sensory symptoms, and ataxia (Aguzzi and Calella, 2009).  It is 
distinguished by the abnormal age of onset (19y -39y) as opposed to sCJD (55y-70y) and 
its shorter duration of illness.    
 
Shortcomings to the Prion Theory 
 
Opponents of the prion theory have argued that a protein alone cannot account for the 
pathology caused in TSE diseases.  Studies have shown that neuropathology and clinical 
signs can be transmitted without the presence of the pathologic prion (Manuelidis and 
Fritch, 1996; Sklaviadis et al., 1989).  Manuelidis (Manuelidis and Fritch 1996)  
experimentally infected thirty mice with BSE-infected cattle brain homogenates.  All of 
the mice exhibited clinical signs, but 55% of the mice had no detectable abnormal prion 
PrP
res
 accumulation.  Brain homogenates from PrP
res
 negative mice were inoculated into a 
new set of mice which resulted in a mixture of PrP
res
 negative and positive mice.  After 
the third passage of PrP
res
 negative brain homogenates, all mice were PrP
res
 positive. In 
another prion study (Race et al., 2001), there was a one year period post-scrapie infection 
where there was no evidence of replication of PrP
res
 titers in mouse brains.  Following 
this period of inactivity a period of active replication of infectivity as well as adaptation 
of new strains of agent capable of causing disease in mice was seen.  In most mice, 
neither the early phase nor the later replicative phase could be detected by immunoblot 
assay for protease-resistant prion protein.    The transmission of TSE without detectable 
PrP
res
 accumulation supports the theory that in addition to the abnormal prion an 
infectious agent is likely.   
 
With the development of a new cyclic amplification method for prions, the protein-
misfolding cyclic amplification (PMCA), more information has been learned about prions 
in general.  The PMCA is a method in which a subthreshold amount of any abnormal 
strain of prion PrP
TSE
 can, by repeated incubation and sonication in the presence of a 
normal tissue homogenate, be increased to detectable levels (Castilla et al., 2005; Saa et 
al., 2006a; Saa et al., 2006b).  The sensitivity of the PMCA has contributed information 
about the possible presence of misfolded protein species in normal brains.  Experimental 
studies on brain tissue from normal rodents (hamster, mice, and bank voles) subjected to 
many rounds of PMCA cycling have yielded detectable amounts of PrP
TSE
 and 
infectivity.  It has been suggested that misfolded PrP molecules are regularly produced in 
normal brain tissue and require only one or more as yet unidentified triggers to unleash 
the cascade of molecular events that terminate in symptomatic disease (Brown, 2008).   
 
Manuelidis et al. suggests a virus is associated with the infectious agent of TSE 
(Manuelidis, 1997).  In one experiment, an attenuated strain of CJD was inoculated into 
mice and provided interference in PrP
res
 prion development and subsequent development 
of clinical signs.  Manuelidis also suggested that some populations could harbor an 
attenuated CJD agent that makes them less susceptible to low-challenge doses of more 
virulent CJD agents, citing the new variant CJD outbreak from BSE infected meat that 
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only affected a few, although millions were exposed (Manuelidis, 1997).  Researchers 
have also reported that the inactivation, behavior and size of the scrapie agent are very 
similar when compared to viral controls (Rowher, 1984).  Studies of the scrapie agent’s 
sedimentation behavior (Prusiner, 1978; Prusiner et al., 1980), exclusion size in 
permeation chromatography (Diringer and Kimberlin, 1983; Kimberlin et al., 1971), and 
buoyant density also suggest a virus (Diringer and Kimberlin, 1983; Kimberlin et al., 
1971).  These studies are in contrast to previous research that showed the transmissible 
agent to be more resistant to heat and fixatives than most viruses (Alper et al., 1966; 
Burger and Gorham, 1977).    
 
There is evidence that a normal prion isoform on the cell surface may be used as a 
receptor for a bacterium (Watarai et al., 2003).  This study suggests that the abnormally 
folded prion is a product of the infection rather than the cause.  The study was based on 
the concept that intracellular bacteria use lipid rafts preferentially to enter the cell (Manes 
et al., 2003).  Entering the cell in this method, the bacteria are able to avoid degradation 
pathways and lysosomes and both the adaptive and innate immune response (Manes et 
al., 2003).   
 
Further characterization of the pathogenic prion led to the discovery that this protein is 
resistant to the potent protease potential of proteinase K (McKinley et al., 1983).  
Resistance to proteinase K is one of the distinguishing characteristics of the prion.  In 
1987 Bastian et al. (Bastian et al., 1987a) showed that S. mirum also contained proteinase 
K resistant proteins of 28, 30, 66, and 76 kDa.  It was also suggested there is an 
immunological cross-reactivity and morphological similarities to the scrapie prion. In 
1991 evidence Butler (Butler et al., 1991) reported that many of the mollicutes contained 
proteins that were also proteinase K resistant.   
 
Other spiroplasmas are also implicated in neurological disease.  Leafhoppers infected 
with S. citri (Western-X disease) develop notable lesions in the optic lobes and salivary 
glands (Nasu et al., 1970; Whitcomb et al., 1967).  Simultaneous involvement of the optic 
lobes and salivary glands in Western-X is similar to the occurrence of either Sjorgren’s 
syndrome or mucosal inflammation with ocular manifestations in multiple sclerosis (MS) 
(Coyle and Bulbank, 1989; Sandberg-Wollheim et al., 1992).  Brown suggested that 
infection of both plant phloem and insect axons indicates a predilection of the organism 
for components of electrochemical conduction (Brown, 2003).  There are also clinical 
correlations with bee and wasp stings and the subsequent development of MS (Dionne et 
al., 2000).  These reports attribute the disease to bee venom; but bees and wasps are 
known carriers of spiroplasmas, and Brown suggests that the inoculation of humans with 
S. citri by bee or wasp stings could be the mechanism causing MS (Brown, 2003).  
Humphery-Smith et al. (Humphery-Smith et al., 1992) suggested that S. melliferum is a 
potential model for studying central nervous system degenerative disorders because of its 
ability to multiply and survive for up to nine months in intracerebrally inoculated mice.  
It was also found that this spiroplasma causes pathology in neuronal mitochondria in 
vitro and in vivo.  In 1992 a spiroplasma isolated from a tabanid also had the capability of 
multiplication and survival in the suckling mouse brain (Humphery-Smith et al., 1992).   
 
There is also clinical evidence that scrapie can be transmitted via hay mites in sheep.  In 
one experiment, mites from a known infected farm were collected, pooled and 
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homogenized, and inoculated into mice.  Prion disease developed 626 days later.  In 
subsequent passages the incubation time was reduced, and the author concluded that 
mites could be a vector for the disease (Carp et al., 2000). Although mites are not one of 
the major hosts for spiroplasma, Jaenike (Jaenike et al., 2007) showed that mites could 
support different Spiroplasma spp. and therefore could act as a vector for transmission of 
Spiroplasma spp. from host to host.   
 
Discrepancies Seen in Spiroplasma mirum/TSE Publications 
 
There have been many contradictory reports in the literature involving the culturing of S. 
mirum, its resistance to disinfectants and antibiotics, and its role in TSE.  This section 
will be used to highlight those areas of interest.  The contradictions will be the focus of 
the research to follow.   
 
In 1979 Bastian was the first to publish a spiral-like inclusion in CJD brains seen via 
electron microscopy (Bastian, 1979).  Gray and Reyes’ also reported similar findings and 
published pictures (Figure 1.1 A) of the spiral inclusion (Gray et al., 1980; Reyes and 
Hoenig, 1981).  In 1988, Humphery-Smith reported that the inclusions seen in the Gray 
and Reyes’ publication had very similar morphology to crystalline artifacts (Figure 1.1 B 
and C)(Humphery-Smith and Chastel, 1988).  In 1984 Bastian reported visualization of 
the spiroplasma within vacuolated cells of GT48-inoculated brains.  The morphology of 
these organisms was drastically different from those identified in his CJD patients.  These 
findings were of filaments or crescent shapes, both which were also seen in a pelleted 
sample of GT48 for comparison (Bastian et al., 1984).   
 
Leach (Leach et al., 1983) followed up on the association of CJD and spiroplasma, based 
solely on morphologic appearance via electron microscopy, with an attempt to isolate 
spiroplasma from eighteen CJD patients.  The brain tissues were homogenized in SP4 and 
diluted.  The dilutions were plated on SP4 plates, and the remaining cultures were 
allowed to incubate for two weeks.  Sera were also tested for spiroplasma by indirect 
immunofluorescence and metabolism inhibition tests.   
 
 
Figure 1.1 Spiroplasma-like inclusions 
A) Spiroplasma-like inclusion seen in CJD brains by Gray B) Crystalline artifacts labele 
and C) an example of Spiroplasma labeled all seen via electron microscopy. 
  
 
The experimental design was possibly flawed in Leach’s experiments, in that incubation 
was for two weeks only; and a culture was diluted, that if positive most likely had very 
few organisms originally.   The cultures were not reported to be passaged, and no other 
A 
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culture tissues (embryonated eggs) were used.  Furthermore, no antibodies are found 
circulating in experimentally infected animals (Clark, 1964), so the lack of inhibition 
from the serum tested is not indicative of a non-infection.  This is not to argue that 
spiroplasma could be found in these CJD patients but to show the drawbacks in 
experiments that question the S. mirum/TSE correlation.   
 
In a 1984 publication, Bastian (Bastian et al., 1984) experimentally inoculated suckling 
rats intracerebrally with GT48. He reported that at day 15, organisms were at a titer of 
10
7
 to 10
9
; but those animals necropsied at day 60 had considerably lower titers.  The 
brains examined histologically at day 14 revealed microcystic encephalitis.  The neuropil 
was studded with vacuoles and showed a prominent inflammatory infiltrate of 
polymorphonuclear leukocytes and mononuclear cells.  Histological examination of brain 
tissues obtained from rats at 25 days revealed minimal pathologic alteration.  Bastian also 
reported that organisms were readily identified via electron microscopy for rats sacrificed 
at day 14 but not for rats sacrificed at day 25.  In the 2005 publication, Bastian cited the 
previous 1984 study as stating that infection with GT48 spiroplasma produces 
perineuronal vacuoles, lack of inflammation and scattered microglia (Bastian and Fermin, 
2005).  The 1984 publication only found pathology with prominent inflammatory 
infiltrates at day 14 and reported a lack of pathology by day 25 (Bastian et al., 1984).  
Bastian also referenced this experiment again in the same publication stating in the rat 
there is extensive spongiform degeneration without inflammatory response when in 1984 
he reported prominent inflammatory infiltrates of white blood cells and pathology was 
resolved by day 25 (Bastian and Fermin, 2005).   
 
In 1984 another publication from Tully, Bastian and Rose reported on experimental 
spiroplasma infections in rats (Tully et al., 1984).  In this study, three different rat species 
were inoculated intracerebrally with low or high doses of GT48.  Histological sections 
were not reported, only the persistence of the organism over 60 days for the three 
different species.  Responses were not uniform and the authors reported that some rats 
receiving moderate to high levels of GT48 did not harbor viable organisms even in early 
periods after challenge.  They went on to suggest caution in assuming that S. mirum 
strains always induce a consistent brain infection in the rat model (Tully et al., 1984).   
 
In the 2005 publication listed above, Bastian also reports that Spiroplasma can resist 
exposure to temperatures near boiling, as well as glutaraldehyde and other fixatives 
(Bastian and Fermin, 2005).  In 1964, Clark reported that SMCA was ether- and sodium 
desoxycholate- sensitive and was efficiently inactivated by 0.5% phenol, 0.2% formalin, 
and 0.05% B-propiolactone (Clark, 1964).  Clark also found that SMCA was completely 
inactivated following 30 minutes of heating at 56
o
C (Clark, 1964).   
 
Although Bastian et al. was able to produce clinical and neuropathological signs with 
SMCA-inoculated neonatal deer similar to those of CWD in his 2007 publication 
(Bastian et al., 2007), attempts to reproduce this in other species has not been successful 
(Hamir et al., 2011).  Furthermore, evidence of recovery of the organism by culture, 
antibodies, or PCR was not reported and allows further questions regarding spiroplasma 
and its role in neurodegenerative diseases.   
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The discrepancies listed above led to the interest in the association of spiroplasma and 
TSEs and the development of the research proposed in this dissertation. Based on the 
results reported by Bastian et al. in 2007, it is hypothesized that spiroplasma are 
associated with neurodegenerative diseases similar to TSE.  In this work we further 
characterized S. mirum and continued to evaluate the possible correlations found in TSE 
infections.  In order to establish the best overall picture of S. mirum infections, we looked 
at culture conditions, physical and environmental disinfectant resistance, pathology and 
disease in experimental animals, and the immunological reactions found in experimental 
animals.  The following outlines the work in this dissertation. 
  
In chapter two, we determined the optimal growth conditions for the laboratory strains of 
S. mirum, SMCA and GT48.  In M1D, both SMCA and GT48 grew better at 30ºC and a 
typical growth curve was established.  In embryonated egg cultures, SMCA caused death 
in a reliable time frame and GT48 had sporadic death rates.  Both results coincided with 
previous research.  Growth on solid media was established with SP4 plates, and colony 
forming units were used to compare growth rates in liquid and solid media for both 
strains of S. mirum.     
 
Chapter three focuses on the resistance of spiroplasma to a variety of physical and 
chemical disinfectants as well as antibiotics.  Susceptibility was assessed by dilution and 
time for common laboratory disinfectants and an antibiotic profile was established for 
SMCA, GT48, S. citri, and S. melliferum.  Information reported in this chapter was used 
to compare the TSE infectious agent and spiroplasma.  
 
Chapter four reports the clinical and pathological findings of our animal experiments.  In 
order to compare natural TSE infections to spiroplasma-induced disease, we established a 
more long term animal model.  It has been proven that the mouse model does not always 
accurately portray a natural infection and so the ruminant model was chosen for disease 
establishment.  Neonatal goats were inoculated intracerebrally with SMCA and 
monitored for clinical signs for two years.  At the end of the experiment, various tissues 
were collected and examined for pathology and persistence of the organism.  Deer were 
also inoculated at five months and monitored for clinical signs.  Seven months post-
inoculation various tissues were collected and examined for pathology and persistence of 
the organisms.  Information from this experiment was compared to that of Bastian et al. 
(Bastian et al., 2007) and their neonatal deer experiment.  In order to test possible routes 
of transmission SMCA was delivered by intravenous and intradermal routes in neonatal 
goats to evaluate possible vector routes to establish an infection.  Goats were monitored 
for four months for clinical signs and persistence of the organism via various tissues.  
After four months, various tissues were collected and examined for pathology.   
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CHAPTER 2:  
A COMPARISON OF CULTURE MEDIA FOR SPIROPLASMA SPP 
 
Introduction 
  
The successful recovery of mollicutes from clinical specimens is dependent upon a 
number of factors, including host-dependent components (inhibitory enzymes, host 
antibodies, etc) and a variety of cultural or technical factors that may either enhance or 
limit isolation (Tully et al., 1983).  It is established that no single culture medium or 
cultivation procedure is adequate for the isolation of all or even most of the known 
mollicutes (Tully et al., 1983). This is especially true for the unique and varied genus of 
Spiroplasma.  Spiroplasmas were classified as Mollicutes (then Mycoplasmas) in 1972 
because they form “fried egg” colonies on solid media, pass through 0.22 μm filters, fail 
to revert to walled bacteria, are completely resistant to penicillin, and lack cell wall or 
murien cell wall precursors (Bove and Saillard, 1979; Saglio et al., 1971).    
 
Spiroplasmas are a unique group of organisms.  Originally thought to be viruses and then 
mis-identified as spirochetes, spiroplasmas have been difficult to characterize.  They can 
be found in a variety of hosts including plants, insects, and ticks.  They were first 
recognized as helical, wall-less bacteria in 1972 and received their name from a 
description of their motility in 1973 (Davis et al., 1972).  The first named spiroplasma 
was S. citri, the causative agent of citrus stubborn disease, which was originally 
considered a virus (Saglio et al., 1971).  Spiroplasma mirum, strain Suckling Mouse 
Cataract Agent (SMCA), isolated from rabbit ticks, was first considered a virus because it 
was filtered through such a small pore size (Clark, 1964).     Spiroplasmas have also been 
misidentified as spirochetes because of their similar appearance in dark field microscopy. 
The sex ratio organism (SRO), a disease fatal to only males of certain Drosophila 
species, was originally identified as a spirochete in 1961 but was later re-identified as a 
spiroplasma (Williamson et al., 1983).   
 
Spiroplasmas vary greatly in their habitats and therefore require a wide variety of culture 
mediums for isolation and growth.  Media designed for isolates from vertebrates stress 
sodium concentrations and reduced potassium and supply nucleic acid precursors 
(Whitcomb, 1983).  Media designed for insect and flower isolates have much higher 
concentrations of all amino acids.  All spiroplasma media must contain a sterol or lipid 
ingredient in order to support growth (Whitcomb, 1980).  In general spiroplasma media 
usually contain combinations of 10-20% serum, beef heart infusion, peptone and 
tryptone, carbohydrates, and amino acids (Bove and Saillard, 1979; Chen and Davis, 
1979; Whitcomb, 1980; Whitcomb, 1983).  The first sustained cultivation of a 
spiroplasma was S. citri, a flower pathogen, on a moderately simple mycoplasma medium 
(see Table 2.1) (Whitcomb, 1983).  The development of M1A resulted in enhanced 
growth for insect/flower isolates.  The addition of yeast extract for M1D media allowed 
for better growth for some spiroplasma isolates.  In order to cultivate SMCA, a fastidious 
organism, a much more complex medium SP4 (see Table 2.1), with added nutrition, 
especially amino acids, was required (Whitcomb, 1980).  Isolates identified from 
arthropods were thought to be non-cultivatable for years (Tully et al., 1982a).   Clark 
stated that one-half of the spiroplasmas observed in hemolymph of insects were non-
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cultivatable with the media known in 1982 (Clark, 1982). Similar media are being used in 
spiroplasma research today, making further isolation attempts challenging to researchers.   
 
 
 
Table 2.1 Spiroplasma media (yields 300 mLs)  
Ingredients Standard Mycoplasma Medium M1A M1D SP4 
Autoclave at 15 psi for 30 min 
Mycoplasma broth 
base 
4.5 g 2.1 g 1 g 
Bacto-Tryptone  1 g 3 g 
Bacto-Peptone  0.8 g 1.6 g 
Glucose  0.1 g  
Fructose  0.1 g  
Sucrose  1 g  
Sorbitol  7 g  
Distilled water 200 mL 70 mL 197 mL 
For solid media Add 1.6 g Difco Noble Agar to 
autoclavable portion 
Add 2.4 g to 6.8 g Difco Noble 
agar to autoclavable portion 
Sterile filter 
Schneiders Drosophilia 
medium 
 160 mL  
CMRL-1066 (10x 
w/glutamine, w/out 
NaHCO3) 
  15 mL 
Fetal Bovine Serum  50 mL 50 mL 
Horse Serum 60 mL   
Fresh yeast extract 
(25%) 
30 mL  10 mL 10.5 mL 
Phenol Red 0.5% (0.1 %) 6mL 1.2 mL 1.2 mL 
Potassium Penicillin 
(100,000 U/ml) 
1.5 mL 2.5 mL 3 mL 
Yeastolate 2%   30 mL 
Glucose (50% solution) 3 mL  3 mL 
L-arginine-HCl 42% 1.5 mL   
 
 
 
 
A defined media was also developed for S. mirum.  After the growth experiments in SP4, 
researchers began experimenting with a variety of different elements within the recipe in 
order to determine the best recipe for S. mirum growth enhancement.  H-1, a medium 
containing sphingomyelin, was created (Hackett et al., 1987).  This medium contains 
lower concentrations of inorganic salts and higher concentrations of amino acids, nucleic 
acid precursors, and cofactors.  The addition of sphingomyelin and modifications made in 
H-1 allowed SMCA’s doubling time to decrease from 25 hours to 7 hours with higher 
growth yields (Hackett et al., 1987).   
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Culture media has also been modified for different phases of the organisms’ growth.  
Media used for isolation of the organism usually contain a rich mixture of nutrients.  
However, some researchers suggest that for some isolates, the large amount of nutrients 
could be toxic for isolation (Whitcomb, 1983).  Primary isolation also depends on the 
organism, hosts, and the number of organisms available for isolation (Friedlaender et al., 
1976).  This was proven with repeated attempts to isolate spiroplasma from primary tick 
material in different media (Tully et al., 1981; Yunker et al., 1987).  In the case of S. 
mirum isolation, it is speculated that an inoculum of low numbers may benefit from the 
interaction with host cells.  However, after four weeks of various tick cell line cultures, 
all tissue cultures were not viable due to cytopathic effects on host cells and an artificial 
media (SP4) was needed to sustain growth (Yunker et al., 1987).  Once isolated, it is 
common for the spiroplasmas to adapt to a simplified media for continued passage 
(Whitcomb, 1983). 
  
Spiroplasmas vary greatly in their ability to produce colonies on solid media.  Although it 
was one of the distinguishing characteristics in determining Spiroplasma is a mollicute 
(mycoplasma), typical fried-egg or umbonate colony morphology is only observed under 
poor growth conditions (Townsend et al., 1980; Whitcomb, 1983).  Instead, some 
spiroplasma produce small satellite colonies in the vicinity of primary colonies; others 
produce granular-like colonies while still others form extremely diffuse colonies 
(Whitcomb, 1980).  The formation of colonies on solid media is dependent on a number 
of factors, the greatest being the agar content.  An effective strategy for obtaining 
countable colonies with highly motile spiroplasmas is the incorporation of higher 
concentrations of agar (Whitcomb, 1983).  Interestingly, spiroplasmas have been found to 
move faster with more viscous/more gelatinous media (Gilad et al., 2003; Wolgemuth 
and Charon, 2005).  The incubation conditions of the agar plates can also affect the 
growth of spiroplasma colonies.  Many isolates require a gaseous environment of 95% N2 
and 5% CO2 for as long as 14-20 days (Bove and Saillard, 1979; Chen and Davis, 1979). 
Variations in composition of solid media can also affect the ability of spiroplasmas to 
form colonies (Whitcomb, 1980).     
 
Qualitative and quantitative assessments of growth are required for spiroplasma cultures.  
Qualitative monitoring of growth is important especially during continuous passage.  If 
media, temperature, pH, or osmolarity are not optimized, abnormal growth and 
morphology may result (Chen and Davis, 1979; Liao and Chen, 1978).  Phenol red has 
been added as an indicator of growth based on acidic changes in the media because 
cultures entering stationary phase reach a minimal pH (Whitcomb, 1980).  SMCA, one of 
the more fastidious organisms, is slow to acidify media and may reach stationary phase of 
growth before acidifying the media.  For this reason growth of cultures should be 
confirmed by dark field or phase microscopy (Whitcomb, 1980).   
 
Direct quantification of spiroplasmas is accomplished by counting helical organisms 
under dark field microscopy (Liao and Chen, 1977; Williamson, 1969).  This can be time 
consuming and requires the use of a dark field microscope.  Colony-forming units  
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(CFUs) can be obtained by plating liquid culture and counting colonies 7-10 days after 
incubation (Bove and Saillard, 1979; Whitcomb, 1980).  Accurate counts of CFUs may 
be difficult to obtain with spiroplasmas.  Viable organisms from older cultures are less 
likely to form colonies than those in log phase (Whitcomb, 1980).  As stated above, 
spiroplasmas vary in their ability to produce consistent colonies on solid media for 
various reasons.  Some researchers have found that using titration methods resulted in 
accurate counts of spiroplasma cultures.  In a dilution series, the highest dilution that 
shows spiroplasma growth as exhibited via a color change is considered to contain one 
color changing unit (CCU) (Whitcomb, 1980).  This is a statistically crude estimate of 
viable spiroplasma cells but has worked well for estimating organism numbers for the 
more fastidious organisms (Whitcomb, 1980).   
 
Indirect quantification methods have been developed for some spiroplasmas.  Absorbance 
at 660 nm may be used to measure growth of S. citri (Whitcomb, 1980); however the 
measurements of absorbance or turbidity in most spiroplasma cultures may be affected by 
nonspecific changes in the growth media, some which are not necessarily growth related 
(Whitcomb, 1980).  Incorporation of radioactive precursors into nucleic acids has also 
been used to indirectly quantify S. citri (Bove and Saillard, 1979).  This method measures 
the radioactivity of trichloracteic acid insoluble precipitates during logarithmic growth.  
ATP, total adenylate pools, and amounts of incorporated radioactive thymidine and 
phenylalanine also increase during the logarithmic growth phase (Saglio et al., 1971; 
Saglio and Whitcomb, 1979).  Thymidine uptake as a measurement of growth was 
evaluated for S. mirum, one of the more fastidious spiroplasmas.  The growth yields were 
not as high as the compared CFU counts of the same inoculum, but the same growth 
curve pattern was seen in both media (Bastian et al., 1988).      
 
Spiroplasma growth depends on temperature, medium composition, history of inoculum, 
and history of passage in other mediums (Chen and Davis, 1979; Davis, 1978; Liao and 
Chen, 1978).  Growth rates appear to correspond closely with the organism’s natural 
environment (Junca et al., 1980).  Those spiroplasma found on flower surfaces have rapid 
growth rates with doubling times of about 1.8 hr (Whitcomb, 1980).  Spiroplasma citri, 
which can be found in insects and within plants, grows less rapidly with a doubling time 
of 5-6 hr (Saglio and Whitcomb, 1979).  Those spiroplasma that have specialized habitats 
grow slowly with doubling times of 20 hr or more (Liao and Chen, 1977).   
 
The focus of this chapter is to establish optimal culture methods for laboratory strains of 
S. mirum.  A stock solution of SMCA and GT48 are used in all experiments.  Stocks of S. 
melliferum (ATCC strain BC-3 #33219) and S. citri (ATCC strain R8A2 #27556) were 
also used in broth experiments for growth comparisons.  In this laboratory, SMCA and 
GT48 were better adapted to M1D broth media than SP4 for continued passages for 
experimental purposes.  To optimize the best culture method for laboratory strains, 
spiroplasma growth studies in M1D broth, SP4 solid media, and embryonated eggs were 
compared.  Direct quantification was assessed via dark field microscopy in broth cultures 
and embryonated egg cultures.  Colony forming units were used for quantification from 
SP4 plates.   
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Materials and Methods 
 
Bacteria:  Two strains of S. mirum were used, SMCA and GT48.  Strain SMCA was 
obtained from Dr. Frank Bastian, Tulane Medical Center, New Orleans, LA.  GT48, 
ATCC strain #29334, was obtained from ATCC Bioresource Center.  Spiroplasma 
melliferrum (ATCC strain BC-3 #33219 Vc161, created on 17MAR90, pass # 3) and S. 
citri (ATCC strain R8A2 #27556 130 Allen, created on 15Mar95, pass # 4) were also 
obtained from the ATCC Bioresource Center.   
  
M1D Media:  The ingredients for M1D are seen in Table 2.1.   Media was filter sterilized 
through a 0.2 µm filter and stored at -4
o
C.  Media was heated to room temperature and 
containers were sterilized with 70% ethanol before use to reduce possible bacterial 
contamination.  Once inoculated with bacteria, media was monitored for growth via dark 
field microscopy and/or color change. 
 
Embryonated Eggs:  Pathogen-free eggs were obtained from the Poultry Science Unit at 
Louisiana State University Agricultural Center.  Prior to use, eggs were stored at 18°C 
and then incubated for 7 days in a humidified 37°C chamber. After 7 days, eggs were 
candled for viability (Figure 2.1).  Viable eggs were cleaned with 70% ethanol or 10% 
betadine, and a sharp metal pick was used to make a small hole at the crown of the egg 
above the air sac (Figure 2.2).   
 
 
 
      
 Figure 2.1 Egg Candling    Figure 2.2 Egg inoculation 
 
 
   
A 10 μl sample was injected via a 22 gauge 1 inch needle into the allantoic cavity by 
inserting the needle 3/4
th
 of the way into the egg.  Samples were injected into the yolk sac 
by inserting a 22 gauge 1 inch needle at a 90° angle 3/4
th
 of the way into the egg.  The 
injection opening was closed using candle wax or finger nail polish.  Figure 2.3 details 
the placement of each injection route.  The blue line represents the path of chorioallantoic 
inoculation; the red line, the path of yolk sac inoculation. 
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Figure 2.3 Egg inoculation routes  Figure 2.4 Allantoic fluid collection  
 
 
After injection, eggs were placed in a humidifying 37°C incubator (rocking or non-
rocking) and candled daily for viability.  On day 18 (11 days post inoculation) or when 
determined to be non-viable, eggs were cooled to -4°C.  Eggs were cleaned again with 
70% ethanol.  Approximately 1 mL of allantoic fluid was aspirated from each egg using a 
22 gauge needle placed at a 45º angle through the sealed hole used for injection (Figure 
2.4).  Collected allantoic fluid was observed via dark field microscopy.  Fluid was either 
frozen at -80°C or passaged into new embryonated eggs or M1D.   
 
SP4 Plates: A modified SP4 recipe was used for the plates in these experiments.  
Ingredients for plates can be found in Table 2.2.  The base solution was autoclaved for 30 
min at 121°C, 15 psi and then cooled to 56°C.  Supplements were combined and filter 
sterilized through a 0.2 µm filter and then heated to 56°C.  Once combined, media was 
poured immediately into plates which were left under a hood until dry. Recipe makes 
approximately 18 100 x 15 mm plates. Plates were incubated overnight at 37° to check 
for bacterial contaminates.  
 
 
 
  Table 2.2 ATCC SP4 recipe 
Base Solution 
Mycoplasma Broth Base 5.5 g 
Tryptone 5 g 
Distilled H2O 262.5 mL 
Noble Agar 4 g 
Supplements 
Fetal Bovine Serum 85 mL 
Glucose (5%) 50 mL 
Phenol Red (0.1%) 10 mL 
Yeastolate (2%) 45 mL 
CMRL 1066 (10X) 25 mL 
Fresh Yeast Extract (25%) 17.5 mL 
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Dark Field Microscopy:  A 5 µL culture sample was placed on a clean glass microscope 
slide, mounted with a #1.5 cover slip and sealed on all 4 sides with clear finger nail 
polish.  Slides were examined with a Ziess Axio Imager A1 microscope (Carl Zeiss, Inc. 
North America, Thornwood, NY, USA) equipped with a dark-field top lens condenser 
1.2-1.4 and an EC Paln-NeoFluar x100 oil immersion objective (Carl Zeiss, Inc. North 
America, Thornwood, NY, USA) with 1.3 iris closed to its lowest setting (0.7).   
 
Dark Field Enumeration:  The average of at least 3 separate counts taken from various 
areas of the 5 μl sample was multiplied by the area of the viewing space.  This yielded the 
approximate number of organisms per 5 μl samples.  Cultures were assumed to be 
uniform, and calculations were made to establish amount of spiral organisms per mL.  
The grid size used to enumerate samples was determined and a formula (484 x 100 x the 
average of three counts) was used to calculate the amount of organisms per 5 µL.  This 
number was used to calculate the total number of organisms per mL and reported in 
Tables 2.4 – 2.11.  Organisms per mL were log 10 trasformed for graphing purposes and 
reported in Figures 2.6 – 2.8.       
 
PCR Methods:  PCR was carried out using oligonucleotide primers that specifically 
identified a 1460 bp portion of the S. mirum-related adhesin gene.  The forward and 
reverse primers were F3 (5’-TCTAGTCTTAATCATTTTACTTATTTATTAGAA -3’) 
and R4 (5’-TTATTAAGTCATTCACTCTCTTTCTTT -3’) respectively.   
The reaction mixture (50 µL total) contained 2 µL of each the forward and reverse 
primers (10 µM each), 1 unit (0.2 µL) of Taq DNA Polymerase (New England BioLabs, 
Ipswich, MA), 2 µL of 10 mM dNTP (AmpliTaq Gold, Applied Biosystems, Foster City, 
CA), and 5 µL of 10x Standard Taq Buffer (New England BioLabs), which contains 15 
mM of MgCl2.  For M1D cultures, 2 μL of culture was added to the reaction mixture 
without prior DNA extraction.  For SP4 plates, agar plugs were taken from 0.8% plates 
and mixed with PBS.  2 μL of this solution was added to the reaction mixture.  Plates 
with higher concentrations allowed cotton swabbing of the surface.  The cotton swab was 
vigorously mixed in PBS and 2 μL of this solution was added to the reaction mixture.  A 
variety of allantoic fluid dilutions were used for PCR from embryonated eggs.  Each 
reaction was brought to a final volume of 50 μL with sterile, nuclease-free H2O.  PCR’s 
were performed using a MyCycler Thermal Cycler (Bio-rad).  The thermal cycler 
program used was 94ºC for 5 minutes, then 30 cycles at 94ºC for 30 seconds, 57ºC for 20 
seconds, and 72ºC for 120 seconds followed by a final extension of 72ºC for 10 minutes.  
All PCR products were electrophoresed on a 1% agarose gel in Tris-acetate-EDTA 
(TAE) buffer, and the DNA was visualized by SYBR Safe (Invitrogen, Eugene, OR) 
DNA gel staining under UV fluorescence. 
 
Statistical Analysis:  To determine the best growth conditions we used an analysis of 
variance of a factorial arrangement of treatments was conducted.  Treatment groups 
included time, temperature, organisms, and daily growth counts.  When overall 
differences were found post-hoc comparisons were conducted with Tukey’s HSD test for 
main effects and pairwise t-test for interaction effects.  All comparisons were considered 
significant when p 0.05.  
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Experiment 1. Growth in M1D 
 
 1a. Growth at 30°C vs. 37°C:   To assess optimal growth temperature, all three 
species of Spiroplasma were incubated at 30°C and 37°C temperatures.  Cultures 
were initiated by adding 100 µL of thawed bacteria stock cultures to 900 μL of M1D 
in a 3 mL polystyrene  tube.  Tubes were placed in a 30°C or 37°C incubator and 
checked daily for color change.  A 5 μL sample of each culture was assessed via dark 
field microscopy daily for 7 days and then once weekly for a total of 21 days.   
 
 1b. Growth patterns of diluted cultures:  Tenfold dilutions out to 10-8 were made from 
a fresh 7 day old culture for both SMCA and GT48 strains and were incubated as 
above.  Growth was monitored daily via dark field microscopy, color change, and 
PCR for 21 days.  
 
 1c. Medusa formation:  While monitoring cultures daily for growth, it was observed 
that SMCA and GT48 aggregated to form medusa-like structures which could affect 
accurate counts.  In order to test this, a fresh culture was made by 1:100 dilution of a 
21 day culture and monitored.  When five or more medusas were noted within the 
daily sample taken for dark field microscopy, the culture was vortexed for a varied 
amount of time: 1 minute, 5 minutes, and 10 minutes.  Culture was checked after 
vortexing for the presence of medusa-like aggregates by dark field microscopy. The 
culture was monitored for growth daily for 7 days and compared to a culture not 
vortexed.   
 
Experiment 2. Growth in Embryonated Eggs 
 
 2a. Injection site and incubation:  To optimize the culture method in embryonated 
eggs, both injection site and type of incubator was assessed.  36 pathogen-free eggs 
were incubated at 37°C in a rocking humidifying incubator for 7 days.  A 10 μL 
sample of 7 day old SMCA cultures was injected into 24 eggs via either the yolk (12) 
or allantoic cavity (12) of the eggs.  A 10 μLsample of M1D was injected into 12 
eggs via either the yolk (6) or allantoic cavity (6) of the control eggs.  Six eggs from 
each injection route and controls were placed in a 37°C non-rocking humidifying 
incubator.  The remaining eggs were returned to the rocking incubator.  Eggs were 
candled daily to check viability.  On day 18 (11 days post inoculation) or at time of 
non viability, eggs were cooled to -4°C. Allantoic fluid was collected and observed 
via dark field microscopy.  Egg deaths and dark field results were recorded per day.  
Egg deaths that occurred 1 day post inoculation were attributed to technical problems 
rather than bacterial deaths.   
 
 2b. Comparison of egg deaths for GT48 and SMCA:  Tenfold dilutions out to 10-8 
were made from fresh 7 day old cultures for both SMCA and GT48 strains. Ninety 
eggs were divided into groups of 6 and incubated at 37°C in a rocking humidifying 
incubator for 7 days.   A 10 μL sample of each dilution (7 dilutions of each strain: 
SMCA and GT48) was injected into 7 day old embryonated eggs.  A 10 μL sample of 
M1D was injected into 6, 7 day old embryonated eggs to serve as controls.  All eggs 
were placed in a 37°C non-rocking humidifying incubator.  Eggs were candled daily 
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to check viability.  On day 18 (11 days post inoculation) or at time of death eggs were 
cooled to -4°C. Allantoic fluid was collected and observed for presence of organisms 
via dark field microscopy and PCR.  Experiment was repeated for accuracy of results.  
Egg deaths and dark field results were recorded per day. Egg deaths that occurred 1 
day post-inoculation were attributed to technical problems rather than bacterial 
deaths.   
 
 2c. SMCA effects on embryonated eggs:  The development of the chick causes a 
great deal of changes within the embryonated egg.  In order to assess the effects 
SMCA has on the development of embryonated eggs, 20 eggs were monitored daily 
for pH changes.  Twelve eggs were injected with 10 μL of viable SMCA culture. To 
serve as controls, 3 eggs were injected with 10 μL of M1D and 3 eggs were not 
inoculated.  At time of inoculation a small aspirate of allantoic fluid was taken and 
pH was assessed with a 6-10 pH strip.  All eggs were placed in a 37°C non-rocking 
humidifying incubator.  Eggs were candled daily to check viability.  A sample of 
allantoic fluid was taken daily from all viable eggs for 7 days and tested on pH strip.  
All samples were also assessed for presence of bacteria via dark field microscopy. 
   
Experiment 3. Growth on SP4 Plates 
 
 3a. Bacteria growth characteristics:  Four 1 mL aliquots of 7 day old cultures (SMCA, 
GT48, S. citri, and S. melliferum) were spun down at 16000xg for 1 hour.  The pellet 
was re-suspended in varying amounts of PBS, and each was inoculated onto modified 
SP4 plates containing 4 grams of noble agar (Table 2.2).  Plates were incubated at 
30°C and 37°C for 14 days, and colonies were observed and counted when possible.     
 
 3b. Agar concentration experiments:  Plates were made following the ATCC SP4 
recipe with 4 grams (0.8%), 8 grams (1.6%), and 12 grams (2.4%) of Noble agar.  
Tenfold dilutions of SMCA and GT48 were made in M1D, and 50 μL of each dilution 
was placed on the agar plates.  Plates were allowed to incubate for 14 days at 30°C 
and 37°C, and colonies were observed and counted.   
  
Results 
 
Experiment 1. Growth in M1D 
 
 1a. Growth at 30°C vs. 37°C :  Incubation at 30°C proved to be significantly better 
(p 0.05) for all four species of spiroplasma based on daily dark field enumeration.  
Spiroplasma citri had limited growth at 37°C.  Spiroplasma melliferum cultures were 
sustained at both temperatures, with 30°C yielding higher numbers.  SMCA and 
GT48 had very similar growth patterns at 30°C and 37°C, with 30°C sustaining 
cultures for longer time period.  Figure 2.6 and Table 2.3 highlights the dark field 
counts obtained at various time points.  
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Figure 2.5 Spiroplasma organisms as seen via dark field microscopy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6 Comparisons of Spiroplasma growth yields over 3 weeks at 30°C and 37°C.  
Growth yields were determined by dark field observations and compared by pairwise t-
test of least squares means for significance where p 0.05.  Spiroplasma citri, S. 
melliferum, GT48, and SMCA had significantly better growth at 30°C.   
30ºC 
37ºC 
Age of culture 
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Table 2.3 Summary of Spiroplasma growth.  Dark field counts at various time points 
throughout the experiment for all three Spiroplasma species at each temperature tested.  
*: No organisms found via dark field microscopy. 
Organism Temp 
Organisms/mL 
Day 1 Day 3 Day 5 Day 7 Day 14 Day 21 
SMCA 30°C 3.7E+07 2.8E+08 3.1E+08 2.6E+08 2.6E+08 7.7E+07 
SMCA 37°C 1.5E+08 2.4E+08 2.6E+08 1.2E+08 5.1E+07 1.3E+07 
GT48 30°C 2.1E+07 1.7E+08 3.2E+08 2.7E+08 3.2E+08 1.5E+08 
GT48 37°C 1.4E+08 2.9E+08 2.4E+08 2.4E+08 2.8E+07 2.8E+07 
S. melliferum 30°C 2.7E+08 3.6E+08 1.8E+08 2.6E+08 1.8E+08 9.0E+07 
S. melliferum 37°C 3.3E+08 1.8E+08 4.6E+07 2.5E+08 6.8E+07 1.2E+08 
S. citri 30°C 3.1E+07 1.8E+08 2.1E+08 1.6E+08 1.4E+08 3.7E+07 
S. citri 37°C 1.8E+07 7.5E+06 3.2E+06 2.2E+06 * * 
 
 1b. Growth patterns of diluted cultures:  Growth for all dilutions of GT48 and SMCA 
at 30°C and 37°C can be seen in the following figures (Figure 2.8 and 2.9) and tables 
(Tables 2.4 – 2.11).  For GT48 and SMCA cultures between 1-7 days, growth at 37°C 
was significantly better (time points highlighted with * when p 0.05) or the same as 
growth at 30°C.  However, after day 7, growth at 30°C was significantly  better (time 
points highlighted with * when p 0.05).   
 
Cultures were also monitored via PCR.  The PCR results from 3 days post-inoculation 
are seen in Figure 2.7.  As seen via dark field, more organisms were seen in diluted 
cultures earlier in the 37°C cultures.  Figure 2.10 reveals PCR results for 8 days post-
inoculation.  SMCA has reached higher numbers at 30°C as seen with banding in the 
lower dilutions compared to the bands for 37°C.  Positive bands are seen at 1460 bp, 
correlating with the S. mirum-related adhesin gene.     
 
 
Figure 2.7PCR results for tenfold dilutions of SMCA at 30°C and 37°C three days post-
inoculation.  The first two lanes are markers.  The next ten lines represent tenfold 
dilutions of SMCA cultures at 30°C, followed by tenfold dilutions of SMCA at 37°C.  
Positive bands are seen at 1460 bp, correlating with the S. mirum-related adhesin gene. 
M  M 1   2  3   4  5   6  7  8  9  10  1  2  3  4  5  6  7  8  9  10 
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Figure 2.8 Growth of diluted (1x10
-2
 - 1x10
-5
) GT48 and SMCA cultures over 3 weeks at 30°C and 37°C.  Growth yields were determined by 
dark field observations and log transformed data was compared by pairwise t-test of least squares means for significance where p 0.05 (time 
points designated with * when p 0.05). 
Age of culture  
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Table 2.4 Dark field counts for diluted (1x10
-2
) SMCA and GT48 cultures 
Organism Temp Dark field counts: organisms/mL 
  Day 1 Day 3 Day 5 Day 7 Day 14 Day 21 
SMCA 30°C 2.1E+07 1.7E+08 3.2E+08 2.7E+08 3.2E+08 1.5E+08 
SMCA 37°C 1.4E+08 2.9E+08 2.4E+08 2.4E+08 2.8E+07 2.8E+07 
GT48 30°C 3.7E+07 2.8E+08 3.1E+08 2.6E+08 2.6E+08 7.7E+07 
GT48 37°C 1.5E+08 2.4E+08 2.6E+08 1.2E+08 5.1E+07 1.3E+07 
 
 
 
 
Table 2.5 Dark field counts for diluted (1x10
-3
) SMCA and GT48 cultures 
Organism Temp Dark field counts: organisms/mL 
  Day 1 Day 3 Day 5 Day 7 Day 14 Day 21 
SMCA 30°C 5.7E+06 2.2E+08 2.5E+08 1.9E+08 2.5E+08 2.2E+08 
SMCA 37°C 9.4E+07 1.6E+08 2.0E+08 2.0E+08 3.7E+07 2.1E+07 
GT48 30°C 7.1E+06 1.2E+08 1.1E+08 2.3E+08 2.8E+08 1.6E+08 
GT48 37°C 4.1E+07 1.2E+08 2.6E+08 1.2E+08 3.9E+07 1.5E+07 
 
 
 
 
Table 2.6 Dark field counts for diluted (1x10
-4
) SMCA and GT48 cultures 
*: No organisms seen via dark field microscopy 
Organism Temp Dark field counts: organisms/mL 
  Day 1 Day 3 Day 5 Day 7 Day 14 Day 21 
SMCA 30°C 1.1E+06 7.3E+07 9.4E+07 4.3E+08 2.5E+08 3.3E+08 
SMCA 37°C 3.9E+07 1.7E+08 2.5E+08 1.9E+08 9.6E+07 1.3E+07 
GT48 30°C * 3.6E+07 1.1E+08 2.7E+08 5.0E+08 2.3E+08 
GT48 37°C * 7.4E+07 1.4E+08 1.9E+08 6.7E+07 2.6E+07 
 
 
 
 
Table 2.7 Dark field counts for diluted (1x10
-5
) SMCA and GT48 cultures 
*: No organisms seen via dark field microscopy 
Organism Temp Dark field counts: organisms/mL 
  Day 1 Day 3 Day 5 Day 7 Day 14 Day 21 
SMCA 30°C * 2.1E+07 4.4E+07 2.6E+08 3.8E+08 2.3E+08 
SMCA 37°C 5.8E+06 8.5E+07 2.1E+08 1.7E+08 3.0E+07 1.4E+07 
GT48 30°C * 3.2E+06 5.8E+07 1.7E+08 4.0E+08 1.5E+08 
GT48 37°C * 2.8E+07 8.8E+07 2.6E+08 4.1E+07 1.7E+07 
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Figure 2.9 Growth of diluted (1x10
-6
 - 1x10
-9
) GT48 and SMCA cultures over 3 weeks at 30°C and 37°C.  Growth yields were determined by 
dark field observations and log transformed data was compared by pairwise t-test of least squares means for significance where p 0.05 (time 
points designated with * when p 0.05). 
Age of culture  
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Table 2.8 Dark field counts for diluted (1x10
-6
) SMCA and GT48 cultures 
*: No organisms seen via dark field microscopy 
Organism Temp Dark field counts: organisms/mL 
  Day 1 Day 3 Day 5 Day 7 Day 14 Day 21 
SMCA 30°C * * 6.0E+07 1.5E+08 1.7E+08 2.2E+08 
SMCA 37°C * 3.0E+07 1.8E+08 1.9E+08 9.5E+07 2.6E+07 
GT48 30°C * * 1.0E+07 1.3E+08 3.5E+08 1.5E+08 
GT48 37°C * 5.8E+06 1.1E+08 1.8E+08 1.4E+08 2.1E+07 
 
 
 
Table 2.9 Dark field counts for diluted (1x10
-7
) SMCA and GT48 cultures 
*: No organisms seen via dark field microscopy 
Organism Temp Dark field counts: organisms/mL 
  Day 1 Day 3 Day 5 Day 7 Day 14 Day 21 
SMCA 30°C * * 1.1E+07 4.8E+07 2.1E+08 1.5E+08 
SMCA 37°C * * 1.9E+08 2.1E+08 1.0E+08 1.6E+07 
GT48 30°C * * * 6.3E+07 4.7E+08 1.5E+08 
GT48 37°C * * 5.4E+07 1.4E+08 1.2E+08 1.9E+07 
 
 
 
Table 2.10 Dark field counts for diluted (1x10
-8
) SMCA and GT48 cultures 
*: No organisms seen via dark field microscopy 
Organism Temp Dark field counts: organisms/mL 
  Day 1 Day 3 Day 5 Day 7 Day 14 Day 21 
SMCA 30°C * * * 1.4E+07 2.9E+08 7.7E+07 
SMCA 37°C * * 1.8E+07 1.6E+08 5.2E+07 1.4E+07 
GT48 30°C * * * 9.0E+06 * * 
GT48 37°C * * 2.8E+07 1.4E+08 1.1E+07 1.1E+07 
 
 
 
 
Table 2.11 Dark field counts for diluted (1x10
-9
) SMCA and GT48 cultures 
*: No organisms seen via dark field microscopy 
Organism Temp Dark field counts: organisms/mL 
  Day 1 Day 3 Day 5 Day 7 Day 14 Day 21 
SMCA 30°C * * * 3.6E+06 2.3E+08 1.5E+08 
SMCA 37°C * * * 7.9E+07 1.9E+07 5.8E+06 
GT48 30°C * * * * * * 
GT48 37°C * * * 4.4E+07 1.4E+07 9.7E+06 
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Figure 2.10 PCR results for tenfold dilutions of SMCA at 30°C and 37°C eight days post-
inoculation. The first two lanes are markers.  The next ten lines represent tenfold dilutions of 
SMCA cultures at 30°C, followed by tenfold dilutions of SMCA at 37°C. Positive bands are seen 
at 1460 bp, correlating with the S. mirum-related adhesin gene. 
 
 1c. Medusa formation:  After 1 minute of vortexing, large medusas were still present when 
examined with dark field microscopy.  After 5 minutes, only small to medium medusas 
(Figure 2.11) were still present.  After 10 minutes, no medusas were present.  The vortexed 
culture was monitored for growth daily for 7 days and compared to a non-vortexed control 
culture.  The growth curve for vortexed and non-vortexed cultures had no significant 
differences.   
 
 
Figure 2.11 An example of a medusa or aggregate of spiroplasma organisms 
 
Experiment 2. Growth in Embryonated Eggs 
 
 2a. Injection site and incubation:  100% (6/6) of yolk-injected embryonated eggs and 33% 
(2/6) of allantoic-inoculated eggs that were placed in a non-rocking incubator died within 4-8 
days post inoculation.  Only 33% (2/6 ) yolk-injected eggs and 16% (1/6) of allantoic-
inoculated eggs died after continuing to incubate in a rocking incubator for 11 days post 
inoculation.  There were no deaths in control eggs with either treatment. Figure 2.12 depicts 
the results from this experiment.   
M M 1  2  3  4  5  6  7  8  9 10  1 2  3  4  5 6  7  8  9 10 
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Figure 2.12 Comparison of egg viability when injected via allantoic or yolk sac inoculations and 
incubated in a rocking or non-rocking incubator.   
 
 2b. Comparison of egg deaths for GT48 and SMCA:  SMCA had a lethality rate of over 70% 
for all 7 dilutions.  GT48 inoculation resulted in fewer egg deaths as the culture was diluted.  
Visual evidence of spiroplasma in the allantoic fluid via dark field microscopy from non 
viable eggs was higher for GT48 deaths than for SMCA deaths.  Figures 2.13 and 2.14 depict 
the percentages for deaths and those with positive dark field microscopy.   
 
 
Figure 2.13 Comparison of pathogenicity of SMCA and GT48 in embryonated eggs.  Results are 
shown from tenfold dilutions of SMCA and GT48 cultures inoculated into embryonated eggs via 
the yolk sac inoculation route and incubated in a non-rocking incubator.   
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Figure 2.14  Comparison of observed Spiroplasma organisms from non-viable embryonated 
eggs.   
 
 2c. SMCA effects on embryonated eggs:  Figure 2.15 depicts the difference in daily readings 
of pH in SMCA infected eggs and control eggs.  Results from M1D and non inoculated eggs 
are included for the control pH.  The average of all eggs within each group was calculated for 
these results.  If egg death occurred, a note was made and calculations were adjusted based 
on viable eggs at day of reading. Embryonated eggs inoculated with SMCA resulted in a 
lower pH than the control eggs.  The difference in pH was not found to be significant.   
 
 
Figure 2.15 Comparison of pH readings in control embryonated eggs and Spiroplasma 
inoculated embryonated eggs.   
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Experiment 3. Growth on SP4 Plates  
 
 3a. Bacteria growth characteristics:  SP4 plates made with 4 grams (0.8%) of Noble agar 
revealed diffuse colonies for both SMCA and GT48.  S. melliferum and S. citri SP4 plates 
had evidence of multiple small pinpoint colonies throughout the plate.  SMCA and GT48 
inoculated plates revealed circular bodies with multiple satellite bodies when examined under 
light microscopy which could be found at multiple levels within the agar.  Results revealed 
that dilution would be necessary to allow for individual colony growth, and better growth 
may be observed on a more solid media. An example of GT48 and S. melliferum growth can 
be seen in Figure 2.16.  Figure 2.16 A shows 4 inoculation sites of 20 µL GT48 culture (not 
diluted).  Figure 2.16 B shows a view of colonies at 10x under light microscopy.  Figure 2.16 
C shows the growth of 50 μL of non-diluted S. melliferum culture placed in the center of the 
plate and allowed to incubate for 10 days at 30°C.   
 
 
   
Figure 2.16 GT48 and S. melliferum growth on 0.8% Noble agar SP4 plates.  Plates were 
incubated at 30°C for 10 days.  A) 4 inoculation sites of 20 µL GT48 culture (not diluted).  B) 
view of colonies at 10x under light microscopy.  C) Growth of 50 μL of non diluted S. 
melliferum culture placed in the center of the plate and allowed to incubate for 10 days at 30°C.   
 
 3b. Agar concentration experiments:  Results for 0.8% agar plates are seen in Figure 2.16.  
SP4 plates made with 1.6% of noble agar revealed small somewhat irregular colonies for 
both SMCA and GT48 (Figure 2.17). All colonies appeared to be on or near the surface of 
the agar.  Counts were made and recorded in Table 2.12.  Based on pairwise t-test, colony 
forming units were significantly (p 0.05) higher at 37°C than 30°C for both GT48 and 
SMCA on 1.6% agar SP4 plates.  SP4 plates made with 2.4% agar revealed “fried egg” 
colonies for SMCA and GT48.  Colony formation was irregular and sparse for even the less 
diluted cultures.  An example of SMCA culture diluted to 1x10
-3
 can be seen in Figure 2.18.   
 
Positive PCR bands were found from both an agar plug (0.8% plates) and a cotton swab from 
the surface of a SMCA inoculated 1.6% plate (Data not shown).  
B C A 
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Figure 2.17 Growth of diluted SMCA on SP4 plates made with 1.6% Noble agar. 
 
Table 2.12 Summary of CFUs from diluted 1 day old cultures on modified SP4 plates with 1.6% 
Noble agar. 
Dilution SCMA 30°C SMCA 37°C GT48 30°C GT48 37°C 
10
-1
 TNTC TNTC TNTC TNTC 
10
-2
 TNTC TNTC TNTC TNTC 
10
-3
 TNTC TNTC TNTC TNTC 
10
-4
 TNTC TNTC TNTC TNTC 
10
-5
 1.3E+08 1.6E+08 1.6E+08 2.2E+08 
  
 
 
Figure 2.18  Growth of diluted SMCA 10
-3
 on SP4 plates made with 2.4% Noble agar. 
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Discussion  
 
As the literature indicates, spiroplasmas adapt to different temperatures and media by changing 
their typical growth characteristics (Bove and Saillard, 1979; Konai et al., 1996; Tully et al., 
1983; Whitcomb, 1983).  This lab predominantly uses M1D media and therefore needed to 
assess the optimal growth conditions for laboratory strains of SMCA and GT48 in order to 
properly study their growth behaviors.  M1D media has been used for primary isolation and 
maintenance of cultures for both S. citri and S. melliferum (Whitcomb, 1983), and these two 
spiroplasmas were used for comparison in growth yields.   
 
The temperature range for spiroplasma growth is 5
o
- 41°C (Konai et al., 1996).  These 
experiments compare 30°C and 37°C.  In a previous study, S. citri had optimal doubling time at 
32°C; S. melliferum and S. mirum both had optimal doubling times at 37°C (Konai et al., 1996).  
Doubling time was based on color change alone. The literature has evidence that color change 
can be a poor indication of growth for SMCA, since it is slow to acidify media and may reach 
stationary phase of growth before acidifying the media (Whitcomb, 1980).  For this reason, we 
chose to use dark field enumeration to monitor the spiroplasma growth.  Based on dark field 
results, the calculations of organisms per mL are limited to an approximate range of 1x10
5
 to 
1x10
8
.  Without being able to detect a true beginning point in the log phase of the growth curve, 
accurate doubling time cannot be calculated.  This limitation in detection of organisms may also 
limit the accuracy for the peak of growth to determine when stationary phase begins.     
 
All four strains exhibited significantly (p<0.05) better growth at 30°C based on dark field 
enumeration.  Detection of the logarimthmic growth phase for S. citri and S. melliferum was 
limited before they appeared to move into a stationary phase.  GT48 cultures had sporadic 
growth at 37
o
C, and cultures quickly diminished after reaching the high point in our calculation 
range. SMCA appeared to grow well at both temperatures, with higher yields at 30
o
C.  This 
finding is probably an indication of the laboratory strains’ adaptation to grow at both 
temperatures in M1D.    
 
Although an accurate growth curve could not be determined due to the limitations of dark field 
microscopy,  the death phase can be predicted to start sometime after 7 days for cultures at 37°C 
and 14 days for cultures at 30°C, regardless of dilution. For GT48 cultures between 1-7 days, 
growth at 37°C was significantly better or the same as growth at 30°C.  However, after day 7, 
growth at 30°C was significantly better.  The same can be said regarding SMCA cultures. This 
finding indicates that S. mirum does not have a long stationary phase at 37°C but cultures at 30
o
C 
could sustain high levels of organisms for approximatly 1 week before moving into the death 
phase.       
 
The formation of medusa structures has been seen in other spiroplasmas as well.  Whitcomb 
found that in later stages of S. citri cultures, which probably corresponded to the stationary 
phase, aggregates of bodies appeared in which longer forms of spiroplasma were entangled.  He 
hypothesized that these forms arose by simple aggregation of multiple organisms or from 
repeated branching of a single organism (Whitcomb, 1980).  After disrupting the aggregation by 
vortexing for 10 minutes, the organisms were not killed from this manipulation, since dark field 
enumerations post-vortexing were similar to those numbers calculated for a non manipulated 
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culture.  This method appears to be appropriate for disruption of aggregates in order to get 
accurate dark field counts.   
 
SMCA was originally isolated and characterized using embryonated egg cultures (Clark, 1964). 
In order to compare the laboratory strains of S. mirum to the literature, the embryonated egg 
research techniques from previous reports were repeated.  The first step was to optimize the 
methods by comparing inoculation site and incubation methods.  Yolk sac inoculations followed 
by non-rocking incubation of embryonated eggs proved to be the best method for embryonated 
egg experiments based on egg viability results. This followed the findings reported by Clark 
where the most consistent results were found from yolk sac inoculations compared to allantoic, 
amniotic, and chorioallantoic membrane inoculations (Clark, 1964).    
 
The literature states that pathogenicity of spiroplasma can be lost due to repeated passages in 
artificial media (Tully et al., 1982a; Whitcomb, 1980).  It was necessary to determine if these 
laboratory strains had become attenuated after repeated passages in M1D.  Overall, SMCA-
inoculated eggs had a higher death rate than those inoculated with GT48.  These findings also 
correlate well with results found in literature.  Clark (Clark, 1964) found that eggs inoculated 
with SMCA died within four to seven days post yolk sac inoculation.  Eggs inoculated with 
GT48 exhibited a death curve which was delayed and less uniform then that produced by SMCA.  
These findings support that the laboratory strains have not been attenuated and still produce 
reliable results in embryonated eggs.   
 
The visualization of GT48 and SMCA from embryonated eggs was complicated by the 
gelatinous state of the allantoic fluid causing difficulties in dark field microscopy.  PCR results 
were also inhibited by factors within the egg fluids and could not be used as a reliable method for 
presence of the organism.  The negative results for observed organisms in non-viable eggs are 
not a reliable indicator for positive presence of the organism.  A better method for testing for 
presence of the organism within non-viable eggs would be passaging the egg fluids into M1D or 
SP4.   
 
Knowing that spiroplasma acidifies artificial media, it was speculated that the same would be 
true in embryonated eggs.  Spiroplasma did appear to lower the pH within the embryonated egg, 
however, it was not a significant difference (p 0.05).   
 
Obtaining colony plate counts has been historically difficult for spiroplasmas.  Not only do the 
organisms vary in their ability to form colonies, but they are also highly affected by agar content 
and environmental conditions (Whitcomb, 1980).  In experiments conducted by Tully, SMCA 
and GT48 produced colonies on 3.5% noble agar SP4 plates (original recipe).  Typical colonies 
were somewhat diffuse and irregular, and much of their growth occurred within the agar after 14 
to 17 days of incubation at 30
o
C in an atmosphere of 95% N2 and 5% CO2.  Similar results were 
obtained from plates made with 0.8% noble agar.   Following the ATCC SP4 recipe with the 
addition of Noble agar (1.6%) produced consistent countable colonies on or near the surface of 
the agar.  Plates incubated at 37°C did produce a significantly (p 0.05) higher number of CFUs.  
It should be noted that plates should be used immediately for best results.   
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Whitcomb stated that an effective strategy for obtaining countable colonies was the incorporation 
of higher concentrations of agar (Whitcomb, 1983).  The addition of excess Noble agar produced 
“fried egg” like colonies, which were described as an indication for poor growth conditions 
(Whitcomb, 1983).  These plates produced a much lower colony count that did not correlate well 
with our dark field results.    
 
Conclusion 
 
Growth in M1D media at 30°C proved to be significantly better (p<0.05), yielding higher dark 
field counts than cultures at 37°C.  Dark field enumeration appears to be limited to a range of 
1x10
5
 to 1x10
8 
organisms/mL and therefore an accurate growth curve could not be calculated 
using this method.  PCR was used to check for growth daily and results were comparable to dark 
field counts.  Color changes were evident in all dilutions after 7 days, though the more diluted 
cultures were less obvious.  Embryonated egg results were comparable to that in the literature; 
however, the artificial media is better for experimental purposes.  The organism is difficult to 
detect after egg fatality by both dark field and PCR.  PCR results may be skewed due to 
inhibitory factors in the egg fluids.  Embryonated egg experiments support that the laboratory 
strains were not attenuated by multiple passages and still produce similar virulence in 
embryonated egg cultures as seen in literature.  A method for obtaining colony forming units was 
also determined for SMCA and GT48.  Following the ATCC SP4 recipe with the addition of 
Noble agar (1.6%), S. mirum produced consistent countable colonies on or near the surface of the 
agar. Those plates incubated at 37°C yielded higher growth counts and significantly better 
growth (p<0.05) than those at 30°C.   
 
Although the media used in these experiments supported spiroplasma growth, other media 
should still be explored.  Research has been promising for some tissue cultures but none have 
been successful.  The establishment of a culture system may better elucidate the organism’s 
potential hosts and pathogenic nature.   
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CHAPTER 3:   
EFFECTS OF DISINFECTANTS AND ANTIBIOTICS ON SPIROPLASMA SPP. 
 
Introduction 
 
Mollicutes are a class of bacteria distinguished by the absence of a cell wall. The word 
"Mollicutes" is derived from the Latin mollis (meaning "soft" or "pliable") and cutis (meaning 
"skin"). They are very small, typically only 0.2–0.3 μm in size and have a very small genome. 
Mollicutes are the smallest self-replicating organisms known.  They are classified into five 
genera: Acholeplasma, Anaeroplasma, Mycoplasma, Spiroplasma and Ureaplasma (Murray and 
Schleifer, 1994). All members of the genus Spiroplasma are obligately associated with insects, 
either as commensals, pathogens or mutualists (Gasparich, 2002).  Spiroplasmas are also plant 
pathogens implicated in many economical crop diseases.  Spiroplasma mirum, isolated from a 
rabbit tick, is the only spiroplasma that has been found to be experimentally pathogenic to 
vertebrates (Bove, 1997).  Suckling mouse cataract agent (SMCA) represents one of the strains 
of S. mirum.  As the name describes, SMCA inoculated intracerebrally caused suckling mice to 
develop cataracts (Clark, 1964).  The organism was able to persist in suckling mice, specifically 
in the brain tissues for up to two years (Clark and Karson, 1968).  It was able to cross the blood 
brain barrier, assumingly without provoking an immune response, and caused a persistent 
neurologic infection (Bastian, 2005; Bastian and Jennings, 1984; Clark and Karzon, 1968; Tully 
et al., 1984).  Due to this observation, it was tentatively included with the slow viruses or chronic 
infectious neuropathic agents (Hotchin, 1967).  It was implicated as a possible causative agent 
for transmissible spongiform encephalopathies (TSEs) (Bastian, 2005).  
 
TSEs encompass a condition that affects humans and a variety of animals with a fatal 
neurodegenerative disease and associated neurological clinical signs.  The disease presents with 
morphological and pathophysiological features that parallel other progressive encephalopathies 
such as Alzheimer’s and Parkinson’s disease (Aguzzi and Haase, 2003).  Research currently 
supports evidence that the agent responsible for TSE is a prion, a small proteinaceous infectious 
particle (Prusiner, 1982).  The prion is a cell surface glycoprotein (Stahl et al., 1987) with an 
unknown function.  The pathogenesis of the prion is still widely unknown; however it is accepted 
that the normal prion PrP
c
 undergoes some sort of posttranslational modification that converts it 
to a pathogenic prion PrP
sc
.  PrP
sc
 is an insoluble and partially protease-resistant isoform that 
propagates itself by imposing its abnormal conformation onto other PrP
c
 molecules (Aguzzi and 
Calella, 2009).  The human prion diseases include Kuru, Creutzfeldt-Jakob disease (CJD), 
variant CJD, Gerstmann-Straussler-Scheinker (GSS) disease, and fatal familial insomnia (FFI).  
The most common animal TSEs are scrapie, which affects sheep and goats; bovine spongiform 
encephalopathy (BSE); and chronic wasting disease (CWD), which affects deer and elk.  
 
The difficulty of inactivating TSE agents first became apparent when sheep developed scrapie 
post-vaccination against louping-ill.  The vaccine was contaminated with the scrapie agent that 
had survived exposure to 0.35% formalin (Taylor et al., 1999).  Iatrogenic CJD has been 
described in humans in three circumstances: in patients for whom medical equipment was used 
during intracranial placement of contaminated electroencephalography electrodes or 
neurosurgical procedures; in patients who received hormone therapy with cadaveric human 
growth hormone or gonadotropin; and in patients who received an implant of contaminated 
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grafts. All known instances of iatrogenic CJD have resulted from exposure to infectious brain, 
pituitary, or eye tissue (Rutala and Weber, 2010).  It is generally accepted that BSE was caused 
by the transmission of the scrapie agent to bovines via foodstuff.  It is now known that the 
heating process used in many of the rendering procedures used traditionally to manufacture meat 
and bone meal do not completely inactivate BSE or scrapie agents (Taylor et al., 1999).   
 
A multitude of research has been dedicated to determining inactivation procedures for prion-
infected tissues.  Table 3.1 summarizes the research on effective and ineffective decontamination 
procedures (Rutala and Weber, 2010).   
 
Research has also been directed towards determining pre-mortem therapy for TSE infections.  
Forloni found that several compounds have been found to antagonize prion propagation in 
cellular and/or animal models of disease.  These include polyanions, polyene antibiotics, congo 
red, iododoxorubicin, tetrapyrroles, branched polyamines, tetracyclines, and modified PrP 
peptides.  Unfortunately most of these compounds do not cross the blood-brain barrier and are 
therefore useless in TSE therapy (Forloni et al., 2002).   
 
Resistance to a variety of chemical and physical disinfectants has been cited as a common factor 
between Spiroplasma and TSE infectious agents (Bastian, 2005).  Bastian reported that 
Spiroplasma can resist exposure to temperatures near boiling, glutaraldehyde and other fixatives 
(Bastian, 2005).  This chapter will focus on Spiroplasma’s resistance to a variety of physical and 
chemical disinfectants as well as antibiotics.  Susceptibility will be assessed by dilution and time 
of exposure for common laboratory disinfectants, and an antibiotic profile for SMCA, GT48, S. 
citri, and S. melliferum will be determined.  The information gathered from these experiments 
will aid in further evaluating Spiroplasma’s possible role in TSEs.    
 
Spiroplasma’s ability to cross the blood brain barrier, assumingly without provoking an immune 
response, will also be further tested in this chapter.  Complement plays a role in clearing 
invading foreign antigens as part of the body’s innate immune system or is activated  by the 
adaptive immune system via antibodies.  In this chapter, we will test complement’s innate 
activity against spiroplasmas using normal goat complement.  Antibody-mediated complement 
fixation will also be tested using goats hyperimmunized with killed SMCA antigens.  This will 
help determine the immune systems role in spiroplasma clearance. 
 
Materials and Methods 
 
Bacteria:  Two strains of S. mirum were used, SMCA and GT48.  Strain SMCA was obtained 
from Dr. Frank Bastian, Tulane Medical Center, New Orleans, LA.  GT48, ATCC strain #29334, 
was obtained from the ATCC Bioresource Center.  Spiroplasma melliferrum (ATCC strain BC-3 
#33219 Vc161, created on 17MAR90, pass # 3) and S. citri (ATCC strain R8A2 #27556 130 
Allen, created on 15Mar95, pass # 4) were also obtained from the ATCC Bioresource Center.   
 
Stock cultures of all strains of spiroplasma (approximately 1x10
8
 organisms per mL) were used 
for the following experiments.  Cultures were pelleted by centrifugation for 1 hour at 16000xg  
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Table 3.1 Efficacy of decontamination procedures for inactivating prions (Rutala and Weber, 2010) 
Ineffective (< 3 log reduction) Effective (> 3 log reduction) 
Autoclave at standard exposure conditions  
(121°C for 15 minutes) 
Autoclave at 121°C–132°C for 1 hour  
(gravity displacement sterilizer) or  
121°C for 30 minutes (prevacuum sterilizer) 
Autoclave at 134°C for 18 minutes  
(prevacuum sterilizer) 
Autoclave at 134°C for 18 minutes  
immersed in water 
Sodium dodecyl sulfate, 2%, plus acetic acid, 1%, 
plus autoclave at 121°C for 15–30 minutes 
Sodium hydroxide (NaOH), 0.09 N or 0.9 N, for 2 
hours plus autoclave at 121°C for 1 hour (gravity 
displacement sterilizer) 
Acetone  
Alcohol, 50%–100%  
Ammonia, 1.0 M  
Boiling  
Chlorine dioxide, 50 ppm Chlorine, 11,000 ppm 
Dry heat  
Ethylene oxide  
 Guanidine thiocyanate, 13 M 
Formaldehyde, 3.7%  
Glutaraldehyde, 5%  
Hydrochloric acid, 1.0 N  
Hydrogen peroxide, 0.2%, 3%, 6%, 30%, 60% 
Copper, 0.5 mmol/L, and  
hydrogen peroxide, 100 mmol/L 
Hydrogen peroxide, 59% 
Vaporized hydrogen peroxide, 1.5–2 mg/L 
Hydrogen peroxide gas plasma, Sterrad 100S (ASP) Hydrogen peroxide gas plasma (Sterrad NX) 
Iodine, 2%  
Microwave  
Ortho-phthalaldehyde, 0.55%  
Peracetic acid, 0.2%–19% Peracetic acid, 0.2% 
Phenol/phenolics (concentration variable) Phenolic disinfectant (specific formulation), 10.9% 
Potassium permanganate, 0.1%–0.8  
Sodium dodecyl sulfate, 1%–5% Sodium dodecyl sulfate, 2%, and acetic acid, 1% 
 Sodium hydroxide, x1 N 
 Sodium metaperiodate, 0.01 M 
Sodium deoxycholate 5%  
 Radiofrequency gas plasma 
Tego (dodecyl-di[aminoethyl]-glycine), 5%  
Triton X-100, 1%  
Urea, 4–8 M  
UV light Ionizing radiation  
 
and resuspended in sterile PBS.  Growth of Spiroplasma in M1D media was determined by color 
change indicated by phenol red acidification and confirmed by dark field microscopy.   
 
M1D Media:  The ingredients for M1D are seen in Table 3.2.   Media was filter sterilized 
through a 0.2 µm filter and stored at -4
o
C.  Media was heated to room temperature and containers 
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were sterilized with 70% ethanol before use to reduce possible bacterial contamination.  Once 
inoculated with bacteria, media was monitored for growth via dark field microscopy and/or color 
change. 
 
Table 3.2 M1D media (yields 300 mLs)  
Ingredients 
Mycoplasma broth 
base 
2.1 g 
Bacto-Tryptone 1 g 
Bacto-Peptone 0.8 g 
Glucose 0.1 g 
Fructose 0.1 g 
Sucrose 1 g 
Sorbitol 7 g 
Distilled water 70 mL 
Schneiders Drosophilia 
medium 
160 mL 
Fetal Bovine Serum 50 mL 
Fresh yeast extract 
(25%) 
10 mL 
Phenol Red 0.5% 1.2 mL 
Potassium Penicillin 
(100,000 U/ml) 
2.5 mL 
 
Dark Field Microscopy:  A 5 µL culture sample was placed on a clean glass microscope slide, 
mounted with a #1.5 cover slip and sealed on all four sides with clear finger nail polish.  Slides 
were examined with a Ziess Axio Imager A1 microscope (Carl Zeiss, Inc. North America, 
Thornwood, NY, USA) equipped with a dark-field top lens condenser 1.2-1.4 and an EC Paln-
NeoFluar x 100 oil immersion objective (Carl Zeiss, Inc. North America, Thornwood, NY, USA) 
with 1.3 iris closed to its lowest setting (0.7). 
 
Disinfectant experiments: Broth dilution and especially microbroth dilution methods for testing 
disinfectant or antibiotic susceptibility have been modified for mollicutes.  The method employs 
spiroplasma media with decreasing disinfectant concentrations, inoculated with a standardized 
number of microorganisms in a 96-well microtiter plate (Bebear and Bebear, 2002).  The mean 
inhibitory concentration (MIC) is defined as the lowest concentration of disinfectant that 
prevents a color change at the time when the color in the control without disinfectant has 
changed.  Turbidity or inappropriate color change in broth control indicates bacterial 
contamination.   The following experiments will follow these procedures.   
 
100 µL of a specific species of spiroplasma (approximately 1x10
8
 organisms per mL) 
resuspended in PBS was placed in all wells of a 96 well plate.  100 µL of disinfectant was then 
added to the first vertical column of the microtiter plate.  Original concentrations of disinfectants 
are indicated in Table 3.2.  100 µL was then transferred through the adjacent row of wells to 
create 1:2 dilutions.  At set time points (1, 5, 10, 15, 30, and 60 minutes), 20 µL of each dilution 
was transferred into 280 µL fresh M1D media in a separate 96 well plate.  A row in the plate was 
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left with media alone, and the last row was seeded with normal Spiroplasma culture as a positive 
control. All transferred cultures were incubated at 30
o
C for 7 days.  Growth was confirmed via 
dark field microscopy.  A list of disinfectants used can be found in Table 3.3.  The same 
procedure was followed for all liquid disinfectants.  Experiments were duplicated to establish 
reproducibility.       
 
For heat lability experiments, 1 mL of Spiroplasma culture resuspended in PBS was placed in a 
1-mL centrifuge tube and submerged in a water bath at varying temperatures (45
o
C, 50
o
C, 56
o
C).  
For ultraviolet experiments, 1 mL of Spiroplasma culture resuspended in PBS was left in an open 
1 mL polystyrene centrifuge tube and placed under a UV light.  At set time points(1, 5, 10, 15, 
30, and 60 minutes), 20 µL of culture was removed and placed into 280 µL fresh media in a 
separate 96 well plate and incubated as above. A row in the plate was left with media alone, and 
the last row was seeded with normal Spiroplasma culture as a positive control. For autoclaving 
experiments, 1ml of Spiroplasma culture was placed in a glass test tube and autoclaved for 15 
minutes at 121ºC.  100 µl of culture was removed prior to autoclaving and placed in 900 µl of 
fresh M1D to serve as a control. 
 
Table 3.3 Summary of disinfectants tested for spiroplasma susceptibility  
Disinfectant  Range of dilution 
Alcohols 
Ethanol 70-0.02% 
Methanol 100-0.02% 
Isopropanol 100-0.02% 
Aldehydes 
Formalin 20-0.002% 
Gluteraldehyde 100-0.02% 
Oxidizing Agents 
Sodium Hypochlorite 5.25-0.001% 
Povidone-iodine 100-0.02% 
Hydrogen Peroxide 3-0.001% 
Solvent Acetone 100-0.02% 
Surfactants 
Chlorhexidine 2-0.001% 
Sodium Hydroxide (1 Molar) 100-0.02% 
SDS 10-0.002% 
Roccal-D Plus 100-0.02% 
Buffers 
Tris (pH 7) 100-0.02% 
Tween-20 100-0.02% 
Ethylenediaminetetraacetic acid (EDTA) (1 Molar) 100-0.02% 
Irradiation Ultraviolet Light 0-60 minutes of exposure 
Temperature 
Changes 
Autoclave 121
o
C for 15 minutes 
Heat 45
o
C, 50
o
C, 56
o
C 
 
Antibiotic experiments: A fresh 1:100 dilution stock culture was made of each species.  200 µL 
of culture was placed in a TREK Diagnostic Systems Sensititre Avian plate, Cleveland, Ohio.   
Three wells within the diagnostic plate were not seeded with any antimicrobials to serve as 
controls. A list of antimicrobial agents and the ranges tested can be found in Table 3.4.  Each 
plate was incubated at 30
o
C for 7 days.  Growth was confirmed by dark field microscopy.  
Experiments were duplicated to establish reproducibility. 
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Table 3.4 Summary of antibiotics used to test spiroplasma susceptibility 
Antibiotic Range (µg/mL) 
Bacteriocidal or 
Bacteriostatic 
Mechanism of action 
Fluorquinolones Enrofloxacin 2-0.12 Bacteriocidal Inhibits DNA gyrase 
Aminocoumarin Novobiocin 4-0.5 Bacteriocidal Inhibits DNA gyrase 
Penicillins 
Penicillin 8-0.5 
Bacteriocidal Inhibit cell wall synthesis 
Amoxicillin 16-0.25 
Cephalorsporins Cetfiofur 4-0.25 Bacteriocidal Inhibits cell wall synthesis 
Aminoglycosides 
Streptomycin 1024-8 
Bacteriocidal 
Bind 30S ribosome and inhibit 
protein synthesis 
Neomycin 32-2 
Gentamicin 8-0.5 
Aminocyclitols Spectinomycin 64-8 Bacteriostatic 
Bind 30S ribosome and inhibit 
protein synthesis 
Tetracyclines 
Tetracycline 8-0.25 
Bacteriostatic 
Bind 30S ribosome and inhibit 
protein synthesis Oxytetracycline 8-0.25 
Macrolides 
Erythromycin 4-0.12 
Bacteriostatic 
Bind 50S ribosome and inhibit 
protein synthesis Tylosin tartrate 20-2.5 
Florfenicol 8-1 Bacteriostatic 
Bind 50S ribosome and inhibit 
protein synthesis 
Lincosamides Clindamycin 4-0.5 Bacteriostatic 
Bind 50S ribosome and inhibit 
protein synthesis 
Sulfonamides 
Sulfadimethoxine 256-32 
Bacteriostatic 
Inhibits bacterial synthesis of 
folic acid 
Sulphathiazole 256-32 
Trimethoprim/ 
sulfamethoxazole 
2/38-0.5/9.5 
 
 
 
Complement experiments:  Complement susceptibility tests were conducted on all Spiroplasma 
to evaluate its role in the immune system response to spiroplasma.  Blood was collected from the 
jugular vein of a normal goat in a red top vacutainer tube (no additives).  The tubes were 
immediately put on ice to preserve complement.  Tubes were spun at what speed after icing 
overnight, and the complement-preserved serum was removed and stored at -20
o
C.  Blood was 
also collected following the same procedures from goats hyperimmunized with killed SMCA 
antigen.  Previously, two goats were immunized with boiled SMCA antigen.  1 mL of the 
solution was mixed with 1 mL of incomplete freund’s adjuvant.  The 2 mL mixture was injected 
intramuscularly into two different goats. Goats were boosted with 0.5 mL SMCA and 0.5 mL 
incomplete freund’s adjuvant 4 and 6 weeks later.  To serve as controls, 1 mL of complement-
preserved serum from normal goats and hyperimmunized goats was heated in a water bath at 
56
o
C for 1 hour.  500 µL of Spiroplasma culture was mixed with 500 µL of complement-
preserved normal serum, 500 µL of complement-preserved hyperimmunized serum, or the 500 
µLof the heat inactivated controls.  At set time points, 20 uL of culture was removed and placed 
into 280 µL fresh media in a separate 96-well plate and incubated as above.   
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 Results 
 
Disinfectant experiments: Following a two-fold dilution series, the concentration listed in the 
results below is the smallest dilution of disinfectant which inhibited spiroplasma growth. 
 
 Alcohols: Spiroplasma spp. were susceptible to low levels of alcohol treatment.  After 1 
minute of exposure to 35% ethanol, all spiroplasma growth was inhibited (Table 3.5).  
Methanol and isopropanol were also effective on contact and inhibited growth at 50% 
concentration (Table 3.6 and 3.7). 
 
Table 3.5 Concentration of ethanol (70-0.02%) that inhibited spiroplasma growth. 
Time SMCA GT48 S. melliferum S. citri 
1 minute 35% 35% 35% 35% 
5 minutes 35% 35% 35% 35% 
10 minutes 35% 35% 35% 35% 
15 minutes 35% 35% 35% 35% 
30 minutes 35% 35% 35% 35% 
60 minutes 35% 35% 35% 35% 
 
Table 3.6 Concentration of methanol (100-0.02%) that inhibited spiroplasma growth 
Time SMCA GT48 S. melliferum S. citri 
1 minute 50% 50% 100% 50% 
5 minutes 50% 50% 50% 50% 
10 minutes 50% 50% 50% 50% 
15 minutes 50% 50% 50% 50% 
30 minutes 50% 50% 50% 50% 
60 minutes 50% 50% 50% 25% 
 
Table 3.7 Concentration of isopropanol (100-0.02%) that inhibited spiroplasma growth. 
Time SMCA GT48 S. melliferum S. citri 
1 minute 50% 50% 50% 50% 
5 minutes 50% 50% 25% 50% 
10 minutes 50% 50% 25% 50% 
15 minutes 50% 50% 25% 50% 
30 minutes 25% 50% 25% 25% 
60 minutes 12.5% 50% 25% 12.5% 
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 Aldehydes: Spiroplasmas were susceptible to 3-0.04% formalin (Table 3.8).  GT48 was able 
to grow in 50% gluteraldehyde, but all other Spiroplasma tested were inactivated by 0.8% 
gluteraldehyde or less (Table 3.9).   
 
Table 3.8 Concentration of formalin (20-0.002%) that inhibited spiroplasma growth. 
Time SMCA GT48 S. melliferum S. citri 
1 minute 0.6% 2.5% 0.3% 0.04% 
5 minutes 0.6% 2.5% 0.3% 0.04% 
10 minutes 0.6% 2.5% 0.3% 0.04% 
15 minutes 0.6% 2.5% 0.3% 0.04% 
30 minutes 0.6% 2.5% 0.3% 0.04% 
60 minutes 0.6% 2.5% 0.3% 0.04% 
 
Table 3.9 Concentration of gluteraldehyde (100-0.02%) that inhibited spiroplasma growth. 
Time SMCA GT48* S. melliferum S. citri 
1 minute 1.6% 50% 6.2% 1.6% 
5 minutes 1.6% 50% 1.6% 1.6% 
10 minutes 0.8% 50% 1.6% 1.6% 
15 minutes 0.8% 50% 1.6% 0.8% 
30 minutes 0.4% 50% 0.8% 0.8% 
60 minutes 0.2% 50% 0.8% 0.4% 
* GT48 survived in all dilutions of Gluteraldehyde. 
 
 Oxidizing Agents: The oxidizing agents had a major impact on Spiroplasma growth.  Iodine 
did not allow growth at even the lowest dilution (0.02%) for any spiroplasma species (Table 
3.11).  Sodium hypochlorite inhibited growth of all Spiroplasma at very small dilutions 
(Table 3.10) as did hydrogen peroxide (Table 3.12) 
 
Table 3.10 Concentration of sodium hypochlorite (5.25-0.001%) that inhibited spiroplasma 
growth. 
Time SMCA GT48 S. melliferum S. citri* 
1 minute 0.04% 0.04% 0.006% 0.003% 
5 minutes 0.04% 0.04% 0.006% 0.003% 
10 minutes 0.04% 0.04% 0.006% 0.003% 
15 minutes 0.02% 0.04% 0.006% 0.003% 
30 minutes 0.02% 0.04% 0.003% 0.003% 
60 minutes 0.02% 0.04% 0.003% 0.003% 
* S. citri had no growth.  The lowest dilution tested is listed.   
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Figure 3.1 Example of 96-well plate used to study the effects of sodium hypochlorite on 
spiroplasma growth  
 
 
Table 3.11 Concentration of povidone-iodine (100-0.02%) that inhibited spiroplasma growth. 
Time SMCA GT48 S. melliferum S. citri* 
1 minute 1.6% 0.05% 1.6% 0.025% 
5 minutes 0.4% 0.05% 0.4% 0.025% 
10 minutes 0.4% 0.05% 0.4% 0.025% 
15 minutes 0.1% 0.05% 0.1% 0.025% 
30 minutes 0.1% 0.025%** 0.1% 0.025% 
60 minutes 0.025%** 0.025%** 0.025%** 0.025% 
* S. citri had no growth.  The lowest dilution tested is listed.   
**No growth in the lowest dilution tested. 
 
Table 3.12 Concentration of hydrogen peroxide (3-0.001%) that inhibited spiroplasma growth. 
Time SMCA GT48 S. melliferum S. citri 
1 minute 0.09% 0.09% 0.18% 0.09% 
5 minutes 0.09% 0.09% 0.18% 0.09% 
10 minutes 0.09% 0.09% 0.18% 0.09% 
15 minutes 0.09% 0.09% 0.18% 0.05% 
30 minutes 0.09% 0.09% 0.18% 0.05% 
60 minutes 0.05% 0.09% 0.18% 0.05% 
 
60 M 
30 M 
15 M 
10 M 
5 M 
1 M 
Media 
Positive  
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 Solvent: Acetone (50%) was effective against Spiroplasma growth (Table 3.13).  
 
Table 3.13 Concentration of acetone (100-0.02%) that inhibited spiroplasma growth. 
Time SMCA GT48 S. melliferum S. citri 
1 minute 50% 25% 50% 50% 
5 minutes 50% 25% 50% 50% 
10 minutes 50% 25% 50% 50% 
15 minutes 50% 25% 50% 50% 
30 minutes 50% 25% 50% 50% 
60 minutes 50% 25% 50% 50% 
 
 Surfactants: All surfactants tested were able to inhibit spiroplasma growth at low dilutions.  
Chlorhexidine (Table 3.14) and SDS (Table 3.16) were able to inhibit most species tested at 
all dilutions.  Sodium hydroxide, an effective agent for prions, inhibited growth at 3.2% for 
all Spiroplasma (Table 3.15). Roccal-D Plus, used around herd animals, was also very 
effective, inhibiting growth at dilutions of 0.4% and less (Table 3.17). 
 
Table 3.14 Concentration of chlorhexidine (2-0.001%) that inhibited spiroplasma growth. 
Time SMCA GT48 S. melliferum S. citri 
1 minute 0.004% 0.002% 0.008% 0.002% 
5 minutes 0.002% 0.002%. 0.004% 0.002% 
10 minutes 0.002% 0.002%. 0.004% 0.002% 
15 minutes 0.002% 0.002% 0.004% 0.001%** 
30 minutes 0.002% 0.001%** 0.004% 0.001%** 
60 minutes 0.001%** 0.001%** 0.004% 0.001%** 
.**No growth in the lowest dilution tested 
 
Table 3.15 Concentration of sodium hydroxide (1 mol) (100-0.02%) that inhibited spiroplasma 
growth. 
Time SMCA GT48 S. melliferum S. citri 
1 minute 6.2% 3.13% 6.2% 6.2% 
5 minutes 3.13% 3.13% 6.2% 3.13% 
10 minutes 3.13% 3.13% 3.13% 3.13% 
15 minutes 3.13% 3.13% 3.13% 1.6% 
30 minutes 3.13% 3.13% 3.13% 0.8% 
60 minutes 1.6% 3.13% 3.13% 0.8% 
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Table 3.16 Concentration of SDS (10-0.002%) that inhibited spiroplasma growth. 
Time SMCA GT48 S. melliferum S. citri 
1 minute 0.01% 0.02% 0.02% 0.005% 
5 minutes 0.005% 0.02% 0.02% 0.005% 
10 minutes 0.005% 0.02% 0.02% 0.005% 
15 minutes 0.002%** 0.02% 0.01% 0.002%** 
30 minutes 0.002%** 0.02% 0.01% 0.002%** 
60 minutes 0.002%** 0.02% 0.01% 0.002%** 
**No growth in the lowest dilution tested. 
 
Table 3.17 Concentration of Roccal-D Plus (100-0.02%) that inhibited spiroplasma growth. 
Time SMCA GT48 S. melliferum S. citri 
1 minute 0.4% 0.1% 0.8% 0.4% 
5 minutes 0.4% 0.1% 0.8% 0.4% 
10 minutes 0.4% 0.1% 0.4% 0.4% 
15 minutes 0.4% 0.1% 0.4% 0.4% 
30 minutes 0.4% 0.1% 0.2% 0.4% 
60 minutes 0.4% 0.1% 0.2% 0.2% 
 
 Buffers: Tris (pH 7) and Tween-20 allowed growth for all Spiroplasmas at all dilutions and 
all time points (data not shown). 
 
 EDTA: EDTA (1 mol) did not inhibit growth of any Spiroplasma strain tested at any dilution 
or time point (data not shown).  
 
 Irradiation: With the exception of GT48, Spiroplasmas are also susceptible to UV irradiation 
after 1 hour (Table 3.18). 
 
Table 3.18 Spiroplasma growth in the presence of ultraviolet irradiation at various times 
Time SMCA GT48 S. melliferum S. citri 
1 minute Growth Growth Growth Growth 
5 minutes Growth Growth Growth Growth 
10 minutes Growth Growth Growth Growth 
15 minutes Growth Growth Growth Growth 
30 minutes Growth Growth Growth Growth 
60 minutes No Growth Growth No Growth No Growth 
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 Temperature: All Spiroplasma species were inactivated following autoclaving at 121ºC, 
15 psi (Table 3.19).  SMCA was able to survive 1 hour at 40
o
C and 50
o
C but only 10 
minutes at 56
o
C (Tables 3.20-3.22).  Spiroplasma melliferum and S. citri survived only 
30 minutes at both 50
o
C and 56
o
C (Tables 3.20-3.22).  GT48 was able to survive 1 hour 
at all temperatures tested (Tables 3.20-3.22).  
 
Table 3.19 Spiroplasma growth following autoclaving (121
o
, 15psi) 
Time SMCA GT48 S. melliferum S. citri 
15 minutes No Growth No Growth No Growth No Growth 
 
Table 3.20 Spiroplasma growth in the presence of heat (45
o
 C) at various times 
Time SMCA  GT48 S. melliferum S. citri 
1 minute Growth Growth Growth Growth 
5 minutes Growth Growth Growth Growth 
10 minutes Growth Growth Growth Growth 
15 minutes Growth Growth Growth Growth 
30 minutes Growth Growth Growth Growth 
60 minutes Growth Growth Growth Growth 
 
Table 3.21 Spiroplasma growth in the presence of heat (50
o
 C) at various times 
Time SMCA  GT48 S. melliferum S. citri 
1 minute Growth Growth Growth Growth 
5 minutes Growth Growth Growth Growth 
10 minutes Growth Growth Growth Growth 
15 minutes Growth Growth Growth Growth 
30 minutes Growth Growth Growth Growth 
60 minutes Growth Growth No Growth No Growth 
 
Table 3.22 Spiroplasma growth in the presence of heat (56
o 
C) at various times 
Time SMCA GT48 S. melliferum S. citri 
1 minute Growth Growth Growth Growth 
5 minutes Growth Growth Growth Growth 
10 minutes Growth Growth Growth Growth 
15 minutes No Growth Growth No Growth Growth 
30 minutes No Growth Growth No Growth No Growth 
60 minutes No Growth Growth No Growth No Growth 
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Figure 3.2 Examples of cultures growing at 30°C after heat experiments.  The center tube 
contains SMCA after 1 hour at 56°C.  A positive control containing normally incubated bacteria 
in media (yellow fluid) is found to the right and was used to help correlate color change.  A 
negative control of media alone (orange fluid) was heated along with SMCA culture to be sure 
that no color change would occur due to the heating process.   
 
 
 
Overall  Spiroplasma was susceptible to most of the common laboratory disinfectant methods.  
Furthermore we found that the majority were effective at very low concentrations and at 
immediate contact (<1minute).  GT48 was the most resilient of the Spiroplasma tested, showing 
growth at higher concentrations and higher temperatures than the other Spiroplasma.  Table 3.23 
summarizes the smallest percentage of disinfectant positive for Spiroplasma growth and the 
contact time required to reach this end point.  Table 3.24 summarizes the percentage of 
disinfectant positive for Spiroplasma growth after 60 minutes.   
+ 
C
o
n
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Table 3.23 Minimal inhibitory concentration and time required of disinfectants for spiroplasma. 
G: Growth, NG: No growth 
Disinfectant 
Range of 
dilution 
SMCA GT48 S. melliferum S. citri 
Alcohols 
Ethanol 70-0.02% 35% 1m 35% 1m 35% 1m 35% 1m 
Methanol 100-0.02% 50% 1m 50% 1m 50% 5m 25% 60m 
Isopropanol 100-0.02% 12.5% 60m 50% 1m 25% 5m 12.5% 60m 
Aldehydes 
Formalin 20-0.002% 0.6% 1m 2.5% 1m 0.4% 1m 0.04% 1m 
Gluteraldehyde 100-0.02% 0.2% 60m G 60 0.8% 30m 0.4% 60m 
Oxidizing 
Agents 
Sodium 
Hypochlorite 
5.25-0.001% 0.02% 15m 0.04% 1m 0.002% 30m NG 1m 
Povidone-
iodine 
100-0.02% NG 60m NG 30m NG 60m NG 1m 
Hydrogen 
Peroxide 
3-0.001% 0.1% 5m 0.1% 1m 0.18% 1m 0.04% 15m 
Solvent Acetone 100-0.02% 50% 1m 25% 1m 50% 1m 50% 1m 
Surfactants 
Chlorhexidine 2-0.001% NG 60m NG 30m 0.004% 5m NG 15m 
Sodium 
Hydroxide  
(1 Molar) 
100-0.02% 1.6% 60m 3.2% 1m 3.2% 10m 0.8% 30m 
SDS 10-0.002% NG 15m 0.02% 1m 0.01% 15m NG 15m 
Roccal-D Plus 100-0.02% 0.4% 1m 0.1% 1m 0.2% 30m 0.2% 60m 
Buffers 
Tris (pH 7) 100-0.02% G 60m G 60m G 60m G 60m 
Tween-20 100-0.02% G 60m G 60m G 60m G 60m 
EDTA (1 Molar) 100-0.02% G 60m G 60m G 60m G 60m 
Irradiation 
Ultraviolet 
Light 
0-60 
minutes of 
exposure 
G 30m G 60m G 30m G 30m 
Temperature 
Changes 
Autoclave 
121
o
C for 15 
minutes 
NG - NG - NG - NG - 
Heat 
45°C G 60m G 60m G 60m G 60m 
50°C G 60m G 60m G 30m G 30m 
56°C G 10m G 60m G 10m G 15m 
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Table 3.24 Minimal inhibitory concentration of disinfectant for spiroplasma after 60 minutes 
 G: Growth, NG: No growth 
Disinfectant 
Range of 
dilution 
SMCA GT48 S. melliferum S. citri 
Alcohols 
Ethanol 70-0.02% 35% 35% 35% 35% 
Methanol 100-0.02% 50% 50% 50% 25% 
Isopropanol 100-0.02% 12.5% 50% 25% 12.5% 
Aldehydes 
Formalin 20-0.002% 0.6% 2.5% 0.3% 0.04% 
Gluteraldehyde 100-0.02% 0.2% G 0.8% 0.8% 
Oxidizing 
Agents 
Sodium 
Hypochlorite 
5.25-0.001% 0.02% 0.04% 0.002% NG 
Povidone-
iodine 
100-0.02% NG NG NG NG 
Hydrogen 
Peroxide 
3-0.001% 
 
0.04% 0.1% 0.18% 0.04% 
Solvent Acetone 100-0.02% 50% 25% 50% 50% 
Surfactants 
Chlorhexidine 2-0.001% NG NG 0.004% NG 
Sodium 
Hydroxide 
(1 Molar) 
100-0.02% 1.6% 3% 3% 0.8% 
SDS 10-0.002% NG 0.02% 0.01% NG 
Roccal-D Plus 100-0.02% 0.4% 0.1% 0.2% 0.2% 
Buffers 
Tris (pH 7) 100-0.02% G G G G 
Tween-20 100-0.02% G G G G 
EDTA (1 Molar) 100-0.02% G G G G 
Irradiation 
Ultraviolet 
Light 
0-60 
minutes of 
exposure 
NG G NG NG 
Temperature 
Changes 
Autoclave 
121
o
C for 15 
minutes 
NG NG NG NG 
Heat 
45°C G G G G 
50°C G G NG NG 
56°C NG G NG NG 
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Antibiotic experiments:  Overall we found Spiroplasma to be susceptible to macrolides, 
florfenicol, and tetracylcines.  They were most affected by bacteriostatic antibiotics that targeted 
the 50S ribosome.  Spiroplasmas were most susceptible to the macrolide tylosine tartrate that 
inhibited growth at all concentrations.  Table 3.25 summarizes Spiroplasma susceptibility to all 
antibiotics tested.   
 
 
 
Table 3.25 Spiroplasma susceptibility to antibiotics.   
Antibiotic 
Range 
(ug/ml) 
S/C Mechanism of action 
Spiroplasma susceptibility 
S G S.m S.c 
Fluorquinolones Enrofloxacin 2-0.12 C Inhibits DNA gyrase R R 1 1 
Aminocoumarin Novobiocin 4-0.5 C Inhibits DNA gyrase R R R R 
Penicillins 
Penicillin 8-0.5 
C 
Inhibit cell wall 
synthesis 
R R R R 
Amoxicillin 16-0.25 R R R R 
Cephalosporins Cetfiofur 4-0.25 C 
Inhibits cell wall 
synthesis 
R R R R 
Aminoglycosides 
Streptomycin 1024-8 
C 
Bind 30S and inhibit 
protein synthesis 
512 R 512 256 
Neomycin 32-2 R R R R 
Gentamicin 8-0.5 R R R R 
Aminocyclitols Spectinomycin 64-8 S 
Bind 30S and inhibit 
protein synthesis 
R R R R 
Tetracyclines 
Tetracycline 8-0.25 
S 
Bind 30S and inhibit 
protein synthesis 
2 4 4 4 
Oxytetracycline 8-0.25 2 4 4 2 
Macrolides 
Erythromycin 4-0.12 
S 
Bind 50S and inhibit 
protein synthesis 
0.25 0.5 2 0.5 
Tylosin tartrate 20-2.5 2.5 2.5 2.5 2.5 
Florfenicol 8-1 S 
Bind 50S and inhibit 
protein synthesis 
2 4 R R 
Lincosamides Clindamycin 4-0.5 S 
Bind 50S and inhibit 
protein synthesis 
0.5 0.5 4 1 
Sulfonamides 
Sulfadimethoxine 256-32 
S 
Inhibits bacterial 
synthesis of folic acid 
R R R R 
Sulphathiazole 256-32 R R R R 
Trimethoprim/ 
sulfamethoxazole 
2/38-
0.5/9.5 
R R R R 
 
Antibiotics are listed in their categories and the different antibiotics that were tested.  The range 
of antibiotics is listed as well as their mechanisms of action.  Bactericidal and bacteriostatic are 
indicated with C (bacteriocidal) and S (bacteriostatic).  The lowest concentration of antibiotic 
that inhibited growth is listed for each Spiroplasma.  Those antibiotics that allowed sprioplasma 
growth at all levels of antibiotic tested are indicated with an R for resistant.  Three different 
species of Spiroplasma were tested: S. mirum’s (S) SMCA; S. mirum’s (G) GT48; (S.m) S. 
melliferum; and (S.c) S.citri.    
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Complement experiments:  Spiroplasma spp. were not susceptible to normal goat complement 
(Table 3.26).  All three species were susceptible to goat complement following opsonization with 
hyperimmune serum (Table 3.27).  Spiroplasma spp. grew in all heat inactivated complement 
controls (data not shown).   
 
Table 3.26 Spiroplasma growth in the presence of normal goat complement 
Time SMCA  GT48 S. melliferum S. citri 
1 minute Growth Growth Growth Growth 
5 minutes Growth Growth Growth Growth 
10 minutes Growth Growth Growth Growth 
15 minutes Growth Growth Growth Growth 
30 minutes Growth Growth Growth Growth 
60 minutes Growth Growth Growth Growth 
 
Table 3.27 Spiroplasma growth in the presence of hyperimmunized goat complement 
Time SMCA  GT48 S. melliferum S. citri 
1 minute Growth Growth Growth Growth 
5 minutes Growth Growth Growth Growth 
10 minutes Growth Growth Growth Growth 
15 minutes Growth Growth Growth Growth 
30 minutes No Growth No Growth No Growth No Growth 
60 minutes No Growth No Growth No Growth No Growth 
 
 
Discussion 
 
The lack of cell wall in spiroplasmas explains most of the susceptibility seen for the disinfectants 
tested.  However, GT48 was resistant to higher dilutions of many of the disinfectants as well as 
higher temperatures and requires more testing to determine its virulence factors.  In general, the 
spiroplasmas were susceptible to most disinfectants that are ineffective for prions.   
 
Alcohols are a common disinfectant used in everyday laboratory use. They have limited residual 
activity due to evaporation, which results in brief contact times unless the surface is submerged, 
and have a limited activity in the presence of organic material. Alcohols are most effective when 
combined with purified water to facilitate diffusion through the cell membrane; 100% alcohol 
typically denatures only external membrane proteins.   Ethyl alcohol (C2H5OH), isopropyl 
alcohol ((CH3)2CHOH), and methanol (CH3OH) cause membrane damage, rapid denaturation of 
proteins, and subsequent interference on metabolism resulting in cell lysis.  Alcohols are 
generally effective against vegetative bacteria, viruses, and fungi (McDonnell and Russell, 
1999).  They are reported to be an ineffective disinfectant for prions at concentrations of 50-
100% (Rutala and Weber, 2010).  Spiroplasma, however, were susceptible to low levels of 
alcohol treatment.  After 1 minute of exposure to 35% ethanol, all spiroplasma growth was 
inhibited.  Methanol and isopropanol were also effective on contact and inhibited growth at 50% 
concentration.  This can be attributed to the membrane damage and rapid denaturation of 
proteins that alcohols cause on contact.  This study correlates well with Stanek’s findings in 
 58 
1981.  He reported that S. citri, S. melliferum, and SMCA were susceptible to ranges of ethanol 
from 40-20% over a 40 minute time period (Stanek et al., 1981). 
 
Aldehydes, such as formaldehyde (CH2O) and glutaraldehyde (CH2(CH2CHO)2), have wide 
microbiocidal activity and are sporocidal and fungicidal.  Formaldehyde mixed in an aqueous 
solution is commonly referred to as formalin.  Both of these aldehydes kill cells quickly by 
crosslinking proteins and may be used as a disinfectant or fixative for infected tissues.  
Formaldehyde (3.7%) and gluteraldehyde (5%) have been shown to be ineffective against prion 
fixation.  Spiroplasmas were susceptible to 3-0.02% formalin which agrees with Clark and 
Stanek’s publications reporting inactivation of Spiroplasma after exposure to 2-0.03% formalin 
(Clark, 1964; Stanek et al., 1981).  GT48 was able to grow in 50% gluteraldehyde (see Table 
3.28), and Bastian also reported Spiroplasma could resist gluteraldehyde (Bastian, 2005).  All 
other Spiroplasma were inactivated by 0.8% gluteraldehyde or less.  This also correlates with 
Stanek’s findings for gluteraldehyde (inactivation range: 0.5-0.06%) (Stanek et al., 1981).  
Formaldehyde appears to be the more suitable fixative for spiroplasma-infected tissues due to its 
ability to cross link proteins and kill the organisms.  Gluteraldehyde was less effective, especially 
for GT48, and more research is needed to determine the strain’s survival factors.   
 
Oxidizing agents act by oxidizing the cell membrane of microorganisms, which results in a loss 
of structure and leads to cell lysis and death. A large number of disinfectants function in this 
way.  Sodium hypochlorite (NaClO), povidone-iodine, and hydrogen peroxide (H2O2) are 
examples of oxidizing agents that were studied in this paper.  Household bleach, sodium 
hypochlorite normally sold as a 5.25% concentration, is used at 10% solution in laboratory 
conditions to keep harmful corrosive effects to a minimum.  It is effective against 99% of 
bacteria, viruses and some types of mold (Estrela et al., 2002).  Povidone-iodine contains 9-12% 
available iodine (I2) and is effective against bacteria, viruses, fungus, and protozoan cysts 
(Reimer et al., 1998).  Hydrogen peroxide, diluted to 3%, is a common disinfectant in 
laboratories and households.  These agents had a major impact on Spiroplasma survival.  Iodine 
did not allow growth at even the lowest dilution (0.02%) for any spiroplasma species.  Sodium 
hypochlorite inhibited growth of all Spiroplasma at very small dilutions (0.04%) as did hydrogen 
peroxide (0.1%).  The oxidizing agents’ efficacy against Spiroplasmas is most likely attributed to 
the lack of a cell wall and easy access for oxidation of the cell membrane.  Prions can be 
inactivated by hydrogen peroxide but only at higher percentages (59%).  They are not affected by 
iodine (2%) (Rutala and Weber, 2010).  
 
A variety of surfactants are used in the laboratory for disinfecting glassware and work surfaces.   
Chlorhexidine (N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl) (imidodicarbonimidic diamide)) 
is commonly used as a topical antiseptic.  It works by damaging the outer cell layers and attacks 
the bacterial cytoplasmic or inner membrane ((McDonnell and Russell, 1999).  Sodium 
hydroxide (NaOH), also known as lye, is a caustic cleaning agent.  Its mechanism of action is 
poorly understood, but it is effective against most bacterial agents. Sodium dodecyl sulfate 
(SDS) (C12H25SO4Na) is an anionic surfactant used in many cleaning agents.  The mode of action 
is attributed to the positive charge, which forms an electrostatic bond with negatively charged 
sites on microbial cell walls. Those electrostatic bonds create stress in the cell wall, leading to 
cell lysis and death. (Simoes et al., 2006).  Roccal (Didecyl dimethyl ammonium chloride 9.2%, 
Alkyl (C12, 61%; C14, 23%; C16, 11%; C18, 2.5%; C8 & C10, 2.5%), dimethyl benzyl 
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ammonium chloride  9.2%, Alkyl (C12, 40%; C14, 50%; C16, 10%) dimethyl benzyl ammonium 
chloride 4.6%, bis-n-tributyltin oxide 1.0%, Inert Ingredients: 76.0%) is a commercial cationic 
surfactant.  It is a bactericide, fungicide, and virucide for veterinary, laboratory animal, kennel 
and animal breeder facilities. It is also a residual bacteriostat and inhibits bacterial growth on 
moist surfaces and contains rust corrosion inhibitors (Drugs.com).  All surfactants tested were 
able to inhibit spiroplasma growth at low dilutions.  Chlorhexidine and SDS were able to inhibit 
most species tested at all dilutions.  Sodium hydroxide, an effective agent for prions, inhibited 
growth at 3.2% for all spiroplasma. Roccal, used around veterinary operations and herd animals, 
was also very effective inhibiting growth at dilutions of 0.4% and less.   Surfactants’ efficacy for 
Spiroplasma, like the oxidizing agents, is also attributed to their attack on the outer cell layers, 
leading to cell lysis and death.   
 
Acetone is an organic compound with the formula (CH3)2CO.  In the laboratory, acetone is used 
as a polar aprotic solvent in a variety of organic reactions, such as SN2 reactions.  It is typically 
the solvent of choice for cleaning purposes of laboratory glassware because of its low cost and 
volatility (McDonnell and Russell, 1999).  Acetone (50%) was effective against Spiroplasma 
survival, due to its quick denaturing properties.  It is not effective at any percentage for prion 
inactivation. 
 
Tris ((HOCH2)3CNH2) and Tween-20 are common compounds found in many laboratory buffers.  
It has reported that Tris inhibits a number of enzymes;
 
and therefore, it should be used with care 
when studying proteins. (Desmarais et al., 2002).  EDTA is a chelating agent that is mainly used 
to sequester metal ions in aqueous solution.  Animal experiments frequently use blood collecting 
tubes that contain EDTA as an anticoagulant.   As a precaution, dilutions of EDTA were also 
used in the disinfectant studies to be sure that there was no interference in spiroplasma recovery.  
Spiroplasma spp. were able to grow in the presence of all concentrations of Tris, Tween, and 
EDTA, supporting the presumption that all other experiments with these compounds will not be 
affected by their use. EDTA has also been suggested as a disrupting agent for biofilms.  S. citri 
has the potential to create a biofilm because it uses the phosphoenolpyruvate:phosphotransferase 
system (PTS) (Bove et al., 2003).  Although we did not test the efficacy of EDTA’s ability to 
disrupt Spiroplasma biofilms, our results indicate that it will not cause Spiroplasma death. 
 
When subjected to changing temperatures, various bacteria have different susceptibilities.  
Spiroplasma have been reported to grow at temperature ranges from 5-43
o
C (Konai et al., 1996).  
Konai also found that SMCA had no color change at 43
o
C, but slow growth may have occurred 
without acidifying the media.  SMCA was able to survive 1 hour at 40
o
C and 50
o
C but only 10 
minutes at 56
o
C.  S. melliferum and S. citri survived only 30 minutes at both 50
o
C and 56
o
C.  
GT48 was able to survive 1 hour at all temperatures tested.  The lack of cell wall is a reasonable 
explanation for the vulnerability to higher temperatures.  GT48’s ability to survive at the higher 
temperatures is another reason for further testing of its resistant properties.  Prions are able to 
sustain a wide range of dry heat temperatures (Rutala and Weber, 2010).   
 
An autoclave is used for sterilization purposes in many laboratories.  It works by subjecting 
items placed inside to high pressure steam at 121 °C for 15–20 minutes depending on the size of 
the load and the contents.  This inactivates all bacteria, viruses, spores, and fungi.  Its efficacy 
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against prions has not been proven.  All Spiroplasma spp. were inactivated following 
autoclaving, another example of their vulnerability to high temperatures. 
    
Ultraviolet lamps are used to sterilize workspaces and tools used in biology laboratories and 
medical facilities. UV light at germicidal wavelengths causes adjacent thymine molecules on 
DNA to dimerize; if enough of these defects accumulate on a microorganism's DNA, its 
replication is inhibited, thereby rendering it harmless. With the exception of GT48, Spiroplasmas 
are also susceptible to UV irradiation after 1 hour.  UV irradiation is ineffective for GT48 as well 
as prions.  GT48’s resistance to UV irradiation gives further evidence for protective mechanisms 
not seen in the other spiroplasmas tested.   
 
Spiroplasma’s lack of cell wall was a contributing factor to its susceptibility to many of the 
disinfectants tested, but it is a survival factor against many of the antibiotics used in today’s 
therapies.  Mollicutes’ lack a cell wall that makes them innately resistant to all antimicrobials 
which target the cell wall.  These antimicrobials include polymyxins, sulfonamides, 
trimethoprim, nalidixic acid, and rifampin (Bebear and Bebear, 2002).  With this explanation, the 
resistance found for the penicillins and cephalosporins tested was not surprising.  Although 
results in this study agreed with the research for resistance to sulfonamides and trimethoprim, in 
1984 Bastian found trimethoprim/sulfamethoxazole (TMP/SMX) inhibited clinical and 
pathological signs in SMCA-inoculated suckling rats. Suckling rats received 200 mg/kg SMX 
and 40 mg/kg TMP in 5%sterile dextrose by IV infusion from day 5-15 post SMCA-inoculation.  
Rats were followed to day 25 of the infection.  The use of TMP/SMX treatment reduced the 
mortality rate significantly.  Spiroplasma was recovered from TMP/SMX treated rats, but the 
titers were significantly lower (Bastian et al., 1989).  Bastian did report that this data disagreed 
with their preliminary in vitro findings.  He went on to suggest that mortality was not an 
appropriate end point and that only viability titers in the brain should be considered.    
 
Spiroplasma was also resistant to the aminoglycosides neomycin and gentamicin, and the 
aminocyclitols spectinomycin.  Aminoglycosides are bactericidal antibiotics that are used in the 
treatment of infections caused by Gram-negative aerobes.  They bind to the 30S ribosome and 
inhibit the rate of protein synthesis and the fidelity of messenger ribonucleic acid (mRNA) 
translation, resulting in the synthesis of abnormal proteins.  Aminoglycoside uptake by bacteria 
involves an energy-dependent step that is oxygen-linked.  Therefore uptake is inhibited by an 
anaerobic or acidic environment.  Streptomycin represents one of the oldest members of this 
group.  Neomycin, another aminoglycoside, is used to treat enteric infections and topically to 
treat skin, ear, and eye infections.  Gentamicin and kanamycin are extended-spectrum 
aminoglycosides that are used for the treatment of septicemia and infections of the skin, 
respiratory tract, ear, eye and urinary tract.  Aminocyclitols are chemically related to the 
aminoglycocides.  They also bind to the 30S ribosome and inhibit protein synthesis.  Unlike 
aminoglycosides, they are bacteriostatic.  They are effective against Gram-negative and 
Mycoplasma bacteria.  Spectinomycin is an aminocyclitol used for treatment of enteric and 
respiratory disease (Papich, 2007).  These antibiotics have been used for treatment of other 
genera of mollicutes, the Mycoplasma.  Resistance was also found when different concentrations 
of the broad-spectrum antibiotics kanamycin and novobiocin failed to inhibit the multiplication 
of SMCA in chick embryos and rabbit lens organ cultures (Bastardo et al., 1974; Schwartz and 
Elizan, 1972).   
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Spiroplasmas, with the exception of GT48, were susceptible to streptomycin, one of the oldest 
members of the aminoglycosides. This antibiotic works on the 30S ribosome as do the 
tetracyclines.  Tetracyclines are bacteriostatic inhibitors of a broad spectrum of bacteria 
including, rickettsia, spirochetes, chlamydiae, mycoplasmae, and some protozoa.  They inhibit 
bacterial protein synthesis by binding to the 30S ribosome and preventing attachment of the 
aminoacyl transfer ribonucleic acid (tRNA) to the mRNA-ribosome complex.  They block the 
addition of amino acids to the growing peptide chain.  Tetracyline and oxytetracycline are used 
in the treatment of local and systemic bacterial, chlamydial, rickettsial, and protozoal infections 
(Papich, 2007).  All three species of Spiroplasma were also susceptible to tetracyclines in this 
study.  However, in vivo, tetracycline did not protect suckling rats against SMCA-induced 
cataracts when inoculated (50 µg/animal, repeated 4 days pi) at time of SMCA inoculation or 4 
hours prior (Clark, 1974).  Rats born to mothers given tetracycline in drinking water 
(approximately 500 µg/ml) prior to parturition and during the nursing period were not protected 
against SMCA-induced cataracts (Clark, 1974).   Tetracyclines have been studied as possible 
therapy for TSE infections.  Tetracyclines interact with aggregates obtained by synthetic PrP 
peptides or pathological PrP (PrP
sc
) extracted from TSE brains, and they destabilize the structure 
of amyloid fibrils, reducing their resistance to digestion by proteinase K. Tetracyclines also 
interact with peptide oligomeric structures and inhibit the protein misfolding associated with 
PrP
sc
 formation (Forloni et al., 2002). 
  
There were mixed reactions for Spiroplasma susceptibility to enrofloxacin and florfenicol.  
Enrofloxacin is a fluoroquinolone that inhibits bacterial DNA gyrase.  In vivo, it is distributed 
throughout the CNS, bone, and prostate and has broad spectrum bactericidal effects on most 
bacteria. Florfenicol is a thiamphenicol derivative bacteriostatic agent that also binds to the 
bacterial 50S ribosome unit to inhibit peptide bond formation and protein synthesis. It has broad 
spectrum against most anaerobic bacteria and Mycoplasmas and is used for respiratory, CNS, 
and ocular infections (Papich, 2007).  S. melliferum and S. citri were susceptible to enrofloxacin.  
SMCA and GT48 were susceptible to florfenicol.   Both of these antibiotics can reach high 
intracellular concentrations, which may be an advantage for spiroplasma infections.    
 
Novobiocin is an aminocoumarin antibiotic that is a very potent inhibitor of bacterial DNA 
gyrase.   It targets a different site on DNA gyrase than that of the flouroquinolones, targeting the 
GyrB subunit of the enzyme involved in energy transduction. Novobiocin as well as the other 
aminocoumarin antibiotics act as competitive inhibitors of the ATPase reaction catalysed by 
GyrB.  It is bacteriocidal and is used predominantly for staphylococcal infections(Papich, 2007).  
Unlike florfenicol, all Spiroplasmas were resistant to novobiocin.   
 
Spiroplasmas, like Mycoplasmas are susceptible to macrolides and lincosamides.  Macrolides are 
bacteriostatic antibiotics that work primarily against Gram-positive bacteria and Mycoplasma.  
They inhibit bacterial protein synthesis by binding to the 50S ribosome, preventing translocation 
of amino acids to the growing peptide chain.  Erythromycin, a macrolide, is used as an 
alternative to penicillin for the treatment of infections caused by Gram-positive bacteria.  
Tylosin, another macrolide, is used for the treatment of local and systemic infections caused by 
mycoplasma, Gram-positive bacteria, and some Gram-negative pathogens.  Lincosamides 
represent another group of antibiotics that inhibit protein synthesis by binding to the 50S 
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ribosome.  They are also bacteriostatic and are active against Gram-positive bacteria, 
Toxoplasma, and Mycoplasma species.   Clindamycin, a lincosamide antibiotic, is used for 
periodontal disease, osteomyelitis, dermatitis, and deep soft tissue infections caused by Gram-
positive bacteria (Papich, 2007).  Kotani (Kotani et al., 1986)Kotani, Phillips et al. 1986) found 
that a combination of tylosine (30 µg/ml) and gentamycin (50 µg/ml) inhibited the 
transformation of NIH-3T3 and CV-1 cells by SMCA.  Furthermore, cells with history of 
spiroplasma infection were negative for the bacteria after the addition of these antibiotics and 
tylosine appeared to be the active inhibiting compound in that experiment.   
 
Spiroplasma spp. were not adversely affected by normal goat complement showing that they do 
not activate the alternative pathway of complement.  All three species were susceptible to 
SMCA-hyperimmunized goat serum in the presence of complement.  This indicates that 
complement mediated lysis does occur via activation of the classical pathway.  This provides 
evidence that an acquired immune response is required for killing of the organism by 
complement.  
 
Conclusion 
 
Although Spiroplasma are similar to prions in their persistence in neurologic tissues, 
Spiroplasma do not share the same resistant properties as prions.  A comparison of efficacy for 
the disinfectants against Spiroplasma and prions can be seen in Table 3.28.  The three species of 
Spiroplasma tested were susceptible to minimal dilutions of common laboratory disinfectants.  
They were also susceptible to many of the antibiotics in use for other mollicutes.  We did find 
strain differences in S. mirum in that GT48 was more resistant to many of the disinfectants and 
antibiotics tested.  More research is needed to determine if this resistance is associated with any 
virulence factors it may possess. 
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Table 3.28 Comparison of disinfectant efficacy against Spiroplasma and prions.   
All disinfectants that were found to inhibit spiroplasma are indicated with effective.  For a select 
few, all species of Spiroplasma were inhibited with the exception of GT48.  These disinfectants 
are indicated with (GT48).  
Disinfectant Spiroplasma Prions  
Alcohols 
Ethanol 70% Effective Ineffective 
Methanol Effective Ineffective 
Isopropanol Effective Ineffective 
Aldehydes 
Formalin 3% Effective Ineffective 
Gluteraldehyde 50% Effective (GT48) Ineffective 
Oxidizing Agents 
Sodium Hypochlorite Effective Not tested 
Povidone-iodine 2% Effective Ineffective 
Hydrogen Peroxide 3% Effective Ineffective 
Solvent Acetone Effective Ineffective 
Surfactants 
Chlorhexidine Effective Ineffective 
Sodium Hydroxide  Effective Effective 
SDS 5% Effective Ineffective 
Roccal Effective Not tested 
Irradiation Ultraviolet Light Effective (GT48) Ineffective 
Temperature 
Changes 
Autoclave Effective Ineffective 
Heat 45
o
C Ineffective Ineffective 
Heat 50
o
C Ineffective Ineffective 
Heat 56
o
C Effective (GT48) Ineffective 
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CHAPTER 4:   
CLINICAL SIGNS AND PATHOLOGY OF SPIROPLASMA MIRUM  SUCKLING 
MOUSE CATARACT AGENT IN SMALL RUMINANTS 
 
Introduction 
 
Spiroplasma mirum is the only spiroplasma that has been found to be pathogenic to vertebrates 
(Bove, 1997).  As the name describes, Suckling Mouse Cataract Agent (SMCA) when inoculated 
intracerebrally (IC) caused suckling mice to develop cataracts (Clark, 1964).  The organism was 
able to persist in suckling mice, specifically the brain tissues, for up to two years (Clark and 
Karson, 1968).  Due to this observation, it was tentatively included with the slow viruses or 
chronic infectious neuropathic agents (Hotchin, 1967).  When inoculated into suckling rats, 70% 
developed cataracts and 36% developed mild to severe hydrocephalus (Elizan et al., 1972).  The 
organism causes death between four to seven days post inoculation in seven day old 
embryonated eggs (Clark, 1964).  In day-old chicks inoculated IC or subcutaneously (SQ), S. 
mirum caused death within five days (Clark, 1974).  When inoculated IC into day old hamsters, 
CNS signs and severe weight loss were observed (Kirchhoff et al., 1981).  Death and severe 
microophthalmia were seen in rabbits inoculated IC less than twenty-four hours after birth.  No 
clinical signs were seen when S. mirum was inoculated into adult mice, roosters, hamsters, 
rabbits, guinea pigs, and rhesus monkeys (Clark, 1974).   
 
The organism’s persistence for long periods of time within the brains of animals led researchers 
to categorize SMCA as a “slow virus.” This family included the infectious agent for scrapie in 
sheep and the agent of Kuru in man (Schwartz and Elizan, 1972).  Tully suggested that this 
organism could be related to the causative agent of scrapie which had not yet been identified 
(Tully et al., 1976).  In 1979 Bastian reported spiral membranous inclusions seen by electron 
microscopy in brain biopsy tissues from a patient with Creutzfeldt-Jakob disease (CJD) (Bastian, 
1979).  Following this initial report of spiroplasma-like inclusions in CJD tissues, Reyes 
published two case reports of patients that were suspected of CJD with similar findings. Electron 
microscopy revealed numerous membrane-bound vacuoles within the cell bodies of neurons and 
astrocytes.  Elongated, spiral, membranous inclusions were occasionally present within cortical 
cell processes, as well as in synaptic terminals (Reyes and Hoenig, 1981).  Reyes also reported 
that transmission of CJD to spider monkeys was successful from brain tissues of one of these 
reported patients by Dr. D. C. Gajdusek and C. J. Gibbs.  In 1980 Gray reported a case of CJD to 
have spiral membranous inclusions, indicative of spiroplasma, with five to eight twists seen via 
electron microscopy (Gray et al., 1980).  In 1981 Bastian reported two more cases of CJD with 
similar spiral-like inclusions seen through electron microscopy (Bastian et al., 1981).    
 
Further research was conducted to show similarities between the transmissible agent of CJD and 
spiroplasma.  Bastian reported that the tissue response to experimental spiroplasma infection in 
the suckling rat brain resembles the spongiform degenerative brain diseases of both man and 
other mammals.  The degenerative changes are localized to the gray matter, as seen in CJD cases 
(Bastian et al., 1984).  The optimal growth temperature for S. mirum and other spiroplasma 
isolates was 37ºC, suggesting that spiroplasma could survive in a mammalian host (Bastian, 
2005; Konai et al., 1996).  The organism’s proven ability to produce an acute or
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Table 4.1 Summary of Spiroplasma mirum experimentally infected animals 
Species Age Route Death Disease Persistence of 
organism 
Ref 
Chicks <24 h IC 4 days pi Yellow livers and 
swollen spleens 
NT (Clark, 1974) 
<24 h SQ 5-6 days pi NT (Clark, 1974) 
Mice <96 h IC Rarely Cataracts 
1
 
Stunting 
Death 
827 days (Clark and Karson, 1968) 
>5 days IC No None 133 days (Clark and Karson, 1968) 
<96 h IP No None 9 days
2
 (Clark and Karson, 1968) 
<96 h IV No None NT (Clark and Karson, 1968) 
Adult IC 
 
IV, IN, IP, cornea 
No None 497 days 
 
NT 
(Clark and Karson, 1968) 
Rats <96 h IC Yes Cataracts 
3
 60 days (Clark, 1974) 
 <24 h SQ/IP
4
 No Cataracts 
Weight loss 
Alopecia 
50 days (Bastian et al., 1984) 
(Bastian et al., 1987b) 
Deer Mouse Adult SQ No None NT (Clark and Karson, 1968) 
Roosters Adult IM No None NT (Clark, 1974) 
Hamsters <24 h IC Variable CNS signs 
Dramatic loss of weight 
Runting 
NT (Kirchhoff et al., 1981) 
Adult IV No None NT (Clark, 1974) 
Rabbits <24 h IC 12 days Death 
Severe microphthalmia 
12 days (Kirchhoff et al., 1981) 
Adult IV, SQ No None NT (Kirchhoff et al., 1981) 
Scarified cornea No Ocular lesion AB negative (Clark, 1974) 
Guinea Pigs Adult IP, IM, SQ, cornea No None NT (Clark, 1974) 
Box Turtle Adult IP No None NT (Clark and Karson, 1968) 
Opossum Adult IP No None  NT (Clark and Karson, 1968) 
Rhesus Monkey Adult IV, SQ, cornea No None NT (Clark, 1974) 
IC: Intracereberal, SQ: Subcutaneous, IP: Intraperitoneal, IV: Intravenous, IN: Intranasal, IM: Intramuscular, NT: Not tested 
1 Cataracts were the most common clinical manifestation of SMCA inoculation 
2 Organism was not recovered from brain or eye tissues but was found in liver-spleen suspension  
3 Cataracts in suckling rats were more severe with a higher inoculation levels  
4 Rats were inoculated with S. mirum strain GT48 
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persistent brain infection in small mammals was also used as evidence.  Subsequent studies have 
shown some resistance of spiroplasma organisms to chemical factors with some resemblance to 
the resistance patterns seen in the transmissible agent of CJD (Bastian, 2005).  Bastian concluded 
that the size and membranous nature of spiroplasma would best fit with the data regarding the 
elusive CJD agent (Bastian et al., 1984).   
 
In 1987 a scrapie-associated fibril was identified as a consistent finding and possible infectious 
unit of the transmissible spongiform encephalopathies (TSEs).  Cross reactions with this fibril to 
S. mirum fibril proteins supported evidence of an association between spiroplasma and TSEs 
(Bastian et al., 1987a). In 2001 Bastian and Foster reported the presence of spiroplasma 
ribosomal DNA in CJD and scrapie-infected brains (Bastian and Foster, 2001).  In 2004 eight of 
ten scrapie infected brains, five of seven CWD infected brains, and two of two CJD brains were 
found to be positive for S. mirum via southern blotting of PCR products (Bastian et al., 2004).    
PCR products obtained from the scrapie, CWD, and CJD cases had 99% homology with 
published S. mirum 16S rDNA sequences (Bastian et al., 2004).  In this study, it was reported 
that the mode of DNA extraction was critical.  The most reliable method involved initial 
solubilization with guanidine thiocyanate followed by phenol/chloroform extraction (Bastian et 
al., 2004).  Southern blotting was also acknowledged as a more sensitive method of detection, 
revealing spiroplasma DNA where PCR product was not readily apparent (Bastian et al., 2004).   
 
In 2005 Bastian (Bastian, 2005) cultivated a spiroplasma from homogenates of CWD and scrapie 
infected brains. The brains were homogenized in SP4 media and then inoculated into eight day 
old embryonated eggs.  Allantoic fluids from the inoculated eggs were then passaged into SP4 
media and incubated for sixteen days at 37ºC.  Evidence of spiroplasma growth was found via 
phase microscopy, electron microscopy, and PCR.  DNA sequence analysis showed 98% 
homology with S. mirum but revealed nucleotide substitutions unlike any known spiroplasma 
strain.   The isolates from this experiment were later inoculated into neonatal goats and sheep 
(Bastian et al., 2007).  No clinical signs were seen but all brains had evidence of spongiform 
changes.  At eleven months post inoculation, one goat and one sheep had severe cerebella and 
hippocampal spongiform degeneration with neuronal vacuolization in the brain stem.  All other 
animals were reported to have spongiform changes at a lesser degree.  It was noted that the 
intraneuronal vacuoles in the cerebella cortex and brain stem seen in the Spiroplasma spp. 
inoculated ruminants were identical to lesions typical of naturally occurring TSE (Bastian et al., 
2007).   
 
In 2007 Bastian et al. (Bastian et al., 2007) induced spongiform encephalopathy in neonatal deer 
inoculated intracerebrally with SMCA.  Three of four deer developed clinical signs of 
neurological deterioration between 1.5 months and 5.5 months post inoculation.  One deer 
showed signs of hydrocephalus, while all others were grossly normal.  Histological sections of 
all deer showed spongiform encephalopathy in the cerebral cortex, cerebella cortex, and the brain 
stem.  Severity of neuropathology was noted as incubation time increased.  In the same 
publication, sheep were inoculated intracerebrally with varying dilutions of SMCA.  No clinical 
signs were noted, but spongiform encephalopathy was seen histologically.  Severity of lesions 
was decreased as the dosage of the inoculums decreased.    Neonatal goats were also inoculated 
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intracerebrally with SMCA.  After five months no clinical signs were seen and only minimal 
vacuolization was noted histologically.   
 
In order to compare natural TSE infections to Spiroplasma-induced disease, a long term animal 
model was established.  It has been proven that the mouse model does not always accurately 
portray a natural infection and so the ruminant model was chosen for disease establishment.  
Goats are known for multiple births, ease of handling, and have also been used for scrapie 
research; for these reasons, a herd of research goats were used for experiments with S. mirum.   
Neonatal goats were inoculated intracerebrally with SMCA and monitored for clinical signs for 
two years.  At the end of the experiment, various tissues were collected and examined for 
pathology and persistence of the organism.   
 
Five month old deer were also inoculated and monitored for clinical signs.  Seven months post-
inoculation, various tissues were collected and examined for pathology and persistence of the 
organisms.  Information from this experiment was used to compare to Bastian’s 2007 neonatal 
deer experiment (Bastian et al., 2007).   
 
In order to test possible routes of transmission, experiments were conducted with various 
inoculation routes of SMCA in neonatal goats.  Intravenous (IV) and intradermal (ID) routes 
were used as possible vector routes to establish a mode of transmission.  Goats were monitored 
for four months for clinical signs and persistence of the organism via various tissues.  After four 
months,  tissues were collected and examined for pathology.   
 
Since dose-dependent variations have been reported, pathology and clinical signs seen post-
SMCA inoculations of higher concentrations were compared.  SMCA cultures were concentrated 
ten times the normal and inoculated into neonatal goats.   Goats were monitored for four months 
for clinical signs and persistence of the organism via various tissues.  After four months, various 
tissues were collected and examined for pathology.   
 
Materials and Methods 
 
SMCA: SMCA strain of S. mirum, courtesy of Dr Gail Gasparich, Towson University, 
Baltimore, MD, USA, was used for the inoculums in all experiments and had undergone multiple 
passages in M1D broth. SMCA was grown to log phase (Bastian et al., 1984), aliquoted into 1 
mL portions mixed 50/50 with sterilized 30% glycerol resulting in a 15% glycerol mixture and 
frozen at –80ºC. For all following experiments, a stock of SMCA (approximately 1x108 
organisms per mL) was made by multiple passages at a 1:100 dilution rate into M1D and frozen 
at -80ºC.  Presence of spirals was checked via dark field microscopy for all cultures.   
 
Cultures were diluted in M1D at a 1:10 or 1:100 dilution prior to inoculation.  For ID inoculation 
routes, 2 mLs of SMCA was spun at 16000xg for 1 hour.  The supernatant was discarded and the 
pellet was re-suspended in 20 µL of M1D.    For concentrated SMCA experiments, a stock of 
SMCA was grown to equal 100 mL and frozen in 20 mL aliquots.  At time of inoculation, 20 mL 
were separated into 1 mL aliquots and spun at 16000xg for 1 hour.  The supernatant was 
removed from each tube and the pellet was re-suspended in PBS.  All 20 tubes were combined to 
equal 2 mLs.  For heat-killed concentrated SMCA inoculums, the re-suspended 2 mL PBS 
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culture was heated at 56
o
C in a water bath for 1 hour.  To check sterility, 100 µL of heat killed 
SMCA cultures were inoculated into 900 µL of fresh M1D and incubated for 14 days at 30ºC to 
check for any viable organisms prior to inoculation into animals. 
 
Animals:  White tailed deer were chosen from the LSU AgCenter Idlewild Experiment Station.  
Goats were obtained from the LSU AgCenter BenHur Research herd.  All studies were done 
according to protocols approved by the Louisiana State University Agricultural Center 
Institutional Animal Care and Use Committee.  Experimental animals were housed on concrete 
slabs in an IBRDSC approved isolation research facility.  Control deer were housed at the LSU 
AgCenter Idlewild Experiment Station. 
 
Tissue Samples: 
 Blood Samples:  Jugular blood samples were collected and immediately stored in both EDTA 
coated tubes and serum collection tubes.  100 μL of EDTA mixed blood was then transferred 
to 900 μL of M1D and allowed to incubate at 30ºC for at least 21 days.  Non-additive 
samples were centrifuged at 400 RPMs for 10 minutes to separate serum.  Serum was 
removed and stored at -20ºC for immunoblotting.     
 Brain Tissues: At time of necropsy, heads were separated immediately and the brain was 
removed using a stryker saw.  The right half of the brain was immersed in 10% formalin and 
stored at room temperature.  After two weeks, samples were taken from the cortex, 
hypothalamus, thalamus, hippocampus, cerebellum, midbrain, pons, obex, and spinal cord for 
histological processing. The cortex, hypothalamus, and cerebellum were sampled for 
culturing from the left half of the brain in both M1D and embryonated eggs.  Samples were 
also taken for PCR.  The remaining left half of the brain was frozen at -80ºC.   
 
Histology: Formalin-fixed sections were stained with haematoxylin and eosin.  Using standard 
protocols, the following immunohistochemical stains were applied: Anti-SMCA staining as 
established by Bastian (Bastian et al., 2007) to detect presence of the organism; and glial 
fibrillary acidic protein (GFAP) to detect the presence of astrogliosis.   
 
Dark Field Microscopy:  5 µL of test sample was placed on a clean glass microscope slide, 
mounted with a #1.5 cover slip and sealed on all 4 sides with clear finger nail polish.  Slides 
were examined with a Ziess Axio Imager A1 microscope (Carl Zeiss, Inc. North America, 
Thornwood, NY, USA) equipped with a dark-field top lens condenser 1.2-1.4 and an EC Paln-
NeoFluar x100 oil immersion objective (Carl Zeiss, Inc. North America, Thornwood, NY, USA) 
with 1.3 iris closed to its lowest setting (0.7).   
 
Embryonated Egg cultures: Approximately 100 mg of tissue was taken from the cortex, 
hypothalamus, and cerebellum and homogenized in 1 mL of M1D with 10 mg of vancomycin.  
Cultures were spun at 1000 RPM for 5 minutes to remove tissue debris.  The supernatant was 
removed, and 10 μL was inoculated into the yolk sac of 7 day old embryonated eggs via a 1½ 
inch 22 gauge needle.  Like number of eggs were injected with M1D media alone to serve as 
controls.  Eggs were candled daily to monitor viability.  At death or time of harvest, allantoic 
fluid was collected by aspiration via 1 inch 20 gauge needle and 3 ml syringe.  The fluid was 
observed via dark field microscopy for spiral organisms.  10 μL of allantoic fluid was passaged 
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back into 7 day old embryonated eggs as well as M1D.  Second passage of eggs followed above 
protocol; M1D was monitored for a color change until 21 days.     
 
M1D cultures: Approximately 100 mg of tissue was homogenized in 1 mL of M1D with 10 mg 
of vancomycin.  Cultures were spun at 1000 RPM for 5 minutes to remove large chunks of tissue 
debris.  The top half of culture (500 μL) was removed and combined with fresh M1D with 
vancomycin to 1 mL.  M1D with vancomycin was added to the original homogenized tissue 
culture to 1 mL.  Cultures as well as a media control were incubated at either 30ºC or 37ºC, 
dependent on the experiment, for at least 21 days.  At 21 days, cultures were checked via dark 
field microscopy for presence of spiral organisms.  All cultures were also checked by PCR for 
presence of SMCA organisms.   Cultures were passaged at least once at a 1:100 dilution into 
fresh M1D with vancomycin.  Second passages were checked for spiral organisms via dark field 
microscopy and PCR at 21 days as well.   
 
PCR Methods:  PCR was carried out using oligonucleotide primers that specifically aplified a 
1460 bp portion of the S. mirum-related adhesin gene.  The forward and reverse primers were F3 
(5’-TCTAGTCTTAATCATTTTACTTATTTATTAGAA -3’) and R4 (5’-
TTATTAAGTCATTCACTCTCTTTCTTT -3’) respectively.   
The reaction mixture (50 µL total) contained 2 µL of each the forward and reverse primers (10 
µM each), 1 unit (0.2 µL) of Taq DNA Polymerase (New England BioLabs, Ipswich, MA), 2 µL 
of 10 mM dNTP (AmpliTaq Gold, Applied Biosystems, Foster City, CA), and 5 µL of 10x 
Standard Taq Buffer (New England BioLabs), which contains 15 mM of MgCl2.  For M1D 
cultures, 2 μL of culture was added to the reaction mixture without prior DNA extraction.  DNA 
extraction followed the QIAamp Blood and Tissue DNA Extraction protocol for all animal tissue 
PCR reactions.  Each reaction was brought to a final volume of 50 μL with sterile, nuclease-free 
H2O.  PCR’s were performed using a MyCycler Thermal Cycler (Bio-rad).  The thermal cycler 
program used was 94ºC for 5 minutes, then 30 cycles at 94ºC for 30 seconds, 57ºC for 20 
seconds, and 72ºC for 120 seconds followed by a final extension of 72ºC for 10 minutes.  All 
PCR products were electrophoresed on a 1% agarose gel in Tris-acetate-EDTA (TAE) buffer, 
and the DNA was visualized by SYBR Safe (Invitrogen, Eugene, OR) DNA gel staining under 
UV fluorescence. 
 
Western Blots:  SMCA cell lysates were made as 3 different antigen preparations: boiled, 
guanidine thiocyanate, and sonicated.   The boiled SMCA antigen preparation was made as 
follows.  Six 1 mL aliquots of SMCA were spun at 16000xg for 1 hour.  Supernatant was 
discarded and 1 mL of PBS was added to each pellet.  Each 1 mL suspension was then boiled for 
10 minutes.  All vials were mixed together to create a stock solution.  Laemmli buffer with 2-
mercaptoethanol was added volume to volume to SMCA solution and boiled for ten minutes.    
The guanidine thiocyanate-SMCA preparation was as described by Bastian (Bastian et al., 2004).  
The preparation was made, and laemmli buffer with 2-mercaptoethanol was added to a like 
amount and boiled for 10 minutes.  The sonicated SMCA preparation was made following the 
same procedures as the boiled preparation.  However, after boiling for 10 minutes, each 1 mL 
aliquot was then sonicated for 10 minutes (Heat-Systems-Ultrasonic, Inc., cycle time 1 sec; duty 
cycle 50%).  All vials were mixed together to create a stock solution and laemmli blue with 2-
mercaptoethanol was added as stated previously.  All solutions were stored at -20ºC.  
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In order to determine an antibody profile for SMCA, 2 goats were immunized with boiled SMCA 
antigen.  1 mL of the solution was mixed with 1 mL of incomplete freund’s adjuvant.  The 2 mL 
mixture was injected intramuscularly into 2 different goats. Goats were boosted with 0.5 mL 
SMCA and 0.5 mL incomplete freund’s adjuvant 4 and 6 weeks later.  The same procedures 
were followed for inoculation of 2 goats with the sonicated antigen preparation.  Serum was 
collected at various time points post-immunization and stored at -20ºC for future analysis.   
 
Western immunoblot analysis was performed using the three cell lysates of SMCA.  
Electrophoresis was performed with a BioRad Mini-Protean II unit (Hercules, California, USA) 
utilizing the Laemmli discontinuous SDS-PAGE method with 5 μL of cell lysate per 20 μL well. 
Nitrocellulose transfer was performed for one hour with 150V in a Mini Trans-Blot 
Electrophoretic Transfer Cell (Bio-Rad). Following transfer the blots were blocked with a 5% 
nonfat milk buffer for one hour followed by washing with tris-buffered saline containing 0.5% 
Tween-20. Three adjoining membrane lanes containing the 3 cell  lysates were then incubated 
for at least 8 hours at 37ºC with a 1:40 dilution of the test serum. Subsequently, the blots were 
washed and incubated with rabbit anti-bovine (deer studies) or anti-goat (goat and sheep studies) 
IgG horseradish peroxidase conjugate (Sigma Chemical Company, Saint Louis, Missouri, USA) 
at a dilution of 1:800 for 45 minutes at room temperature. After washing, the substrate 4-chloro-
1-naphthol (Sigma) was added for at least 10 minutes for color development.   
 
Experiment 1 
One neonatal goat was inoculated IC with 2 mLs of SMCA and a tracer.  Twenty-four hours 
post-inoculation, the goat was humanely euthanized and the skull was removed for gross 
examination of the brain.  The tracer was located in order to establish the area of inoculation in 
vivo.  Various tissue samples were cultured in M1D as described above.  Samples were also 
tested for presence of spiroplasma via PCR.  
 
Experiment 2 
Four, 5 month old deer were tranquilized with Telazol (2.5 mg/kg) and xylazine (0.3 mg/kg) via 
a dart gun and inoculated through the open fontanel of the skull and into the left hemisphere with 
2 mLs of SMCA via an 18 gauge needle.  Four control deer of like age and genetics were 
inoculated with 2 mLs of MID media in the same manner and remained at Idlewild.  Deer were 
observed daily and euthanized at time of clinical signs or 7 months post-inoculation.  The control 
deer were euthanized at the same time as the SMCA-inoculated deer for control tissues.  Brain 
and eye tissues were collected and processed as described above. 
 
Experiment 3 
Twenty-nine 1 month old goats were separated into the following groups: 12 SMCA-inoculated 
goats, 3 SMCA 1:10 dilution goats, 2 SMCA 1:100 dilution goats, 6 M1D inoculated goats, 6 
control goats.  All inoculations equaled 2 mLs and were administered IC through the fontanel of 
the skull.  Goats were separated by sex and housed on concrete slab stalls.  Jugular blood 
samples were obtained every 6 months for immunoblotting.  All animals were observed daily 
and euthanized if exhibiting clinical signs or at 2 years.  Brain and eye tissues were collected and 
processed as described above. 
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Experiment 4 
Twelve newborn goats were injected within 48 hours after birth via different inoculation routes 
and allowed to remain with mother.   Three newborns were injected with 2 mLs of SMCA via 
the open fontanel of the skull; 5 were injected with 2 mLs of SMCA IV via the jugular vein; and 
4 were injected with 0.2 mLs of concentrated SMCA with a 22 gauge needle ID on the lower 
eyelid.  A jugular blood sample was obtained daily for the first 7 days and then weekly. All were 
housed on concrete slab stalls and observed daily for clinical signs.  Goats were euthanized at 
time of clinical signs or 2 months after inoculation.   Brain and eye tissues were collected and 
processed as described above. 
 
Experiment 5 
Three newborn goats were injected 48 hours after birth with concentrated SMCA (10X) via the 
open fontanel of the skull and allowed to remain with mothers.  Two newborns were injected in 
similar manner with heat-killed concentrated SMCA. All goats were housed on concrete slab 
stalls and observed daily for clinical signs.  Goats were euthanized at time of clinical signs or 4 
months after inoculation.  Brain and eye tissues were collected and processed as described above. 
 
 
 
  
Table 4.2 Summary of Experimental Animals 
Exp Species Inoculum Length of Experiment 
1 Caprine SMCA 24 hours 
2 Cervidae SMCA 6 months 
3 Caprine 
SMCA (IC) 
2 months SMCA (IV) 
SMCA (ID) 
4 Caprine 
10x Concentrated SMCA 
4 months 
Heat-killed 10x Concentrated SMCA 
5 Caprine SMCA 2 years 
 
 
 
Results  
 
Experiment 1  
Spiroplasma was recovered at high numbers from the mid-cerebral cortex adjacent to the area of 
inoculation.  Organisms were recovered from the optic nerve, cerebral cortex, hypothalamus, 
thalamus, and hippocampus.  Swabs of the skull cavity were positive for Spiroplasma, providing 
evidence that the inoculum pools within the brain cavity sufficiently soaking all areas of brain 
tissue.  No organisms were found in homogenized cultures of cerebellum, midbrain, pons, obex, 
or spinal chord.  PCR results were the same as culture results.  Figure 4.1 depicts the areas of 
spiroplasma recovery in this experiment.  
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Figure 4.1 Spiroplasma recovery 24 hours post-inoculation.  Positive areas are 
indicated by +, negative areas are indicated by -. 
 
 
 
Experiment 2-5  
 
Clinical Signs: Prior to necropsy seven months post-inoculation, one deer showed minimal 
clinical signs (lethargy and slight weight loss).  No goats exhibited any clinical signs regardless 
of experiment duration, inoculation route or dosage.   
 
Histology:  After extensive review, none of the experimentally infected animals appeared to have 
any pathological changes.  No abnormalities were seen in H&E staining and no sections were 
positive for anti-SMCA antibody staining.  One deer was positive for GFAP staining, however, it 
had been inoculated with M1D only (Figure 4.2 A).  A comparison of SMCA-inoculated deer is 
seen in Figure 4.2 B.   
 
Persistence of SMCA:   
Blood:  SMCA was recovered from the blood of neonatal goats IC and IV inoculated four days 
post inoculation.  The bacteria could not be recovered after five days post inoculation.  No 
organisms were recovered via the blood from any ID inoculated goats.  PCR was conducted on 
all cultures to confirm presence of organisms.   
 
+ 
+++ 
+ 
- 
- 
Inoculation Site 
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Figure 4.2 GFAP staining of experimental animals 
A) GFAP staining from a M1D-inoculated deer six months post inoculation. 
B) GFAP staining from a SMCA-inoculated deer six months post inoculation. 
 
 
 
Figure 4.3 PCR results demonstrating cultures positive for SMCA.  Lanes 1-3: IC goat cultures 
(14 days post-inoculation), Lanes 4-6: IV goat cultures (2 days post-inoculation), Lanes 7-9: ID 
goat cultures (2 days post-inoculation), Lanes 10-11: IC goat cultures (3 days post inoculation), 
Lane 12: water negative, Lanes 13-14: positive controls, Lanes 15-18: IV goats (4 days post 
inoculation).  PCR primers are specific to the S. mirum adhesin gene.   
A B 
M M  1   2  3   4   5   6   7   8   9  10  11 12  13  14  15  16  17  18 
19 20 
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Brain Tissues: 
We were able to recover SMCA from one out of fifty-four animals.  The cortex from an SMCA 
IC inoculated deer in experiment two was positive for spiroplasma organisms. The tissue was 
homogenized in M1D, and the supernatant inoculated into four embryonated eggs.  Pooled 
allantoic samples were taken and inoculated into M1D media.  After two passages in M1D, one 
helical organism was noticed via dark field microscopy (Figure 4.4).  The culture was passaged 
into fresh M1D, but no Spiroplasma growth was found after any passages (M1D) or any 
embryonated eggs cultures that followed.     
  
 
 
Figure 4.4 Spiroplasma seen via dark field microscopy from SMCA-inoculated deer. 
 
 
 
PCR:  No tissue samples from any of the fifty-four experimental animals tested were positive for 
spiroplasma via PCR.  Figure 4.5 is an example PCR blot from SMCA-inoculated tissues.  The 
positive banding seen is from the positive control.  All other samples were negative. 
 
 
 
Figure 4.5 PCR for SMCA-inoculated tissues.  PCR primers are specific to the S. mirum adhesin 
gene. 
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Antibody Production: Multiple serum samples were tested from each animal inoculated with 
SMCA.  For short term experiments, serum samples from six weeks and eight weeks were tested.  
For long term experiments, serum samples were taken at six weeks and then once every six 
months.  There was no spiroplasma-specific banding on any immunoblots for SMCA antibodies.  
There were minor non-specific bands found on SMCA-inoculated animals as well as M1D-
inoculated animals. The antibody profiles from a goat hyperimmunized with boiled SMCA 
antigen can be seen in Figure 4.6 C below.  Figure 4.6 A is an example of a western blot from a 
M1D-inoculated goat and B is from an SMCA-inoculated animal.  
 
 
 
 
 
A  B  C   
Figure 4.6 Immunoblots from experimental animals 
A) Immunoblot from M1D-inoculated animal, B) Immunoblot from SMCA-inoculated animal., 
C) Immunoblot from goat hyperimmunized with boiled SMCA antigen. 
The first line in all blots is the marker, the second line is the boiled antigen preparation, the third 
line is the guanidine thiocyanate-SMCA preparation.  The last line is a from a Yesinia antigen 
preparation, used as a positive control.   
 
 
 
 
Discussion  
 
For the purpose of discussion, we will include all ruminant experiments done in this laboratory.  
This will include the experiments published by Bastian et al. in 2007 (Bastian et al., 2007).  
Table 4.3 summarizes all ruminant experiments.  Figure 4.7 depicts an overall timeline for 
SMCA ruminant experiments. 
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Table 4.3 Summary of ruminant experiments 
Exp Species Inoculum Length of Experiment 
Bastian 
2007 
Cervidae SMCA 6 months 
2 Cervidae SMCA 6 months 
Bastian 
2007 
Ovis 
SMCA 
1.5 years 1:10 SMCA 
1:100 SMCA 
Caprine SMCA 4 months 
3 Caprine 
SMCA (IC) 
2 months SMCA (IV) 
SMCA (ID) 
4 Caprine 
10x Concentrated SMCA 
4 months 
Heat-killed 10x Concentrated SMCA 
5 Caprine SMCA 2 years 
 
 
 
 
Figure 4.7 An overall timeline for SMCA ruminant experiments. 
 
The experiments in this paper did not result in any evidence of pathology or persistence of 
SMCA.  None of the fifty-four experimental animals were positive for spongiform 
encephalopathy, and only one was positive for the organism after six months of incubation.  
Tully suggested that pathogenicity is dependent on the S. mirum strain, the animal host, and the 
history of the inoculum (Tully et al., 1983).  In the case of SMCA, after continued passage on 
artificial media, the LD50 for suckling rats increased; and the strain no longer induced cataracts, 
while the LD50 for chick embryos decreased (Bove, 1997). Loss of pathogenicity due to multiple 
passages could be an explanation for the contrasting results found in our experiments compared 
to those from 2007 (Bastian et al., 2007) however, virulence was seen in embryonated egg 
experiments previously reported in this body of work.   
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Clark found that SMCA pathology was dependent on dose, age, and host strain (Clark and 
Karson, 1968). This may account for the differences seen in deer experiments since our deer 
were five months old at time of inoculation.  Clark also found that the larger the dose and the 
younger the host the greater pathology produced (Clark and Karson, 1968).  This did not hold 
true in our neonatal goat experiments where we inoculated ten times the normal inoculum within 
seventy-two hours of birth.  In 1984 Bastian reported microcystic encephalitis in rats one day 
after intracranial inoculation of GT48.  The same experimental group of rats had minimal 
pathological alterations at day twenty-five (Bastian et al., 1984).  Spiroplasma was still recovered 
in these tissues, but no pathology was associated in this experiment.  These results could suggest 
that there is a transition time for pathology in different species.  However, we tested goats at two 
months, four months, and two years and no pathology was detected at any time point.   
 
For spiroplasma experiments and prion research, bacteria/prion strain has played a role in 
susceptibility.  Mice strains also played a role in susceptibility.    Our neonatal experiments were 
conducted using animals from the same genetic pool.  One could argue that these strains have 
resistance to our organisms; however, Bastian’s experiments resulted in pathology and the 
current study did not.  Experiments using tissues from 2007 animals found no persistence of the 
organisms in brain tissues or production of antibodies at any time (data not published) which 
concurs with the present studies.   
 
Spiroplasma was recovered from one experimentally infected animal.  The results from 
experiment 1 (24 hour neonatal goat experiment) were used to determine the concentrations in 
certain areas for best options for organism recovery.  Although spiroplasma was recovered from 
these areas in this experiment, the organism may migrate to different areas over time.  In 
reported mice experiments, the maximal SMCA titer attained in the brain was at day fifteen post 
intracerebral inoculation.  SMCA was recovered from blood of mice eighteen days post 
inoculation.  No organisms were recovered after twenty-one days.  Research found that the titer 
was always higher in the brain compared to blood (Clark, 1969).  Titers peaked at day fifteen in 
brain tissues and subsequently decreased very slowly, with minimal titers of SMCA in mice 
sacrificed at after 800 days post inoculation (Clark and Karson, 1968).   In experiments using 
other inoculation routes, no persistence of the organism was noted.   One researcher has 
suggested that the failure to observe spiroplasma-like bodies in infected brains suggests that the 
site of localization of the infection has not yet been ascertained, or less likely but more 
intriguing, that the agent may be present in an unrecognizable form within the central nervous 
tissue (Clark, 1974). 
 
SMCA was able to avoid the immune system resulting in a lack of antibody production in 
experimental animals.  Immunoblots with three different SMCA antigen presentations were 
unable to detect any antibody from any time points in the experiments.  In his 1984 rat 
experiments, Bastian (Bastian et al., 1984) also found a lack of antibody production and 
suggested that the presence of spiroplasma in the tissues without inflammatory response could be 
indicative of a unique adaptation of the organism to the host.  This peculiar host adaptation may 
be related to the intracellular localization of the organisms.  Clark did find evidence of antibody 
production in his mice experiments in 1968.  Dams infected while pregnant did not transfer 
SMCA to their offspring (Clark and Karzon, 1968).  The mothers were, however, able to transfer 
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protective antibodies to their offspring, who never developed cataracts post- intracerebral 
inoculation.  Furthermore, following generations were able to pass protection to their offspring 
and prevent disease.  The same experiments were repeated and found to hold true with GT48 
(Clark and Karzon, 1968).   
 
Spiroplasma mirum has only been isolated naturally from the rabbit tick.  The true pathogenicity 
has been questioned since the organism has only experimentally induced disease either by 
inoculation into the yolk sac of seven day old chick embryos; intracerebral injection into 
newborn rats, mice or hamsters; or by inoculation into scarified cornea of adult rabbits (Bove, 
1997).  The fastidious nature of the organism makes primary isolation challenging and leaves 
researchers questioning other possible hosts.  In these experiments different inoculation routes 
were tested in order to prove a hematogenous transmission route.  No changes were seen within 
these experimental animals.  In 1987 Bastian induced cataracts, weight reduction, and alopecia in 
rats with GT48 inoculated intraperitoneal or subcutaneously.  The organism was recovered at 
low titers fifty days post inoculation.  The brains of rats evaluated at day fifty showed minimal 
neuronal vacuolization in the hippocampus region.  The peripheral route of inoculation failed to 
produce the moribund state and vacuolar encephalopathy shown when suckling rats were 
inoculated intracerebrally with spiroplasma (Bastian et al., 1987b).  These findings do not 
support a hematogenous transmission route which would be needed for transmission from a tick 
to an animal.   
 
Conclusion 
 
The results reported in this chapter establish that the inoculation of this laboratory’s S. mirum 
strain SMCA into neonatal goats did not mimic the clinical signs or pathology seen in 
transmissible spongiform encephalopathies.  SMCA did not cause spongiform encephalopathy 
when inoculated intracerebrally, intravenous, or intradermally into neonatal goats.  No 
pathology, clinical signs, or immune responses were noted over a two year time period; and the 
organism was not detected via PCR or culture from any experimentally inoculated animals.  
When inoculated into five month old white-tailed deer, SMCA did cause minimal clinical signs 
in one animal but did not cause spongiform encephalopathy after seven months.  Spiroplasma 
was recovered from the cortex of the clinically-affected deer after multiple passages in culture.   
 
Although the goat experiments in this chapter did not result in TSE-like disease, the 
methodology has been established for an animal model.  Further research should be conducted 
using similar methods in neonatal white-tailed deer to better compare CWD and deer 
spiroplasmosis.  Experiments using sheep may also allow for better comparisons to scrapie.   
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CONCLUSION 
 
There have been many contradicting reports in the literature involving the culturing of S. mirum, 
its resistance to disinfectants and antibiotics, and its role in Transmissible Spongiform 
Encephalopathy (TSE).  These discrepancies led to the interest in a possible connection between 
spiroplasma and TSEs and the development of the research in this document. Based on the 
results reported by Bastian et al. in 2007, it was hypothesized that Spiroplasma was associated 
with a neurodegenerative disease such as TSE.  In this work we further characterized S. mirum 
and continued to evaluate the possible correlations found in TSE infections.  In order to establish 
the best overall picture of S. mirum infections, we optimized culture conditions, determined a 
susceptibility profile for physical and environmental disinfectants and anitbiotics, and improved 
the methodology for creating an animal model for spiroplasmosis.   From this information, a 
better comparison may be made to the presumed infectious agent of TSEs, the prion.   
 
To optimize recovery of S. mirum from experimental infections, we established reproducible 
culture conditions in M1D media, embryonated eggs, and SP4 plates in chapter two.  Growth in 
M1D media at 30°C proved to be significantly better (p<0.05), yielding higher dark field counts 
than cultures at 37°C.  Dark field enumeration appears to be limited to a range of 1x10
5
 to 1x10
8 
organisms/mL and therefore an accurate growth curve could not be calculated using this method.  
PCR was used to check for growth daily and results were comparable to dark field counts.  Color 
changes were evident in all dilutions after 7 days, though the more diluted cultures were less 
obvious.  Embryonated egg results were comparable to that in the literature; however, the 
artificial media is better for experimental purposes.  The organism is difficult to detect after egg 
fatality by both dark field and PCR.  PCR results may be skewed due to inhibitory factors in the 
egg fluids.  Embryonated egg experiments support that the laboratory strains were not attenuated 
by multiple passages and still produce similar virulence in embryonated egg cultures as seen in 
literature.  A method for obtaining colony forming units was also determined for SMCA and 
GT48.  Following the ATCC SP4 recipe with the addition of Noble agar (1.6%), S. mirum 
produced consistent countable colonies on or near the surface of the agar. Those plates incubated 
at 37°C yielded higher growth counts and significantly better growth (p<0.05) than those at 
30°C.   
 
Because of the organism’s fastidious nature, tissue culture may be more appropriate for 
spiroplasma research.  Attempts have been made to cultivate S. mirum in a variety of 
mammalian, avian and tick cell cultures, but these were unsuccessful due to cytopathic effects 
and slow growth of the organism (Bastardo et al., 1974; Clark, 1964; Fabiyi et al., 1971; Yunker 
et al., 1987).  SMCA has also been found to permanently transform NIH 3T3 mouse embryo 
fibroblast cells (Bove, 1997; Kotani et al., 1986).  SMCA also transformed monkey kidney CV-1 
cells (Kotani et al., 1986).  Due to the formation of cataracts in suckling mice, Megraud et al. 
experimented with the affinity the organism showed for ocular tissues (Megraud et al., 1983).  
Even though some research has been promising, successful tissue cultures have yet to be 
established.  Although no tissue culture experiments were conducted in this body of work, the 
establishment of a tissue culture system may better elucidate the organism’s potential hosts and 
pathogenic nature.   
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Chapter three establishes a susceptibility profile for disinfectants and antibiotics and compares 
these results to known prion susceptibility.  Although Spiroplasma and prions may persist in 
murine neurologic tissues for a long period of time, the two do not share the same properties of 
resistance.  The three species of Spiroplasma tested were susceptible to minimal dilutions of 
common laboratory disinfectants.  They were also susceptible to many of the antibiotics in use 
for other mollicutes.  We did find strain differences in S. mirum in that GT48 was more resistant 
than SMCA to many of the disinfectants and antibiotics tested.  More research is needed to 
determine the factors it may possess in order to achieve this resistance. 
 
The animal experiment results reported in chapter four establishes that the inoculation of this 
laboratory’s S. mirum strain SMCA into neonatal goats did not mimic the clinical signs or 
pathology seen in TSEs.  SMCA did not cause spongiform encephalopathy when inoculated 
intracerebrally, intravenous, or intradermally into neonatal goats.  No pathology, clinical signs, 
or immune responses were noted over a two year time period; and the organism was not detected 
via PCR or culture from any experimentally inoculated animals.  When inoculated into five 
month old white-tailed deer, SMCA did cause minimal clinical signs in one animal but did not 
cause spongiform encephalopathy after seven months.  Spiroplasma was recovered from the 
cortex of the clinically-affected deer after multiple passages in culture.  The tissue was 
homogenized in M1D and the supernatant inoculated into four embryonated eggs.  Pooled 
allantoic samples were taken and inoculated into M1D media.  After two passages in M1D, one 
helical organism was noticed via dark field microscopy.  The culture was passaged into fresh 
M1D, but no growth was found after any passages (M1D or embryonated eggs).  
 
Tully suggested that pathogenicity is dependent on the S. mirum strain, the animal host, and the 
history of the inoculum (Tully et al., 1983). Loss of pathogenicity due to multiple passages could 
be an explanation for the contrasting results found in our experiments compared to those from 
2007 (Bastian et al., 2007); however, virulence was seen in embryonated egg experiments.  Clark 
found that SMCA pathology was dependent on dose, age, and host strain (Clark and Karson, 
1968).  This may account for the differences seen in deer experiments since our deer were five 
months old at time of inoculation.  Clark also found that the larger the dose and the younger the 
host the greater pathology produced (Clark and Karson, 1968).  This did not hold true in our 
neonatal goat experiments where we inoculated ten times the normal inoculum within seventy-
two hours of birth.  Although the goat experiments in this chapter did not result in TSE-like 
disease, the methodology has been established for an animal model.  Further research should be 
conducted using similar methods in neonatal white-tailed deer.  
 
Spiroplasma mirum’s growth at both 30oC and 37oC may suggest the possibility for two hosts.  
Research on S. citri has established its ability to survive in multiple hosts.  At least two 
mechanisms are utilized for sugar uptake by S. citri: the 
phosphoenolpyruvate:phosphotransferase system (PTS) and the SBP-ABC transporter system 
(Bai and Hogenhout, 2002; Gaurivaud et al., 2000b).  This could be characteristic of multiple-
host bacteria that need to rapidly adapt from a host or host-compartment that uses one sugar to a 
host or host-compartment that uses a different sugar (Bove et al., 2003).  As more spiroplasma 
genomes are completed, a better understanding of these organisms’ ability to utilize different 
substrates in their environment will be obtained, which may determine the different hosts the 
organisms may inhabit.  Spiroplasma citri’s use of the PTS system may also allow this organism 
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to create a biofilm (Bove et al., 2003).  The creation of a biofilm may affect the virulence of this 
organism and may be the reason Spiroplasma is so difficult to recover from tissues.  More 
research is needed to establish that Spiroplasmas create biofilms and what changes in resistance 
this could create.   
 
Other strains of spiroplasma may also have the potential to cause neurodegenerative disease.  
Spiroplasma melliferum has also been shown to persist in suckling mice post intracerebral 
inoculation.  Only one mouse exhibited CNS-like signs, and the organism was only isolated from 
one experimentally infected mouse after 284 days (not the clinical one).  Spiroplasma melliferum 
was isolated at day seventy at a rate of 10
7
 to 10
10
 CCU/ml in brain titers.  These titers were lost 
after repeated passages in suckling mice.   No neurological signs were observed, and histological 
changes were limited to discrete diffuse capillary congestion in brain sections.  There was no 
antibody response from the suckling mice to S. melliferum, as is the case for S. mirum (Chastel et 
al., 1991).  Leafhoppers infected with S. citri (Western-X disease) develop lesions, notably in the 
optic lobes and salivary glands (Nasu et al., 1970; Whitcomb et al., 1967).  Simultaneous 
involvement of the optic lobes and salivary glands in Western-X has similarity to the occurrence 
of either Sjorgren’s syndrome or mucosal inflammation with ocular manifestations in Multiple 
Sclerosis (MS) (Coyle and Bulbank, 1989; Sandberg-Wollheim et al., 1992).  Brown suggested 
that the infection of both plant phloem and insect axons suggests a predilection of the organism 
for components of electrochemical conduction (Brown, 2003).  Clinical correlations have been 
made with bee and wasp stings and the subsequent development of MS (Dionne et al., 2000).  
These reports attribute the disease to bee venom; but bees and wasps are known carriers of 
spiroplasmas, and Brown suggests that the inoculation of humans with S. citri by bee or wasp 
stings could be the mechanism causing MS (Brown, 2003).  Using the methodology for an 
animal model set forth in chapter four, further research with these spiroplasma strains may 
provide insight into their potential association with neurodegenerative diseases. 
 
Clark suggested that the SMCA system could provide a useful model for the study of intraocular 
infection (Clark, 1969).  Bastian has isolated Spiroplasma from ocular fluid taken aseptically 
from scrapie-infected sheep.  Minced corneal tissues were inoculated into M1D, and 
Spiroplasma organisms were evident via dark field microscopy.  These organisms did not 
propagate and the culture was lost after several passages (Bastian et al., 2011).  This has recently 
been repeated and efforts are ongoing to passage the spiroplasma to a substantial culture (data 
not published).  There has been evidence in the literature that mycoplasma-like organisms were 
isolated from the aqueous humors of eleven of nineteen human eyes with unexplained uveitis 
(Zeigel and Clark, 1974) and S. mirum may be a causative agent of uveitis in ruminants.  Its 
affinity for ocular tissue has been established, and more research is needed in unexplained uveitis 
cases in order to prove this association.        
 
Based on the experiments performed in this body of work, further research should be conducted 
with S. mirum.  The genomes of multiple strains of spiroplasma are presently being determined 
(Landry et al., 2010).  Optimal growth characteristics have been established, and research can 
now move into genetic manipulations to evaluate possible virulence factors for spiroplasma.  
With the organism’s affinity for neurologic and ocular tissues, spiroplasma could be genetically 
manipulated to be used as a potential therapeutic agent for infections affecting these tissues.   
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